2019冠状病毒病疫苗 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "2019冠状病毒病疫苗" in Chinese language version.

refsWebsite

Global rank Chinese rank

561web.archive.org

1^st place

72reuters.com

49^th place

81^st place

68clinicaltrials.gov

5,225^th place

4,888^th place

34doi.org

2^nd place

23^rd place

32nih.gov

4^th place

5^th place

30worldcat.org

5^th place

12^th place

23nytimes.com

7^th place

31^st place

17sina.com.cn

144^th place

3^rd place

15xinhuanet.com

309^th place

19^th place

13dw.com

204^th place

124^th place

13freezepage.com

5,120^th place

545^th place

12bbc.com

20^th place

41^st place

11cna.com.tw

527^th place

24^th place

9huanqiu.com

2,206^th place

65^th place

8rfi.fr

559^th place

76^th place

8udn.com

392^nd place

10^th place

8rthk.hk

2,797^th place

109^th place

8wsj.com

79^th place

143^rd place

8yahoo.com

38^th place

9^th place

7elsevier.com

610^th place

388^th place

7statnews.com

8,771^st place

9,752^nd place

7chinanews.com

1,432^nd place

50^th place

7rdif.ru

low place

7who.int

195^th place

179^th place

5theguardian.com

12^th place

60^th place

5un.org

97^th place

122^nd place

5go.com

48^th place

146^th place

4hk01.com

379^th place

11^th place

4modernatx.com

low place

4cnn.com

28^th place

71^st place

4zaobao.com.sg

2,796^th place

104^th place

4thepaper.cn

1,497^th place

54^th place

4sohu.com

343^rd place

13^th place

4sld.cu

5,873^rd place

low place

4thelancet.com

2,393^rd place

1,199^th place

4irct.ir

low place

4cctv.com

2,386^th place

101^st place

4qq.com

381^st place

15^th place

3europa.eu

68^th place

209^th place

3nature.com

234^th place

227^th place

3marketwatch.com

1,303^rd place

1,372^nd place

3nejm.org

2,374^th place

1,457^th place

3apnews.com

129^th place

436^th place

3guancha.cn

4,433^rd place

170^th place

3zaobao.com

5,400^th place

195^th place

3ettoday.net

371^st place

7^th place

3ecns.cn

low place

3hindustantimes.com

71^st place

1,063^rd place

3medrxiv.org

low place

3cnbc.com

220^th place

426^th place

3yicai.com

low place

482^nd place

3on.cc

495^th place

21^st place

3news.cn

1,956^th place

86^th place

3sciencemag.org

857^th place

506^th place

2swissmedic.ch

low place

2semanticscholar.org

11^th place

332^nd place

2oup.com

485^th place

489^th place

2trust.org

9,070^th place

9,930^th place

2fda.gov

447^th place

581^st place

2bloomberg.com

99^th place

225^th place

2bharatbiotech.com

low place

2inform.kz

4,199^th place

2,502^nd place

2aa.com.tr

754^th place

2,412^th place

2businessinsider.com

140^th place

399^th place

2khmertimeskh.com

5,543^rd place

8,179^th place

2rappler.com

874^th place

4,417^th place

2chictr.org.cn

low place

2arabnews.com

1,365^th place

3,762^nd place

2france24.com

481^st place

798^th place

2thestar.com.my

574^th place

461^st place

2irna.ir

643^rd place

low place

2trackvaccines.org

low place

2tass.com

1,763^rd place

1,901^st place

2pfizer.com

low place

7,863^rd place

2medicalxpress.com

8,255^th place

low place

2novavax.com

low place

2ctri.nic.in

low place

2anzctr.org.au

low place

2astrazeneca.com

low place

2minsal.cl

low place

2nhc.gov.cn

low place

2,074^th place

2rfa.org

1,893^rd place

94^th place

2takungpao.com

5,624^th place

219^th place

2gov.mo

low place

677^th place

2ltn.com.tw

302^nd place

6^th place

2twse.com.tw

low place

2,435^th place

2kankanews.com

low place

1,244^th place

2xmnn.cn

low place

1,840^th place

2fx168.com

low place

8,191^st place

2xhby.net

low place

739^th place

2cnstock.com

low place

1,045^th place

2hkej.com

8,654^th place

328^th place

1biomedcentral.com

2,747^th place

1,988^th place

1bworldonline.com

5,578^th place

low place

1britannica.com

40^th place

100^th place

1harvard.edu

18^th place

57^th place

1cbsnews.com

108^th place

449^th place

1sciencedirect.com

149^th place

292^nd place

1tandfonline.com

507^th place

610^th place

1futuremedicine.com

low place

1nhs.uk

1,989^th place

2,409^th place

1springer.com

274^th place

320^th place

1frontiersin.org

4,679^th place

2,220^th place

1shinyapps.io

low place

1buzzfeednews.com

1,368^th place

4,144^th place

1ourworldindata.org

2,263^rd place

5,757^th place

1bmj.com

1,226^th place

890^th place

1clinicaltrialsarena.com

low place

1cnet.com

272^nd place

459^th place

1cepi.net

low place

1dwnews.com

4,516^th place

180^th place

1gov.cn

1,676^th place

62^nd place

1zytzb.gov.cn

low place

4,270^th place

1taihainet.com

low place

1,635^th place

1ahyouth.com

low place

1letemps.ch

1,980^th place

low place

1rti.org.tw

5,831^st place

230^th place

1swissinfo.ch

1,485^th place

1,674^th place

1jnj.com.cn

low place

1washingtonpost.com

34^th place

129^th place

1246.250

low place

1cnyes.com

low place

371^st place

1bjnews.com.cn

1,192^nd place

44^th place

1caixin.com

7,276^th place

307^th place

1aastocks.com

low place

2,162^nd place

1sinovac.com

low place

1twitter.com

23^rd place

34^th place

1astanatimes.com

8,381^st place

9,590^th place

1bioworld.com

low place

1cri.cn

2,251^st place

164^th place

1kpwashingtonresearch.org

low place

1zj.gov.cn

low place

1,732^nd place

1ssrn.com

703^rd place

1,016^th place

1uol.com.br

74^th place

1,700^th place

1dailytimes.com.pk

1,625^th place

3,690^th place

1kathmandupost.com

3,868^th place

low place

1dhakatribune.com

2,157^th place

low place

1businesstimes.com.sg

9,172^nd place

8,607^th place

1statista.com

776^th place

1,302^nd place

1info.gov.hk

2,665^th place

114^th place

1jamanetwork.com

2,650^th place

1,976^th place

1theglobalherald.com

low place

1republicworld.com

low place

4,863^rd place

1newstracklive.com

low place

1naharnet.com

low place

1colombogazette.com

low place

1nationalpost.com

818^th place

1,332^nd place

1statehouse.gov.sc

low place

1exmoo.com

low place

707^th place

1lexpress.mu

low place

1novastan.org

low place

1rferl.org

737^th place

997^th place

1globaltimes.cn

low place

1,577^th place

1brecorder.com

4,490^th place

low place

1indiatoday.in

94^th place

1,782^nd place

1gov.vc

low place

1eurasianet.org

3,649^th place

4,238^th place

1telesurenglish.net

low place

1cecmed.cu

low place

1trend.az

4,569^th place

9,681^st place

1cnnphilippines.com

2,993^rd place

8,965^th place

1medigenvac.com

low place

1focustaiwan.tw

3,164^th place

1,453^rd place

1politico.eu

1,347^th place

2,260^th place

1e-cspc.com

low place

1cfi.cn

low place

1newssc.org

low place

1,763^rd place

1jrj.com.cn

low place

824^th place

1nseindia.com

9,492^nd place

low place

1taiwannews.com.tw

3,205^th place

560^th place

1clinicaltrialsregister.eu

low place

1curevac.com

low place

1aca.kp

low place

1imperial.ac.uk

7,025^th place

4,775^th place

1altimmune.com

low place

1moneydj.com

low place

1,669^th place

1bio.org

low place

1youtube.com

9^th place

2^nd place

1chinadaily.com.cn

831^st place

134^th place

1chinatimes.com

440^th place

14^th place

1covidvaccine.gov.hk

low place

1kyodonews.net

4,267^th place

2,052^nd place

1upmedia.mg

3,392^nd place

112^th place

1sse.com.cn

low place

1,804^th place

1technews.tw

low place

454^th place

1fda.gov.tw

low place

1,125^th place

1storm.mg

2,424^th place

75^th place

1nbcnews.com

137^th place

538^th place

1aljazeera.com

268^th place

470^th place

1cincainews.com

low place

1,806^th place

1thehill.com

476^th place

1,277^th place

1ftvnews.com.tw

6,057^th place

213^th place

18world.com

low place

711^th place

1swarajyamag.com

low place

1wikipedia.org

low place

1singtao.ca

6,710^th place

249^th place

1ndtv.com

138^th place

1,399^th place

1indianexpress.com

60^th place

1,119^th place

1firstpost.com

283^rd place

2,869^th place

1vietnamplus.vn

5,113^th place

883^rd place

1chinaqw.com

low place

1,427^th place

1nbd.com.cn

low place

390^th place

1people.com.cn

351^st place

20^th place

1chinanews.com.cn

2,979^th place

106^th place

1pts.org.tw

4,825^th place

167^th place

1chinacourt.org

low place

1,121^st place

1medicalnewstoday.com

3,011^th place

3,493^rd place

1thejournal.ie

2,703^rd place

8,910^th place

1nasdaq.com

2,740^th place

1,760^th place

1am730.com.hk

3,427^th place

119^th place

1asiaone.com

2,155^th place

1,370^th place

1aifa.gov.it

low place

1ifeng.com

542^nd place

27^th place

1voachinese.com

2,382^nd place

72^nd place

1bostonglobe.com

553^rd place

1,930^th place

1precisionvaccinations.com

low place

1news-medical.net

8,069^th place

8,814^th place

1medpagetoday.com

9,274^th place

low place

1mingpao.com

876^th place

33^rd place

1stheadline.com

1,660^th place

56^th place

1politifact.com

3,208^th place

7,644^th place

1factcheck.org

7,075^th place

low place

1thestandnews.com

4,504^th place

168^th place

1881903.com

low place

409^th place

1ft.com

210^th place

353^rd place

1uschamber.com

low place

246.250 (Global: low place; Chinese: low place)

202.100.246.250

全球首款吸入式新冠疫苗亮相海南. ^{[失效連結]}

881903.com (Global: low place; Chinese: 409^th place)

世貿總幹事：期望年底達成解決方案. 商業電台. [2021-05-16]. （原始内容存档于2021-05-16）.

8world.com (Global: low place; Chinese: 711^th place)

法国病例每周以两位数百分比增长当局不排除再次封城. [2021-11-22]. （原始内容存档于2021-11-22）.

aa.com.tr (Global: 754^th place; Chinese: 2,412^th place)

Kazakhstan starts using indigenous COVID-19 vaccine. Meiramgul Kussainova. Anadolu Agency. 2021-04-26 [2021-07-09]. （原始内容存档于2021-05-10）.
Aliyev, Jeyhun. Azerbaijan kicks off COVID-19 vaccination. Anadolu Agency. [2021-02-07]. （原始内容存档于2021-02-06）.

aastocks.com (Global: low place; Chinese: 2,162^nd place)

中國生物製藥回應科興新冠疫苗停產：還有4億存貨已獲分紅近60億. 阿斯達克. 2024-01-15.

aca.kp (Global: low place; Chinese: low place)

mirae.aca.kp

신형코로나비루스후보왁찐을 새로 개발. 朝鮮國家科學技術委員會. 2020-07-18 [2021-05-03]. （原始内容存档于2021-05-03）.

ahyouth.com (Global: low place; Chinese: low place)

芜湖开展冬春季新冠疫苗摸底官方：接种时间未定 -安青网. www.ahyouth.com. [2021-04-06]. （原始内容存档于2020-12-09）.

aifa.gov.it (Global: low place; Chinese: low place)

AIFA imposes ban of use of AstraZeneca batch. Investigations in progress in coordination with EMA. 意大利药品管理局. [2021-03-11]. （原始内容存档于2021-03-11）（意大利语）.

aljazeera.com (Global: 268^th place; Chinese: 470^th place)

US vaccine roll-out falls short of 20 million jabs by end of 2020. Al Jazeera. 2020-12-31 [2021-01-05]. （原始内容存档于2021-01-24）.

altimmune.com (Global: low place; Chinese: low place)

ir.altimmune.com

Altimmune Announces Update On AdCOVID™ Phase 1 Clinical Trial. Altimmune. 2021-06-29 [2021-07-03]. （原始内容存档于2021-07-20）.

am730.com.hk (Global: 3,427^th place; Chinese: 119^th place)

科興接種須知更新　政府列「貝爾面癱」為副作用. AM730. 2021-07-15 [2021-07-21]. （原始内容存档于2021-07-21）.

anzctr.org.au (Global: low place; Chinese: low place)

Trial registered on ANZCTR. 澳大利亚-新西兰临床试验注册中心. 2020-09-08 [2020-09-25]. （原始内容存档于2021-10-06）.
An interventional study to evaluate the safety and immune response of a vaccine against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2, the virus that causes COVID-19 infection) when given to healthy adult participants.. 澳大利亚-新西兰临床试验注册中心. 2020-07-24 [2020-11-10]. （原始内容存档于2020-12-09）.

apnews.com (Global: 129^th place; Chinese: 436^th place)

WHO authorizes AstraZeneca's COVID vaccine for emergency use. [2021-02-15]. （原始内容存档于2021-02-23）.
Huizhong Wu. China approves two more COVID-19 vaccines for wider use. 美联社. 2020-02-25 [2021-03-16]. （原始内容存档于2021-05-16）.
Susan Fraser. Turkey approves China-based Sinovac vaccine’s emergency use. 美联社. 2021-01-13 [2021-01-13]. （原始内容存档于2021-01-24）.

arabnews.com (Global: 1,365^th place; Chinese: 3,762^nd place)

Muhammad Abu Zaid. Egypt approves Chinese Sinopharm COVID-19 vaccine. Arab News. 2021-01-03 [2021-01-04]. （原始内容存档于2021-01-19）.
Iraq grants emergency approval for Pfizer COVID-19 vaccine. Arab News. 2020-12-27 [2021-01-20]. （原始内容存档于2021-12-22）.

asiaone.com (Global: 2,155^th place; Chinese: 1,370^th place)

Higher risk of Bell's palsy after Sinovac's Covid-19 vaccine: Study. AsiaOne. 2021-08-17 [2021-08-30]. （原始内容存档于2021-08-17）（英语）.

astanatimes.com (Global: 8,381^st place; Chinese: 9,590^th place)

Assel Satubaldina. Human Trials for Kazakh COVID-19 Vaccine to Start in September. Astana Times. 2020-08-06 [2021-07-09]. （原始内容存档于2021-05-25）.

astrazeneca.com (Global: low place; Chinese: low place)

COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India. 阿斯利康. [2020-10-11]. （原始内容存档于2020-12-19）.
AZD1222 US Phase III primary analysis confirms safety and efficacy. www.astrazeneca.com. [2021-04-06]. （原始内容存档于2021-06-03）（英语）.

bbc.com (Global: 20^th place; Chinese: 41^st place)

新冠疫苗：英国率先批准辉瑞疫苗大规模使用，高危人群几天内开始接种. [2020-12-02]. （原始内容存档于2020-12-24）.
英國正式開啟疫苗接種「值得紀念但挑戰巨大」. BBC. 2020-12-09 [2021-03-16]. （原始内容存档于2021-01-02）.
Covax捐贈計劃首批物資運抵加納. BBC. 2021-02-25 [2021-03-16].
Coronavirus: South Africa rolls out vaccination programme. 2021-02-17 [2021-02-19]. （原始内容存档于2021-02-22） –通过www.bbc.com.
新冠疫情：美国批准第二种疫苗莫德纳　彭斯夫妇接种疫苗. [2020-12-19]. （原始内容存档于2020-12-19）.
英国批准辉瑞疫苗上市后美国疫苗注射进入倒计时. [2020-12-06]. （原始内容存档于2020-12-15）.
新冠疫苗：欧美欢呼两款产品现曙光，中国品牌出海面临审视. [2020-12-07]. （原始内容存档于2020-12-18）.
新冠疫苗缺口巨大，欧盟愤怒要求阿斯利康英国工厂提高供应. [2021-01-30]. （原始内容存档于2021-02-03）.
新冠疫苗：世卫组织批评欧盟疫苗出口管制计划. [2021-01-30]. （原始内容存档于2021-01-30）.
米歇爾·羅伯茲. 肺炎疫情：美國志願者進行首次冠狀病毒疫苗人體試驗. 英國廣播公司. 2020-03-18.
疫苗全球速报：以色列有民众接种首剂疫苗后确诊香港未放弃采购科兴疫苗. [2021-01-23]. （原始内容存档于2021-01-23）.
拜登稱支持新冠疫苗知識產權豁免，世衛稱是抗疫的"不朽時刻". BBC. 2021-05-06 [2021-05-08]. （原始内容存档于2021-05-08）.

bharatbiotech.com (Global: low place; Chinese: low place)

Bharat Biotech Announces Phase 3 Results of COVAXIN®: India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81% (PDF). 巴拉特生技. 2021-03-03 [2021-03-16]. （原始内容存档 (PDF)于2021-05-29）.
Bharat Biotech and ICMR Announce Interim Results from Phase 3 trials of COVAXIN®; Demonstrates overall Interim Clinical Efficacy of 78% and 100% efficacy against Severe COVID-19 disease (PDF). Bharat Biotech. 2021-04-21 [2021-05-08]. （原始内容存档 (PDF)于2021-04-21）.

bio.org (Global: low place; Chinese: low place)

Clinical Development Success Rates 2006-2015 (PDF). BIO Industry Analysis. June 2016 [2020-03-27]. （原始内容存档 (PDF)于2019-09-12）.

biomedcentral.com (Global: 2,747^th place; Chinese: 1,988^th place)

jbiomedsci.biomedcentral.com

Li, Yen-Der; Chi, Wei-Yu; Su, Jun-Han; Ferrall, Louise; Hung, Chien-Fu; Wu, T.-C. Coronavirus vaccine development: from SARS and MERS to COVID-19. Journal of Biomedical Science. 2020-12, 27 (1): 104 [2024-08-14]. ISSN 1423-0127. PMC 7749790 . PMID 33341119. doi:10.1186/s12929-020-00695-2. （原始内容存档于2021-02-19）（英语）.

bioworld.com (Global: low place; Chinese: low place)

Elise Mak. China approves first homegrown COVID-19 vaccine to enter clinical trials. BioWorld. 2020-03-18 [2020-03-24]. （原始内容存档于2020-03-28）.

bjnews.com.cn (Global: 1,192^nd place; Chinese: 44^th place)

王卡拉. 康希诺吸入用新冠疫苗被纳入加强针紧急使用，无创接种疫苗受关注. 新京报. 2022-09-05 [2022-09-06].

bloomberg.com (Global: 99^th place; Chinese: 225^th place)

Jinshan Hong. China’s Covid Shot Has Four Wildly Different Efficacy Rates. 彭博新闻社. 2021-01-12 [2021-02-27]. （原始内容存档于2021-02-19）.
Bangladesh Approves Sinovac Vaccine for Emergency Use. [2021-06-06]. （原始内容存档于2021-06-06）.

bmj.com (Global: 1,226^th place; Chinese: 890^th place)

So, Anthony D; Woo, Joshua. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. 2020-12-15: m4750 [2021-02-21]. ISSN 1756-1833. PMC 7735431 . PMID 33323376. doi:10.1136/bmj.m4750. （原始内容存档于2020-12-16）（英语）.

bostonglobe.com (Global: 553^rd place; Chinese: 1,930^th place)

Health officials lift pause on Johnson & Johnson vaccine following panel recommendation. The Associated Press. 2021-04-23 [2021-04-24]. （原始内容存档于2021-05-05）.

brecorder.com (Global: 4,490^th place; Chinese: low place)

Desk, BR Web. China's CanSinoBIO COVID-19 vaccine approved for emergency use in Pakistan. Brecorder. 2021-02-12 [2021-04-06] （英语）.

britannica.com (Global: 40^th place; Chinese: 100^th place)

Rogers K. COVID-19 vaccine. Encyclopædia Britannica. 11 May 2022 [12 June 2022]. （原始内容存档于12 June 2022）.

businessinsider.com (Global: 140^th place; Chinese: 399^th place)

Andrew Dunn. The first study of a potential coronavirus vaccine will soon start recruiting healthy volunteers in Georgia at Emory University. Business Insider. 2020-03-24 [2020-03-24]. （原始内容存档于2020-03-25）.
Taiwan grants emergency AstraZeneca COVID-19 vaccine authorization and orders 10 million doses. [2021-02-20]. （原始内容存档于2021-02-24）.

businesstimes.com.sg (Global: 9,172^nd place; Chinese: 8,607^th place)

Unvaccinated barred from workplaces from Jan 1, 2022; Singapore approves Sinovac use. [2021-10-23]. （原始内容存档于2021-10-23）.

buzzfeednews.com (Global: 1,368^th place; Chinese: 4,144^th place)

Dan Vergano. COVID-19 Vaccines Work Way Better Than We Had Ever Expected. Scientists Are Still Figuring Out Why.. BuzzFeed News. 2021-06-05 [2021-08-12]. （原始内容存档于2021-10-06）.

bworldonline.com (Global: 5,578^th place; Chinese: low place)

Padilla TB. No one is safe unless everyone is safe. BusinessWorld. 24 February 2021 [24 February 2021]. （原始内容存档于23 February 2021）.

caixin.com (Global: 7,276^th place; Chinese: 307^th place)

美加英相继批准新冠二价疫苗日本新冠感染下降｜大流行手记（9月3日）. [2022-09-07]. （原始内容存档于2022-09-24）.

cbsnews.com (Global: 108^th place; Chinese: 449^th place)

COVID-19 vaccines saved nearly 20 million lives in a year, study says. CBS News. 24 June 2022 [27 June 2022]. （原始内容存档于29 June 2022）.

cctv.com (Global: 2,386^th place; Chinese: 101^st place)

news.cctv.com

张玉玲. 阿塞拜疆开始大规模接种中国产新冠疫苗. news.cctv.com. [2021-04-06].
《老铁加油！巴基斯坦全国范围内中国疫苗接种工作启动》. 央视网. [2021-02-04].
《匈牙利批准中国疫苗紧急使用授权匈总理：我对中国疫苗最为信任》. 央视网. [2021-01-30]. （原始内容存档于2021-08-18）.

m.news.cctv.com

中国康希诺新冠疫苗在智利获紧急使用许可. [2021-09-07]. （原始内容存档于2021-09-07）.

cecmed.cu (Global: low place; Chinese: low place)

Aprueba el CECMED el Autorizo de Uso de Emergencia del candidato vacunal cubano ABDALA. CECMED. 2021-07-09 [2021-07-09]. （原始内容存档于2021-07-17）.

cepi.net (Global: low place; Chinese: low place)

CEPI welcomes UK Government's funding and highlights need for $2 billion to develop a vaccine against COVID-19. Coalition for Epidemic Preparedness Innovations, Oslo, Norway. 2020-03-06 [2020-03-23]. （原始内容存档于2020-03-22）.

cfi.cn (Global: low place; Chinese: low place)

石药集团(01093):自愿公告 - 新型冠状病毒MRNA疫苗 (SYS6006) 在中国纳入紧急使用. 2023-03-22 [2023-04-14]. （原始内容存档于2023-04-14）.

chictr.org.cn (Global: low place; Chinese: low place)

新型冠状病毒肺炎(COVID-19)灭活疫苗（Vero细胞）III期临床试验. 中国临床试验注册中心. 2020-11-28 [2020-12-11]. （原始内容存档于2021-01-11）.
鼻喷流感病毒载体新冠肺炎(COVID-19)疫苗（DelNS1-2019-nCoV-RBD- OPT1）II期临床试验. 中国临床试验注册中心. 2020-11-06 [2020-11-14]. （原始内容存档于2020-11-19）.

chinacourt.org (Global: low place; Chinese: 1,121^st place)

智利批准科兴新冠疫苗在3至6岁人群中紧急使用. [2021-11-26]. （原始内容存档于2021-11-26）.

chinadaily.com.cn (Global: 831^st place; Chinese: 134^th place)

language.chinadaily.com.cn

陈丹妮. 警惕！完成疫苗接种者依然会传播新冠病毒. language.chinadaily.com.cn. [2021-12-04]. （原始内容存档于2021-12-04）.

chinanews.com (Global: 1,432^nd place; Chinese: 50^th place)

日本通过《预防接种法》民众可免费接种新冠疫苗. [2020-12-02]. （原始内容存档于2020-12-08）.
国家卫健委官员：下一步考虑适度扩大新冠疫苗紧急使用的范围-中新网. www.chinanews.com. [2021-04-25]. （原始内容存档于2021-04-25）.
日本正式启动新冠疫苗接种-中新网. www.chinanews.com. [2021-04-06].
以色列近半人口已接种疫苗商场等场所重新开放. [2021-02-22]. （原始内容存档于2021-02-23）.
法国逾8万人本周接种新冠疫苗民众接种疫苗意愿上升. 中新网. 2021-01-09 [2021-04-06]. （原始内容存档于2021-01-09）.
意大利疫苗接种率接近80% 伦巴第大区率先完成目标. [2021-10-10]. （原始内容存档于2021-09-16）.
中国新冠疫苗在巴西获紧急使用许可. 中新网. [2021-01-18]. （原始内容存档于2021-01-18）.

chinanews.com.cn (Global: 2,979^th place; Chinese: 106^th place)

西班牙80岁以上高龄人群将接种第四剂加强针. [2022-07-27]. （原始内容存档于2022-07-28）.

chinaqw.com (Global: low place; Chinese: 1,427^th place)

华媒：希腊新冠疫苗接种即将开始，如何预约？. 中国侨网. 2020-12-14 [2021-04-06]. （原始内容存档于2020-12-14）.

chinatimes.com (Global: 440^th place; Chinese: 14^th place)

、香港今日正式啟動新冠疫苗接種 - 兩岸. 中時新聞網. [2021-04-06]. （原始内容存档于2021-02-26）（中文（臺灣））.

cincainews.com (Global: low place; Chinese: 1,806^th place)

综合报导, 2020年 12月 05日星期六 05:37 下午 Myt. 全球第一国！俄罗斯今起大规模施打新冠疫苗. 精彩大马. [2021-04-06] （中文）.

clinicaltrials.gov (Global: 5,225^th place; Chinese: 4,888^th place)

A Phase I Clinical Trial in 18-60 Adults - Full Text View - ClinicalTrials.gov. clinicaltrials.gov. US National Library of Medicine, National Institutes of Health. [2020-03-25]. （原始内容存档于2020-03-24）（英语）.
A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19. ClinicalTrials.gov, US National Library of Medicine. 2020-11-30 [2021-03-06]. （原始内容存档于2021-04-30）.
Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV). ClinicalTrials.gov, US National Library of Medicine. 2020-07-02 [2021-03-07]. （原始内容存档于2020-10-20）.
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine (COVID-19). ClinicalTrials.gov, US National Library of Medicine. 2020-08-11 [2021-03-07]. （原始内容存档于2020-10-20）.
Clinical Trial For SARS-CoV-2 Vaccine (COVID-19). ClinicalTrials.gov, US National Library of Medicine. 2020-10-09 [2021-03-07]. （原始内容存档于2020-10-20）.
Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults. ClinicalTrials.gov, US National Library of Medicine. 2020-11-05 [2021-03-07]. （原始内容存档于2020-11-12）.
Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults (CoronaVac3CL). ClinicalTrials.gov, US National Library of Medicine. 2020-12-03 [2021-03-07]. （原始内容存档于2021-05-01）.
A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above (COVID-19). ClinicalTrials.gov. 2020-10-30 [2020-12-21]. （原始内容存档于2020-09-14）.
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Adult Population In Peru (Cov-Peru). ClinicalTrials.gov. 2020-11-03 [2020-12-21]. （原始内容存档于2021-01-14）.
Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19). ClinicalTrials.gov. 美国临床试验注册中心. 2020-09-23 [2020-09-30]. （原始内容存档于2021-10-09）.
An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers. ClinicalTrials.gov, US National Library of Medicine. 2020-11-23 [2021-03-06]. （原始内容存档于2020-11-26）.
Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine. ClinicalTrials.gov. [2021-01-06]. （原始内容存档于2021-01-14）.
A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19). ClinicalTrials.gov. [2021-05-18]. （原始内容存档于2021-05-03）.
The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19. ClinicalTrials.gov, US National Library of Medicine. 2020-12-09 [2021-01-12]. （原始内容存档于2021-01-21）.
Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above. ClinicalTrials.gov. 2021-01-08 [2021-01-21]. （原始内容存档于2020-09-18）.
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 (RESIST). ClinicalTrials.gov. 2020-08-28 [2020-09-17]. （原始内容存档于2020-09-12）.
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus. ClinicalTrials.gov. 2020-10-01 [2020-10-26]. （原始内容存档于2020-11-29）.
Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela (VENEZUELA). ClinicalTrials.gov. [2021-01-19]. （原始内容存档于2021-01-17）.
A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE (SPUTNIK-UAE). ClinicalTrials.gov, US National Library of Medicine. 2020-12-07 [2021-03-07]. （原始内容存档于2021-04-11）.
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults. ClinicalTrials.gov. 2021-01-12 [2021-01-21]. （原始内容存档于2020-08-23）.
A Study of a Candidate COVID-19 Vaccine (COV003). ClinicalTrials.gov, US National Library of Medicine. 2020-09-02 [2021-03-08]. （原始内容存档于2021-05-26）.
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants (ENSEMBLE). ClinicalTrials.gov, US National Library of Medicine. 2020-08-10 [2020-09-24]. （原始内容存档于2021-10-24）.
Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light (SPUTNIK-LIGHT). ClinicalTrials.gov. [2021-05-08]. （原始内容存档于2021-05-08）.
Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19. ClinicalTrials.gov, US National Library of Medicine. 2021-03-03 [2021-03-06]. （原始内容存档于2021-04-24）.
A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19. ClinicalTrials.gov. 美国临床试验注册中心. 2020-09-28 [2020-10-02]. （原始内容存档于2020-07-29）.
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals. ClinicalTrials.gov, US National Library of Medicine. 2020-04-30 [2021-03-06]. （原始内容存档于2020-10-11）.
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults. ClinicalTrials.gov. United States National Library of Medicine. 2021-10-06 [2021-12-09]. （原始内容存档于2021-01-21）.
A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2. ClinicalTrials.gov, US National Library of Medicine. 2020-11-02 [2021-03-27]. （原始内容存档于2021-05-10）.
A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom. ClinicalTrials.gov, US National Library of Medicine. 2020-10-12 [2021-03-27]. （原始内容存档于2021-05-25）.
Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine (COV-COMPARE). ClinicalTrials.gov, US National Library of Medicine. [2021-05-14]. （原始内容存档于2021-05-20）.
A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above. ClinicalTrials.gov, US National Library of Medicine. [2021-06-01]. （原始内容存档于2021-04-23）.
Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine. ClinicalTrials.gov. United States National Library of Medicine. [2021-06-29]. （原始内容存档于2021-07-09）.
Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older (VAT00008). ClinicalTrials.gov, US National Library of Medicine. [2021-05-29]. （原始内容存档于2021-06-02）.
A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells). ClinicalTrials.gov, US National Library of Medicine. [2021-06-01]. （原始内容存档于2021-06-03）.
Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19. ClinicalTrials.gov. [2021-06-14]. （原始内容存档于2021-06-12）.
A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers. ClinicalTrials.gov. 2021-02-26 [2021-03-20]. NCT04773067. （原始内容存档于2021-05-21）.
A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine. ClinicalTrials.gov. 2020-12-24 [2021-03-20]. NCT04683224. （原始内容存档于2021-05-06）.
Study of GRAd-COV2 for the Prevention of COVID-19 in Adults (COVITAR). ClinicalTrials.gov. 2020-03-10 [2021-03-12]. （原始内容存档于2021-04-30）.
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19 (SCB-2019). ClinicalTrials.gov. United States National Library of Medicine. 2021-01-08 [2021-01-09]. （原始内容存档于2021-01-11）.
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults. 美国临床试验注册中心. 2020-11-19 [2020-11-28]. （原始内容存档于2021-01-23）.
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure. 美国临床试验注册中心. 2020-11-24 [2020-11-28]. （原始内容存档于2021-01-18）.
Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19). ClinicalTrials.gov. 2020-12-07 [2021-01-06]. （原始内容存档于2021-01-21）.
SARS-CoV-2 Vaccine (COH04S1) Versus Emergency Use Authorization SARS-COV-2 Vaccine for the Treatment of COVID-19 in Patients With Blood Cancer. ClinicalTrials.gov. United States National Library of Medicine. [2021-08-03]. （原始内容存档于2021-10-06）.
Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells). ClinicalTrials.gov. United States National Library of Medicine. 2021-03-24 [2021-03-25]. （原始内容存档于2021-05-06）.
Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell). ClinicalTrials.gov, US National Library of Medicine. [2021-08-09]. （原始内容存档于2021-10-06）.
Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine (COVID-19). ClinicalTrials.gov, US National Library of Medicine. [2021-07-15]. （原始内容存档于2021-07-20）.
A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults. ClinicalTrials.gov, US National Library of Medicine. 2020-12-16 [2021-01-07]. （原始内容存档于2021-01-13）.
Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine. ClinicalTrials.gov, US National Library of Medicine. 2020-11-03 [2020-11-09]. （原始内容存档于2020-12-07）.
KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers. ClinicalTrials.gov. 2021-01-11 [2021-01-12]. （原始内容存档于2020-10-02）.
A Clinical Trial of COVAC Vaccines in Healthy Adults. ClinicalTrials.gov. 2021-01-29 [2021-02-19]. （原始内容存档于2021-02-12）.
Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19). ClinicalTrials.gov. 2021-02-08 [2021-05-11]. （原始内容存档于2021-05-24）.
Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19). ClinicalTrials.gov. [2021-05-12]. （原始内容存档于2021-05-24）.
B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency (B-pVAC). ClinicalTrials.gov. United States National Library of Medicine. [2021-07-16]. （原始内容存档于2021-07-19）.
Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults. ClinicalTrials.gov. 2021-01-20 [2021-01-21]. （原始内容存档于2021-05-03）.
GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19). ClinicalTrials.gov. 2020-12-24 [2021-02-11]. （原始内容存档于2021-02-07）.
Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19. 美国临床试验注册中心. 2020-11-06 [2020-12-06]. （原始内容存档于2021-01-22）.
Study of the Safety of Prophylactic Vaccination With 2nd Generation E1/E2B/E3-Deleted Adenoviral-COVID-19 in Normal Healthy Volunteers. 美国临床试验注册中心. 2020-10-22 [2020-11-10]. （原始内容存档于2020-11-11）.
Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults. ClinicalTrials.gov (Registry). United States National Library of Medicine. 2020-09-24 [2020-09-25]. NCT04563702. （原始内容存档于2021-12-23）.
Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19. ClinicalTrials.gov. United States National Library of Medicine. 2020-09-29 [2020-09-30]. （原始内容存档于2021-11-21）.
A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine. ClinicalTrials.gov. United States National Library of Medicine. 2020-09-24 [2020-12-17]. （原始内容存档于2021-10-09）.
Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19). ClinicalTrials.gov. 2021-02-18 [2021-05-11]. （原始内容存档于2021-05-25）.
Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19. 美国临床试验注册中心. 2020-10-27 [2020-11-09]. （原始内容存档于2021-01-02）.
CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) (CORVax12). 美国临床试验注册中心. 2020-11-13 [2020-12-06]. （原始内容存档于2021-01-21）.
A Clinical Trial of a Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults. ClinicalTrials.gov. 2020-11-24 [2021-01-03]. （原始内容存档于2021-01-22）.
ChulaCov19 mRNA Vaccine in Healthy Adults. ClinicalTrials.gov. United States National Library of Medicine. 2020-10-06 [2020-12-19]. （原始内容存档于2021-01-01）.
Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine (COVID-19-101). ClinicalTrials.gov. United States National Library of Medicine. 2020-09-28 [2020-11-23]. （原始内容存档于2020-12-08）.
Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001). ClinicalTrials.gov. United States National Library of Medicine. 2020-11-13 [2020-11-19]. （原始内容存档于2020-11-28）.
Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study). ClinicalTrials.gov. United States National Library of Medicine. 2021-01-19 [2021-02-10]. （原始内容存档于2021-02-25）.

clinicaltrialsarena.com (Global: low place; Chinese: low place)

Praveen Duddu. Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19 （页面存档备份，存于互联网档案馆）. [clinicaltrialsarena.com clinicaltrialsarena.com] 19 February 2020.

clinicaltrialsregister.eu (Global: low place; Chinese: low place)

COVID-19: A Phase 2b/3, Randomized, Observer-Blinded, Placebo Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older. EU Clinical Trials Register. [2021-05-08]. （原始内容存档于2021-02-13）.

cna.com.tw (Global: 527^th place; Chinese: 24^th place)

高端疫苗通過EUA 衛福部核准專案製造. 中央社. 2021-07-19 [2021-07-19]. （原始内容存档于2021-07-23）.
中央社記者張良知. 高端：COVID-19疫苗將申請WHO緊急使用授權. 中央社. 2022-06-30 [2022-09-06]. （原始内容存档于2022-07-18）（中文（臺灣））.
中國科興疫苗停產惹議此前專家籲別打滅活疫苗. 中央通訊社. 2024-01-13.
莫德納疫苗獲緊急授權自費AZ疫苗供應不間斷. [2021-05-07]. （原始内容存档于2021-05-07）.
Omicron蔓延非洲台灣贈索馬利蘭15萬劑高端疫苗. 中央社. 2021-12-28. （原始内容存档于2021-12-28）.
台灣為什麼不買中國疫苗？指揮中心QA一次看. 中央通讯社. 2021-01-27 [2021-01-27]. （原始内容存档于2021-01-28）（中文（臺灣））.
莫德納將供台灣500萬劑COVID-19疫苗年中交付. [2021-02-10]. （原始内容存档于2021-02-18）.
率先施打AZ疫苗蘇貞昌：沒有任何痠痛不舒服[影]CNA. 中央社. [2021-04-06]. （原始内容存档于2021-04-20）（中文（臺灣））.
18到22歲納BNT優先接種族群陳時中：確保每個年紀打到疫苗. 自由時報. 2021-09-01 [2021-09-03]. （原始内容存档于2021-10-07）.
陳彥鈞、林治平. 台灣核准莫德納用於6至11歲各國兒童疫苗政策一次看. 中央通訊社. 2022-04-18. （原始内容存档于2022-04-18）.
歐盟告AZ疫苗延誤交貨法院裁定9月底前補貨即可. 中央通訊社. 2021-06-19 [2021-06-24]. （原始内容存档于2021-06-24）.

cnbc.com (Global: 220^th place; Chinese: 426^th place)

AstraZeneca-Oxford Covid vaccine approved for use by European regulator. [2021-01-29]. （原始内容存档于2021-01-29）.
Ellyatt, Holly. Johnson & Johnson's one-shot Covid vaccine cleared for use in the EU. CNBC. 2021-03-11 [2021-04-06]. （原始内容存档于2021-03-26）（英语）.
存档副本. [2021-02-14]. （原始内容存档于2021-02-17）.

cnet.com (Global: 272^nd place; Chinese: 459^th place)

Shankland, Stephen. Sixteen supercomputers tackle coronavirus cures in US. CNET. [2020-03-23]. （原始内容存档于2020-07-26）（英语）.

cnn.com (Global: 28^th place; Chinese: 71^st place)

Ziady, Hanna. Biotech company Moderna says its coronavirus vaccine is ready for first tests. CNN. 2020-02-26 [2020-03-02]. （原始内容存档于2020-02-28）.
Kate Sullivan. Biden receives first dose of Covid-19 vaccine on live television. CNN. 2020-12-21 [2021-02-07]. （原始内容存档于2021-02-18）.
Madeline Holcombe; Holly Yan; Steve Almasy. The Moderna vaccine is now in some Americans' arms as Covid-19 cases in the US pass 18 million. CNN. 2020-12-21 [2020-12-22]. （原始内容存档于2021-01-22）.
CNN, Ben Tinker and Elizabeth Cohen. CDC and FDA recommend US pause use of Johnson & Johnson's Covid-19 vaccine over blood clot concerns. CNN. [2021-04-13]. （原始内容存档于2021-06-07）.

cnnphilippines.com (Global: 2,993^rd place; Chinese: 8,965^th place)

PH authorizes Pfizer's COVID-19 vaccine for emergency use. CNN菲律宾. 2021-01-14 [2021-01-14]. （原始内容存档于2021-01-21）.

cnstock.com (Global: low place; Chinese: 1,045^th place)

news.cnstock.com

中国生物奥密克戎株新冠mRNA疫苗获国家药监局临床批件. [2023-01-20]. （原始内容存档于2023-01-20）.

paper.cnstock.com

北京神州细胞生物技术集团股份公司自愿披露关于控股子公司新冠疫苗SCTV01E被纳入紧急使用的公告. 上海证券报. 2023-03-23 [2023-04-14]. （原始内容存档于2023-04-17）. 公司自主研发的重组新冠病毒4价（Alpha/Beta/Delta/Omicron变异株）S三聚体蛋白疫苗（项目代号：SCTV01E）经国家有关部门论证被纳入紧急使用

cnyes.com (Global: low place; Chinese: 371^st place)

news.cnyes.com

〈高端股東會〉WHO新冠疫苗三期試驗已達解盲條件隨時公布數據. Anue鉅亨. 2022-06-30 [2022-09-06]. （原始内容存档于2022-07-12）（中文（臺灣））.

colombogazette.com (Global: low place; Chinese: low place)

NMRA approves sinopharm vaccine for emergency use. Colombo Gazette. 2021-03-19 [2021-04-06]. （原始内容存档于2021-03-19）（英国英语）.

covidvaccine.gov.hk (Global: low place; Chinese: low place)

香港新冠疫苗接種資料概覽. 香港衛生防護中心. [2021-04-28]. （原始内容存档 (PDF)于2021-03-14）.

cri.cn (Global: 2,251^st place; Chinese: 164^th place)

news.cri.cn

国家药监局附条件批准两家公司新冠疫苗注册申请. 中央广电总台央视新闻客户端. 2021-02-25 [2021-02-25]. （原始内容存档于2021-08-17）.

ctri.nic.in (Global: low place; Chinese: low place)

A phase III, randomized, multi-centre, double blind, placebo controlled, study to evaluate efficacy, safety and immunogenicity of Novel Corona Virus -2019-nCov vaccine candidate of M/s Cadila Healthcare Limited.. Clinical Trials Registry - India. [2021-06-14]. （原始内容存档于2021-06-15）.
Biological E’s novel Covid-19 vaccine of SARS-CoV-2 for protection against Covid-19 disease.. 印度临床试验注册中心. 2020-11-12 [2020-11-14]. （原始内容存档于2020-12-01）.

curevac.com (Global: low place; Chinese: low place)

CureVac Provides Update on Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV. CureVac. 2021-06-16 [2021-06-17]. （原始内容存档于2021-06-24）.

dailytimes.com.pk (Global: 1,625^th place; Chinese: 3,690^th place)

Pakistan allows third Chinese vaccine for emergency use. [2021-04-09]. （原始内容存档于2021-04-09）.

dhakatribune.com (Global: 2,157^th place; Chinese: low place)

Saudi Arabia approves Sinovac and Sinopharm vaccines. [2021-08-25]. （原始内容存档于2021-08-25）.

doi.org (Global: 2^nd place; Chinese: 23^rd place)

Li, Yen-Der; Chi, Wei-Yu; Su, Jun-Han; Ferrall, Louise; Hung, Chien-Fu; Wu, T.-C. Coronavirus vaccine development: from SARS and MERS to COVID-19. Journal of Biomedical Science. 2020-12, 27 (1): 104 [2024-08-14]. ISSN 1423-0127. PMC 7749790 . PMID 33341119. doi:10.1186/s12929-020-00695-2. （原始内容存档于2021-02-19）（英语）.
Subbarao, Kanta. The success of SARS-CoV-2 vaccines and challenges ahead. Cell Host & Microbe. 2021-07, 29 (7): 1111-1123 [2024-08-14]. ISSN 1931-3128. PMC 8279572 . PMID 34265245. doi:10.1016/j.chom.2021.06.016. （原始内容存档于2025-01-16）.
Mallapaty, Smriti; Callaway, Ewen; Kozlov, Max; Ledford, Heidi; Pickrell, John; Van Noorden, Richard. How COVID vaccines shaped 2021 in eight powerful charts. Nature. 2021-12-23, 600 (7890): 580-583 [2024-08-14]. Bibcode:2021Natur.600..580M. ISSN 0028-0836. PMID 34916666. S2CID 245262732. doi:10.1038/d41586-021-03686-x. （原始内容存档于2021-12-16）（英语）.
Watson, Oliver J; Barnsley, Gregory; Toor, Jaspreet; Hogan, Alexandra B; Winskill, Peter; Ghani, Azra C. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. The Lancet Infectious Diseases. 2022-09, 22 (9): 1293-1302. ISSN 1473-3099. PMC 9225255 . PMID 35753318. doi:10.1016/s1473-3099(22)00320-6.
Wang, Hui; Xu, Ran; Qu, Shijin; Schwartz, Marlene; Adams, Aaron; Chen, Xiang. Health inequities in COVID-19 vaccination among the elderly: Case of Connecticut. Journal of Infection and Public Health. October 2021, 14 (10): 1563–1565 [29 December 2022]. PMID 34326008. S2CID 236515442. doi:10.1016/j.jiph.2021.07.013. （原始内容存档于2022-12-29）.
Cavanagh, Dave. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathology. 2003-12, 32 (6): 567–582 [2021-02-21]. ISSN 0307-9457. PMC 7154303 . PMID 14676007. doi:10.1080/03079450310001621198. （原始内容存档于2020-09-29）（英语）.
Gao, Wentao; Tamin, Azaibi; Soloff, Adam; D'Aiuto, Leonardo; Nwanegbo, Edward; Robbins, Paul D; Bellini, William J; Barratt-Boyes, Simon; Gambotto, Andrea. Effects of a SARS-associated coronavirus vaccine in monkeys. The Lancet. 2003-12, 362 (9399): 1895–1896 [2021-02-21]. PMC 7112457 . PMID 14667748. doi:10.1016/S0140-6736(03)14962-8. （原始内容存档于2020-12-20）（英语）.
Kim, Eun; Okada, Kaori; Kenniston, Tom; Raj, V. Stalin; AlHajri, Mohd M.; Farag, Elmoubasher A.B.A.; AlHajri, Farhoud; Osterhaus, Albert D.M.E.; Haagmans, Bart L. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice. Vaccine. 2014-10, 32 (45): 5975–5982 [2021-02-21]. PMC 7115510 . PMID 25192975. doi:10.1016/j.vaccine.2014.08.058. （原始内容存档于2020-12-22）（英语）.
Jiang, Shibo; Lu, Lu; Du, Lanying. Development of SARS vaccines and therapeutics is still needed. Future Virology. 2013-01, 8 (1): 1–2 [2021-02-21]. ISSN 1746-0794. PMC 7079997 . PMID 32201503. doi:10.2217/fvl.12.126. （原始内容存档于2020-10-19）（英语）.
Greenough, Thomas C.; Babcock, Gregory J.; Roberts, Anjeanette; Hernandez, Hector J.; Thomas, Jr., William D.; Coccia, Jennifer A.; Graziano, Robert F.; Srinivasan, Mohan; Lowy, Israel. Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice. The Journal of Infectious Diseases. 2005-02-15, 191 (4): 507–514 [2021-02-21]. ISSN 0022-1899. PMC 7110081 . PMID 15655773. doi:10.1086/427242. （原始内容存档于2017-07-28）（英语）.
Tripp, Ralph A.; Haynes, Lia M.; Moore, Deborah; Anderson, Barbara; Tamin, Azaibi; Harcourt, Brian H.; Jones, Les P.; Yilla, Mamadi; Babcock, Gregory J. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. Journal of Virological Methods. 2005-09, 128 (1-2): 21–28 [2021-02-21]. PMC 7112802 . PMID 15885812. doi:10.1016/j.jviromet.2005.03.021. （原始内容存档于2020-10-01）（英语）.
Roberts, Anjeanette; Thomas, William D.; Guarner, Jeannette; Lamirande, Elaine W.; Babcock, Gregory J.; Greenough, Thomas C.; Vogel, Leatrice; Hayes, Norman; Sullivan, John L. Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters. The Journal of Infectious Diseases. 2006-03, 193 (5): 685–692 [2021-02-21]. ISSN 0022-1899. PMC 7109703 . PMID 16453264. doi:10.1086/500143. （原始内容存档于2017-07-27）（英语）.
Shehata, Mahmoud M.; Gomaa, Mokhtar R.; Ali, Mohamed A.; Kayali, Ghazi. Middle East respiratory syndrome coronavirus: a comprehensive review. Frontiers of Medicine. 2016-06, 10 (2): 120–136. ISSN 2095-0217. PMC 7089261 . PMID 26791756. doi:10.1007/s11684-016-0430-6 （英语）.
Butler, Declan. SARS veterans tackle coronavirus. Nature. 2012-10, 490 (7418): 20–20 [2021-02-21]. ISSN 0028-0836. doi:10.1038/490020a. （原始内容存档于2021-11-06）（英语）.
Modjarrad, Kayvon; Roberts, Christine C; Mills, Kristin T; Castellano, Amy R; Paolino, Kristopher; Muthumani, Kar; Reuschel, Emma L; Robb, Merlin L; Racine, Trina. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. The Lancet Infectious Diseases. 2019-09, 19 (9): 1013–1022 [2021-02-21]. PMC 7185789 . PMID 31351922. doi:10.1016/S1473-3099(19)30266-X. （原始内容存档于2021-01-23）（英语）.
Yong, Chean Yeah; Ong, Hui Kian; Yeap, Swee Keong; Ho, Kok Lian; Tan, Wen Siang. Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus. Frontiers in Microbiology. 2019-08-02, 10: 1781. ISSN 1664-302X. PMC 6688523 . PMID 31428074. doi:10.3389/fmicb.2019.01781.
Mullard, Asher. How COVID vaccines are being divvied up around the world. Nature. 2020-11-30: d41586–020–03370–6 [2021-02-21]. ISSN 0028-0836. PMID 33257891. doi:10.1038/d41586-020-03370-6. （原始内容存档于2021-02-24）（英语）.
So, Anthony D; Woo, Joshua. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. 2020-12-15: m4750 [2021-02-21]. ISSN 1756-1833. PMC 7735431 . PMID 33323376. doi:10.1136/bmj.m4750. （原始内容存档于2020-12-16）（英语）.
Fauci, Anthony S.; Lane, H. Clifford; Redfield, Robert R. Covid-19 — Navigating the Uncharted. New England Journal of Medicine. 2020-03-26, 382 (13): 1268–1269 [2021-02-21]. ISSN 0028-4793. PMC 7121221 . PMID 32109011. doi:10.1056/NEJMe2002387. （原始内容存档于2021-02-25）（英语）.
Gates, Bill. Responding to Covid-19 — A Once-in-a-Century Pandemic?. New England Journal of Medicine. 2020-04-30, 382 (18): 1677–1679 [2021-02-21]. ISSN 0028-4793. doi:10.1056/NEJMp2003762. （原始内容存档于2020-10-18）（英语）.
Tanriover, Mine Durusu; Doğanay, Hamdi Levent; Akova, Murat; Güner, Hatice Rahmet; Azap, Alpay; Akhan, Sıla; Köse, Şükran; Erdinç, Fatma Şebnem; Akalın, Emin Halis. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. The Lancet. 2021-07-17, 398 (10296): 213–222. ISSN 0140-6736. PMID 34246358. doi:10.1016/S0140-6736(21)01429-X （英语）.
Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M.; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults. JAMA. 2021-05-26 [2021-05-26]. ISSN 0098-7484. doi:10.1001/jama.2021.8565. （原始内容存档于2021-06-04）（英语）.
Ella, Raches; Reddy, Siddharth; Blackwelder, William; Potdar, Varsha; Yadav, Pragya; Sarangi, Vamshi; Aileni, Vinay Kumar; Kanungo, Suman; Rai, Sanjay; Reddy, Prabhakar; Verma, Savitha; Singh, Chandramani; Redkar, Sagar; Mohapatra, Satyajit; Pandey, Anil; Ranganadin, Pajanivel; Gumashta, Raghavendra; Multani, Manish; Mohammad, Shameem; Bhatt, Parul; Kumari, Laxmi; Sapkal, Gajanan; Gupta, Nivedita; Abraham, Priya; Panda, Samiran; Prasad, Sai; Bhargava, Balram; Ella, Krishna; Vadrevu, Krishna Mohan. Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial. 2021-07-02 [2021-07-03]. doi:10.1101/2021.06.30.21259439. （原始内容存档于2021-07-17）.
Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L.; Grousova, Daria M. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet (London, England). 2021-02-20, 397 (10275): 671–681 [2021-04-06]. ISSN 1474-547X. PMC 7852454 . PMID 33545094. doi:10.1016/S0140-6736(21)00234-8. （原始内容存档于2021-05-27）.
Voysey, Merryn; Costa Clemens, Sue Ann; Madhi, Shabir A; Weckx, Lily Y; Folegatti, Pedro M; Aley, Parvinder K; Angus, Brian; Baillie, Vicky L; Barnabas, Shaun L. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. 柳叶刀. 2021-03, 397 (10277): 881–891 [2021-04-06]. PMC 7894131 . PMID 33617777. doi:10.1016/S0140-6736(21)00432-3. （原始内容存档于2021-05-28）（英语）.
Jerald Sadoff; Glenda Gray; An Vandebosch; Vicky Cárdenas; Georgi Shukarev; Beatriz Grinsztejn; Paul A. Goepfert; Carla Truyers; Hein Fennema; Bart Spiessens; Kim Offergeld; Gert Scheper. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. 新英格兰医学杂志. 2021-04-21 [2021-05-16]. doi:10.1056/NEJMoa2101544. （原始内容存档于2021-05-16）.
Heath, Paul T.; Galiza, Eva P.; Baxter, David Neil; Boffito, Marta; Browne, Duncan; Burns, Fiona; Chadwick, David R.; Clark, Rebecca; Cosgrove, Catherine; Galloway, James; Goodman, Anna L.; Heer, Amardeep; Higham, Andrew; Iyengar, Shalini; Jamal, Arham; Jeanes, Christopher; Kalra, Philip A.; Kyriakidou, Christina; McAuley, Daniel F.; Meyrick, Agnieszka; Minassian, Angela M.; Minton, Jane; Moore, Patrick; Munsoor, Imrozia; Nicholls, Helen; Osanlou, Orod; Packham, Jonathan; Pretswell, Carol H.; Ramos, Alberto San Francisco; Saralaya, Dinesh; Sheridan, Ray P.; Smith, Richard; Soiza, Roy L.; Swift, Pauline A.; Thomson, Emma C.; Turner, Jeremy; Viljoen, Marianne Elizabeth; Albert, Gary; Cho, Iksung; Dubovsky, Filip; Glenn, Greg; Rivers, Joy; Robertson, Andreana; Smith, Kathy; Toback, Seth. Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant. medRxiv. 2021-05-14 [2021-05-25]. doi:10.1101/2021.05.13.21256639. （原始内容存档于2021-05-25）.
Wadman, Meredith. Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less potent in South Africa. Science. 2021-01-28 [2021-04-06]. ISSN 0036-8075. doi:10.1126/science.abg8101. （原始内容存档于2021-05-25）.
Singanayagam, Anika; Hakki, Seran; Dunning, Jake; Madon, Kieran J.; Crone, Michael A.; Koycheva, Aleksandra; Derqui-Fernandez, Nieves; Barnett, Jack L.; Whitfield, Michael G. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet. Infectious Diseases. 2021-10-29: S1473–3099(21)00648–4 [2021-12-04]. ISSN 1474-4457. PMC 8554486 . PMID 34756186. doi:10.1016/S1473-3099(21)00648-4. （原始内容存档于2021-12-28）.
Singanayagam, Anika; Hakki, Seran; Dunning, Jake; Madon, Kieran J.; Crone, Michael A.; Koycheva, Aleksandra; Derqui-Fernandez, Nieves; Barnett, Jack L.; Whitfield, Michael G. ” transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet Infectious Diseases. 2021-10-29, 0 (0) [2021-12-04]. ISSN 1473-3099. PMID 34756186. doi:10.1016/S1473-3099(21)00648-4. （原始内容存档于2023-07-30）（英语）.
Greinacher, Andreas; Thiele, Thomas; Warkentin, Theodore E.; Weisser, Karin; Kyrle, Paul A.; Eichinger, Sabine. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. New England Journal of Medicine. 2021-06-03, 384 (22): 2092–2101. ISSN 0028-4793. PMC 8095372 . PMID 33835769. doi:10.1056/NEJMoa2104840.
Schultz, Nina H.; Sørvoll, Ingvild H.; Michelsen, Annika E.; Munthe, Ludvig A.; Lund-Johansen, Fridtjof; Ahlen, Maria T.; Wiedmann, Markus; Aamodt, Anne-Hege; Skattør, Thor H. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. New England Journal of Medicine. 2021-06-03, 384 (22): 2124–2130. ISSN 0028-4793. PMC 8112568 . PMID 33835768. doi:10.1056/NEJMoa2104882.
Muir, Kate-Lynn; Kallam, Avyakta; Koepsell, Scott A.; Gundabolu, Krishna. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. New England Journal of Medicine. 2021-05-20, 384 (20): 1964–1965. ISSN 0028-4793. PMC 8063883 . PMID 33852795. doi:10.1056/NEJMc2105869.
Yeh TY, Contreras, GP. Full vaccination suppresses SARS-CoV-2 delta variant mutation frequency. medRxiv. 2021-08-10 [2021-08-15]. doi:10.1101/2021.08.08.21261768. （原始内容存档于2021-09-13）.

dw.com (Global: 204^th place; Chinese: 124^th place)

Welle (www.dw.com), Deutsche. 让世界公平接种疫苗？Covax雄心难实现. DW.COM. [2021-02-21]. （原始内容存档于2020-11-24）（中文（中国大陆））.
阿斯利康&牛津疫苗有效性可达90%. [2020-11-24]. （原始内容存档于2020-12-12）.
中国吸入用新冠疫苗试验获认可各国积极研发口服形式. DW.COM. 2021-08-02 [2021-08-30]. （原始内容存档于2021-08-05）（中文（中国大陆））.
世卫：接种中国疫苗的长者应打加强针. DW. 2021-10-12 [2021-10-13]. （原始内容存档于2021-10-27）.
一受试者患病秘鲁暂停中国疫苗临床试验. DW.COM. 2020-12-12 [2021-04-06]. （原始内容存档于2020-12-14）（中文（中国大陆））.
阿联酋正式批准使用中国新冠疫苗. [2020-12-10]. （原始内容存档于2020-12-18）.
Welle (www.dw.com), Deutsche. 新冠疫情升温以色列率先施打第三针. DW.COM. 2021-08-01 [2021-08-02]. （原始内容存档于2021-08-09）（中文（中国大陆））.
都可以打了？德国6月7日起取消接种排序. 德國之聲. 2021-05-18 [2021-05-20] （中文（中国大陆））.
德国新冠疫苗完全接种者比例近66%. [2021-10-24]. （原始内容存档于2021-11-03）.
德国通过医护人员义务接种新冠疫苗法案. [2021-12-11]. （原始内容存档于2021-12-11）.
奥地利将成为欧洲首个强制接种疫苗的国家. [2021-11-20]. （原始内容存档于2021-11-22）.
Welle (www.dw.com), Deutsche. 偏心？违约？欧盟与阿斯利康的疫苗供货之争. DW.COM. 2021-01-28. （原始内容存档于2021-01-30）（中文（中国大陆））.
疫苗严重交付不足欧盟正式起诉阿斯利康. [2021-04-27]. （原始内容存档于2021-05-27）.

dwnews.com (Global: 4,516^th place; Chinese: 180^th place)

多维新闻. 【新冠肺炎】习近平推重磅举措中国疫苗将为全球公共产品. 多维新闻. 2020-05-18 [2021-02-21]. （原始内容存档于2021-10-23）（中文（中国大陆））.

e-cspc.com (Global: low place; Chinese: low place)

石药集团mRNA疫苗在江苏开打. 石藥集團. 2023-05-31 [2023-06-11]. （原始内容存档于2023-06-11）. 石药集团丘远征博士就《中国首个新冠mRNA疫苗（度恩泰）研究进展》做报告

ecns.cn (Global: low place; Chinese: low place)

Colombia announces emergency use of Sinovac vaccines-Ecns.cn. ECNS. [2021-04-06].
Sinovac's COVID-19 vaccine gets conditional approval in Malaysia-Ecns.cn. ECNS. [2021-04-06].
China's CanSino COVID-19 vaccine approved for emergency use in Hungary. www.ecns.cn. [2021-04-06]. （原始内容存档于2021-03-23）.

elsevier.com (Global: 610^th place; Chinese: 388^th place)

linkinghub.elsevier.com

Subbarao, Kanta. The success of SARS-CoV-2 vaccines and challenges ahead. Cell Host & Microbe. 2021-07, 29 (7): 1111-1123 [2024-08-14]. ISSN 1931-3128. PMC 8279572 . PMID 34265245. doi:10.1016/j.chom.2021.06.016. （原始内容存档于2025-01-16）.
Watson, Oliver J; Barnsley, Gregory; Toor, Jaspreet; Hogan, Alexandra B; Winskill, Peter; Ghani, Azra C. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. The Lancet Infectious Diseases. 2022-09, 22 (9): 1293-1302. ISSN 1473-3099. PMC 9225255 . PMID 35753318. doi:10.1016/s1473-3099(22)00320-6.
Gao, Wentao; Tamin, Azaibi; Soloff, Adam; D'Aiuto, Leonardo; Nwanegbo, Edward; Robbins, Paul D; Bellini, William J; Barratt-Boyes, Simon; Gambotto, Andrea. Effects of a SARS-associated coronavirus vaccine in monkeys. The Lancet. 2003-12, 362 (9399): 1895–1896 [2021-02-21]. PMC 7112457 . PMID 14667748. doi:10.1016/S0140-6736(03)14962-8. （原始内容存档于2020-12-20）（英语）.
Kim, Eun; Okada, Kaori; Kenniston, Tom; Raj, V. Stalin; AlHajri, Mohd M.; Farag, Elmoubasher A.B.A.; AlHajri, Farhoud; Osterhaus, Albert D.M.E.; Haagmans, Bart L. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice. Vaccine. 2014-10, 32 (45): 5975–5982 [2021-02-21]. PMC 7115510 . PMID 25192975. doi:10.1016/j.vaccine.2014.08.058. （原始内容存档于2020-12-22）（英语）.
Tripp, Ralph A.; Haynes, Lia M.; Moore, Deborah; Anderson, Barbara; Tamin, Azaibi; Harcourt, Brian H.; Jones, Les P.; Yilla, Mamadi; Babcock, Gregory J. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. Journal of Virological Methods. 2005-09, 128 (1-2): 21–28 [2021-02-21]. PMC 7112802 . PMID 15885812. doi:10.1016/j.jviromet.2005.03.021. （原始内容存档于2020-10-01）（英语）.
Modjarrad, Kayvon; Roberts, Christine C; Mills, Kristin T; Castellano, Amy R; Paolino, Kristopher; Muthumani, Kar; Reuschel, Emma L; Robb, Merlin L; Racine, Trina. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. The Lancet Infectious Diseases. 2019-09, 19 (9): 1013–1022 [2021-02-21]. PMC 7185789 . PMID 31351922. doi:10.1016/S1473-3099(19)30266-X. （原始内容存档于2021-01-23）（英语）.
Voysey, Merryn; Costa Clemens, Sue Ann; Madhi, Shabir A; Weckx, Lily Y; Folegatti, Pedro M; Aley, Parvinder K; Angus, Brian; Baillie, Vicky L; Barnabas, Shaun L. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. 柳叶刀. 2021-03, 397 (10277): 881–891 [2021-04-06]. PMC 7894131 . PMID 33617777. doi:10.1016/S0140-6736(21)00432-3. （原始内容存档于2021-05-28）（英语）.

ettoday.net (Global: 371^st place; Chinese: 7^th place)

奧克蘭動物園開打新冠疫苗！老虎雪貂都打了「下批輪到豬和蝙蝠」. ETtoday新聞雲. [2021-08-30]. （原始内容存档于2021-07-11）（中文（繁體））.
台灣搶新冠疫苗「另找3家疫苗廠談」　陳時中證實接洽. ETtoday新聞雲. 2021-02-03 [2021-02-04]. （原始内容存档于2021-02-09）.
趙蔡州. 快訊／英國女王夫婦接種「新冠疫苗」　白金漢宮曝光細節. ETtoday新聞雲. 2021-01-09 [2021-01-09]. （原始内容存档于2021-01-11）.

eurasianet.org (Global: 3,649^th place; Chinese: 4,238^th place)

Turkmenistan: Master Berdymukhamedov goes to Moscow. Eurasianet. [2021-04-25]. （原始内容存档于2021-04-28）（英语）.

europa.eu (Global: 68^th place; Chinese: 209^th place)

ema.europa.eu

EMA recommends first COVID-19 vaccine for authorisation in the EU. European Medicines Agency (EMA) (新闻稿). 21 December 2020 [21 December 2020]. （原始内容存档于30 January 2021）.
Medical Director of AstraZeneca AB. Direct healthcare professional communication (DHPC): Vaxzevria (previously COVID-19 Vaccine AstraZeneca): link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia (PDF). 欧洲药品管理局. 2021-04-13 [2021-04-13]. （原始内容存档 (PDF)于2022-07-18）.
COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. [2021-04-20]. （原始内容存档于2021-06-06）.

exmoo.com (Global: low place; Chinese: 707^th place)

林嘉欣. 首批10萬劑國藥疫苗抵澳特區政府順利接收. 力報. 2021-02-06 [2021-02-07]. （原始内容存档于2021-10-23）.

factcheck.org (Global: 7,075^th place; Chinese: low place)

McDonald, Jessica. Social Media Posts Spread Bogus Coronavirus Conspiracy Theory. FactCheck.org. Annenberg Public Policy Center. 2020-01-24 [2020-02-08]. （原始内容存档于2020-02-06）.

fda.gov (Global: 447^th place; Chinese: 581^st place)

Pfizer-BioNTech COVID-19 Vaccine. www.fda.gov. Food and Drug Administration. [2021-03-16]. （原始内容存档于2021-01-14）.
Commissioner, Office of the. FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine. FDA. 2021-03-02 [2021-04-06]. （原始内容存档于2021-03-18）（英语）.

fda.gov.tw (Global: low place; Chinese: 1,125^th place)

衛福部食藥署核准莫德納疫苗用於6至11歲兒童接種. 衛生福利部食品藥物管理署. 2022-04-17. （原始内容存档于2022-04-17）.

firstpost.com (Global: 283^rd place; Chinese: 2,869^th place)

Sumeysh Srivastava. CoWIN app quirks show just how Phase 4 of India's vaccination programme excludes entire class of Indians. Firstpost. 2021-05-10 [2021-05-11]. （原始内容存档于2021-05-13）（英语）.

focustaiwan.tw (Global: 3,164^th place; Chinese: 1,453^rd place)

Taiwan to donate domestic COVID-19 vaccines to Somaliland. Focus Taiwan. 2021-12-28 [2022-01-07]. （原始内容存档于2022-04-18）.

france24.com (Global: 481^st place; Chinese: 798^th place)

Jordan approves China's Sinopharm Covid vaccine. [2021-01-09]. （原始内容存档于2021-01-09）.
China's Coronavac 80% effective at preventing Covid deaths: Chile results. Santiago: France 24. Agence France-Presse. 2021-04-16 [2021-04-18]. （原始内容存档于2021-04-27）.

freezepage.com (Global: 5,120^th place; Chinese: 545^th place)

澳门市民将自愿及免费接种新冠疫苗. 中共中央统一战线工作社. [2020-12-08]. （原始内容存档于2020-12-08）.
芜湖开展冬春季新冠疫苗摸底官方：接种时间未定 -安青网. www.ahyouth.com. [2021-04-06]. （原始内容存档于2020-12-09）.
世卫组织：已有40多个国家开始接种新冠疫苗. 环球网. [2021-01-12]. （原始内容存档于2021-01-12）.
港府刊宪：引入符合要求的新冠疫苗作紧急使用 _大公网. www.takungpao.com. [2021-04-06]. （原始内容存档于2020-12-24）.
英国开始大规模接种新冠肺炎疫苗. 第一财经. [2020-12-09]. （原始内容存档于2020-12-09）.
克宫新闻发言人：普京将接种“卫星-V”新冠疫苗. 澎湃新闻. [2020-12-28]. （原始内容存档于2020-12-28）.
泰国与中国企业签署新冠疫苗订购协议. 新华网. [2021-01-05]. （原始内容存档于2021-01-05）.
菅义伟：日本2月下旬启动新冠疫苗接种，自己有意率先接种. 观察者网. [2021-01-04]. （原始内容存档于2021-01-04）.
华媒：希腊新冠疫苗接种即将开始，如何预约？. 中国侨网. 2020-12-14 [2021-04-06]. （原始内容存档于2020-12-14）.
中国新冠疫苗在巴西获紧急使用许可. 中新网. [2021-01-18]. （原始内容存档于2021-01-18）.
美国食药监局：辉瑞疫苗试验期间有6人死亡. 财经报社. [2021-01-15]. （原始内容存档于2021-01-15）.
挪威23名老人接种辉瑞新冠疫苗后死亡. 环球网. [2021-01-15]. （原始内容存档于2021-01-15）.
印度开打疫苗首日：首都51人现不良反应 1人被送入ICU. 财经报社. [2021-01-17]. （原始内容存档于2021-01-17）.

frontiersin.org (Global: 4,679^th place; Chinese: 2,220^th place)

Yong, Chean Yeah; Ong, Hui Kian; Yeap, Swee Keong; Ho, Kok Lian; Tan, Wen Siang. Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus. Frontiers in Microbiology. 2019-08-02, 10: 1781. ISSN 1664-302X. PMC 6688523 . PMID 31428074. doi:10.3389/fmicb.2019.01781.

ft.com (Global: 210^th place; Chinese: 353^rd place)

WTO agrees partial patent waiver for Covid-19 vaccines. Financial Times. 2022-06-17 [2022-06-19]. （原始内容存档于2022-06-17）.

ftvnews.com.tw (Global: 6,057^th place; Chinese: 213^th place)

疫情燒　聖彼得堡強制打針　俄人跑鄰國接種. [2021-11-11]. （原始内容存档于2021-11-11）.

futuremedicine.com (Global: low place; Chinese: low place)

Jiang, Shibo; Lu, Lu; Du, Lanying. Development of SARS vaccines and therapeutics is still needed. Future Virology. 2013-01, 8 (1): 1–2 [2021-02-21]. ISSN 1746-0794. PMC 7079997 . PMID 32201503. doi:10.2217/fvl.12.126. （原始内容存档于2020-10-19）（英语）.

fx168.com (Global: low place; Chinese: 8,191^st place)

美国食药监局：辉瑞疫苗试验期间有6人死亡. 财经报社. [2021-01-15]. （原始内容存档于2021-01-15）.
印度开打疫苗首日：首都51人现不良反应 1人被送入ICU. 财经报社. [2021-01-17]. （原始内容存档于2021-01-17）.

globaltimes.cn (Global: low place; Chinese: 1,577^th place)

Leng Shumei. China approves 7th self-developed COVID-19 vaccine, can cross-neutralize variants. 环球时报. 2021-06-09 [2021-06-15]. （原始内容存档于2021-06-24）.

go.com (Global: 48^th place; Chinese: 146^th place)

abcnews.go.com

Japan gives preliminary OK to 2 more COVID-19 vaccines. [2021-05-20]. （原始内容存档于2021-05-21）.
News, A. B. C. Canada clears Johnson & Johnson vaccine, first to approve 4. ABC News. [2021-04-06]. （原始内容存档于2021-03-10）（英语）.
Ivan Pereira. US administers 1st doses of Pfizer coronavirus vaccine. ABC News. [2020-12-14]. （原始内容存档于2021-01-19）.
Justin Gomez. In address, Biden directs that all adults be eligible for COVID-19 vaccine by May 1. ABC新闻. 2021-03-11 [2021-03-14]. （原始内容存档于2021-05-16）.
India giving COVID-19 vaccines to more people as cases rise. ABC新聞. 2021-03-01 [2021-05-11]. （原始内容存档于2021-05-13）（英语）.

gov.cn (Global: 1,676^th place; Chinese: 62^nd place)

宋岩. 李克强出席澜沧江—湄公河合作第三次领导人会议. 中国政府网. 2020-08-24 [2020-08-24]. （原始内容存档于2020-08-31）.

gov.mo (Global: low place; Chinese: 677^th place)

新型冠狀病毒感染應變協調中心. 首批10萬劑國藥集團新型冠狀病毒滅活疫苗抵澳社會文化司歐陽瑜司長、中聯辦嚴植嬋副主任見證接收 (HTML). 澳門特別行政區政府入口網站. 2020-02-08 [2021-02-08] （中文（繁體））.
新型冠狀病毒感染應變協調中心. 首批10萬劑國藥集團新型冠狀病毒滅活疫苗抵澳社會文化司歐陽瑜司長、中聯辦嚴植嬋副主任見證接收. 澳門特別行政區政府入口網站. 2020-02-08 [2021-02-08]. （原始内容存档于2021-02-14）（中文（繁體））.

gov.vc (Global: low place; Chinese: low place)

Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021 (PDF). Government of Saint Vincent and the Grenadines. 2021-02-11 [2021-02-12]. （原始内容 (PDF)存档于2021-02-13）.

guancha.cn (Global: 4,433^rd place; Chinese: 170^th place)

欧盟、世卫批准杨森疫苗：单剂接种的新冠疫苗首次获批. 观察者网. 2021-03-13.
菅义伟：日本2月下旬启动新冠疫苗接种，自己有意率先接种. 观察者网. [2021-01-04]. （原始内容存档于2021-01-04）.
熊超然. 世贸组织达成历史性一揽子协议，美媒酸了：拜登给中国送上“专利大礼”. 观察者网. 2022-06-18 [2022-06-19].

harvard.edu (Global: 18^th place; Chinese: 57^th place)

ui.adsabs.harvard.edu

Mallapaty, Smriti; Callaway, Ewen; Kozlov, Max; Ledford, Heidi; Pickrell, John; Van Noorden, Richard. How COVID vaccines shaped 2021 in eight powerful charts. Nature. 2021-12-23, 600 (7890): 580-583 [2024-08-14]. Bibcode:2021Natur.600..580M. ISSN 0028-0836. PMID 34916666. S2CID 245262732. doi:10.1038/d41586-021-03686-x. （原始内容存档于2021-12-16）（英语）.

hindustantimes.com (Global: 71^st place; Chinese: 1,063^rd place)

Chinese Covid-19 vaccine Sinovac gets local emergency use in Thailand. [2021-02-23]. （原始内容存档于2021-02-23）.
Manral, Karan. Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine. Hindustan Times. 2021-03-04 [2021-03-06]. （原始内容存档于2021-03-05）.
India provides 100,000 doses of Covaxin vaccine to Paraguay. Hindustan Times. 2021-03-30 [2021-04-19]. （原始内容存档于2021-05-04）.

hk01.com (Global: 379^th place; Chinese: 11^th place)

施予. 5000多名人大代表、政協委員接種國藥新冠疫苗. 香港01. 2021-03-04 [2021-04-06]. （原始内容存档于2021-03-10）（中文（香港））.
新冠肺炎｜外交部：中國正式加入世衛COVAX 將提供1000萬劑疫苗. 香港01. 2021-02-03 [2021-02-04]. （原始内容存档于2021-02-09）（中文（香港））.
周禮希, 林劍, 翟睿敏. 林鄭月娥：接種疫苗後「感覺很好」可站立半小時不停答問題. 香港01. 2021-02-22 [2021-04-06]. （原始内容存档于2021-08-03）（中文（香港））.
國藥疫苗｜澳門下周二打第一針衛生局：內地批准上市澳門都准用. 香港01. 2021-02-06 [2021-02-06]. （原始内容存档于2021-02-14）（中文（香港））.

hkej.com (Global: 8,654^th place; Chinese: 328^th place)

www2.hkej.com

專家委員會:沒個案與接種疫苗有因果關係. 信报财经新闻. 2021-06-01 [2021-06-26]. （原始内容存档于2021-08-17）.

health.hkej.com

疫苗副作用──面癱？. 信報. 2020-12-29 [2021-04-21]. （原始内容存档于2020-12-31）.

huanqiu.com (Global: 2,206^th place; Chinese: 65^th place)

world.huanqiu.com

澳门拟采购140万剂新冠疫苗三类人员优先接种→. world.huanqiu.com. [2021-04-06]. （原始内容存档于2021-08-18）.
哈萨克斯坦公布新冠疫苗相关计划. world.huanqiu.com. [2021-04-06].
阿联酋批准国药新疫苗用作加强针.
澳大利亚累计新冠病例逾百万半数上周出现. [2022-01-10]. （原始内容存档于2022-04-22）.
挪威23名老人接种辉瑞新冠疫苗后死亡. 环球网. [2021-01-15]. （原始内容存档于2021-01-15）.
王盼盼. 外交部：发展中国家希望豁免新冠疫苗知识产权的诉求，中方完全理解并支持. 环球网. [2021-05-17]. （原始内容存档于2021-05-17）（中文（简体））.

3w.huanqiu.com

世卫组织：已有40多个国家开始接种新冠疫苗. 环球网. [2021-01-12]. （原始内容存档于2021-01-12）.

china.huanqiu.com

权威快报丨全国新冠疫苗接种剂次超11亿. china.huanqiu.com. [2021-06-27]. （原始内容存档于2021-06-27）.

oversea.huanqiu.com

《印媒：获中国公司帮助巴基斯坦成功在本土生产新冠疫苗》. 环球网. [2021-05-26].

ifeng.com (Global: 542^nd place; Chinese: 27^th place)

news.ifeng.com

出现血栓及死亡事件！德法意紧急停用阿斯利康疫苗欧洲有15国停用. news.ifeng.com. [2021-04-06]. （原始内容存档于2021-06-06）.

imperial.ac.uk (Global: 7,025^th place; Chinese: 4,775^th place)

Andrew Scheuber. Imperial vaccine tech to target COVID mutations and booster doses. 伦敦帝国学院. 2021-01-26 [2021-01-29]. （原始内容存档于2021-01-26）.

indianexpress.com (Global: 60^th place; Chinese: 1,119^th place)

Divya Goyal. Explained: Supply chain of Covid-19 vaccines and how they reach districts. 印度快報. 2021-05-08 [2021-05-11]. （原始内容存档于2021-05-14）（英语）.

indiatoday.in (Global: 94^th place; Chinese: 1,782^nd place)

Sahidul Hasan Khokon. Bangladesh drug regulator approves Oxford-SII's Covid vaccine for emergency use. India Today. 2021-01-08 [2021-01-10]. （原始内容存档于2021-01-13）.

info.gov.hk (Global: 2,665^th place; Chinese: 114^th place)

兩間藥物製造商供應的新冠疫苗獲註冊為香港藥劑製品. www.info.gov.hk. [2023-01-13]. （原始内容存档于2022-12-23）.

inform.kz (Global: 4,199^th place; Chinese: 2,502^nd place)

Kazakhstan to vaccinate 3,000 volunteers with domestic QazCovid-in. 哈萨克国际通讯社. 2020-12-19 [2021-07-09]. （原始内容存档于2021-04-19）.
INFORM.KZ. 新加坡开始大规模接种冠状病毒疫苗. www.inform.kz. 2021-01-19 [2021-04-06] （中文（简体））. ^{[失效連結]}

irct.ir (Global: low place; Chinese: low place)

en.irct.ir

A double-blind, randomized, placebo-controlled Phase II/III Clinical trial to evaluate the safety and efficacy of COVID-19 inactivated vaccine (Shifa-Pharmed) in a population aged 18 to 75 years. Iranian Registry of Clinical Trials. [2021-04-23]. （原始内容存档于2021-04-23）.
Phase 2 trial of safety and immunogenicity of 10 micro gram inactivated SARS-CoV-2 vaccine (FAKHRAVAC), two doses two weeks apart in adults aged 18-70 years: a randomized, double-blind, placebo-controlled, clinical trial. Iranian Registry of Clinical Trials. [2021-06-22]. （原始内容存档于2021-06-16）.
Phase II, Safety and Immunogenicity of RAZI SARS-CoV-2 recombinant Spike protein vaccine (RAZI Cov Pars) in adults aged 18-70 years; a Randomised, double blind, parallel 2 arms clinical trial. Iranian Registry of Clinical Trials. [2021-04-23]. （原始内容存档于2021-05-25）.

irct.ir

A phase II, Randomized, Two-armed, Double-blind, Placebo controlled trial to evaluate efficacy and safety of an adjuvanted recombinant SARS-CoV-2 spike (S) protein subunit vaccine (SpikoGen®) produced by CinnaGen Co. (Two doses of 25µg with dosing interval of 21 days). Iranian Registry of Clinical Trials. [2021-05-28]. （原始内容存档于2021-06-02）.

irna.ir (Global: 643^rd place; Chinese: low place)

en.irna.ir

956. Iran issues permit for emergency use of Sinopharm vaccine. IRNA English. 2021-03-10 [2021-04-06]. （原始内容存档于2021-04-19）（英语）.
Iran issues permit for emergency use for three other COVID-19 vaccines: Official. IRNA English. 2021-02-17 [2021-04-19]. （原始内容存档于2021-02-27）（英语）.

jamanetwork.com (Global: 2,650^th place; Chinese: 1,976^th place)

Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M.; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults. JAMA. 2021-05-26 [2021-05-26]. ISSN 0098-7484. doi:10.1001/jama.2021.8565. （原始内容存档于2021-06-04）（英语）.

jnj.com.cn (Global: low place; Chinese: low place)

世界卫生组织批准强生单剂量新冠肺炎疫苗的紧急使用清单申请. [2021-03-19]. （原始内容存档于2021-11-20）.

jrj.com.cn (Global: low place; Chinese: 824^th place)

finance.jrj.com.cn

神州细胞(688520.SH)：控股子公司新冠疫苗SCTV01E-2被纳入紧急使用. 2023-12-01 [2023-12-01].

kankanews.com (Global: low place; Chinese: 1,244^th place)

视频｜全球：严防疫情卷土重来多国“开打”疫苗加强针菲律宾：批准中国科兴疫苗作为加强针接种. [2021-11-17]. （原始内容存档于2021-11-17）.
视频｜澳大利亚：防止新冠叠加流感 4月起为脆弱人群打第二针加强针.

kathmandupost.com (Global: 3,868^th place; Chinese: low place)

Nepal gives emergency use approval to China's Sinovac Covid-19 vaccine. [2021-06-06]. （原始内容存档于2021-06-06）.

khmertimeskh.com (Global: 5,543^rd place; Chinese: 8,179^th place)

Rinith, Taing. Health Ministry grants Emergency Use Authorization to China's Sinopharm vaccine. Khmer Times. 2021-02-04 [2021-02-04]. （原始内容存档于2024-05-16）.
Health Ministry grants Emergency Use Authorization to China’s Sinopharm vaccine - Khmer Times. 2021-02-04 [2021-04-06]. （原始内容存档于2024-05-16）（美国英语）.

kpwashingtonresearch.org (Global: low place; Chinese: low place)

Kaiser Permanente launches first coronavirus vaccine trial. Kaiser Permanente, Washington Health Research Institute, Seattle. 2020-03-16 [2020-03-23]. （原始内容存档于2020-03-25）.

kyodonews.net (Global: 4,267^th place; Chinese: 2,052^nd place)

china.kyodonews.net

共同社. 详讯：日本宣布向台湾提供124万剂疫苗. 共同网. [2021-06-05]. （原始内容存档于2021-06-05）.

letemps.ch (Global: 1,980^th place; Chinese: low place)

Swissmedic autorise un premier vaccin contre le coronavirus. Le Temps. 2020-12-19 [2020-12-19]. （原始内容存档于2021-01-10）（法语）.

lexpress.mu (Global: low place; Chinese: low place)

Dr Jagutpal: Une cargaison de 200 000 vaccins Covaxin débarque demain. L'Express. 2021-03-19 [2021-04-19]. （原始内容存档于2021-04-21）.

ltn.com.tw (Global: 302^nd place; Chinese: 6^th place)

news.ltn.com.tw

贈台250萬劑莫德納美官員：我們的疫苗沒有附加條件. 自由時報. 2021-06-19 [2021-06-20]. （原始内容存档于2021-06-28）.
林惠琴. 6-11歲打莫德納專家拍板：2劑間隔拉長12週. 自由時報. 2022-04-20. （原始内容存档于2022-04-22）.

marketwatch.com (Global: 1,303^rd place; Chinese: 1,372^nd place)

WHO adds CanSino's COVID-19 vaccine to list of validated shots. [2022-05-19]. （原始内容存档于2022-05-19）.
Lee, Jaimy. These nine companies are working on coronavirus treatments or vaccines — here's where things stand. MarketWatch. 2020-03-07 [2020-03-07]. （原始内容存档于2020-03-18）.
Novavax's stock rallies after its COVID-19 vaccine is granted EUA in India

medicalnewstoday.com (Global: 3,011^th place; Chinese: 3,493^rd place)

What are the side effects of COVID-19 vaccines, and should you worry?. www.medicalnewstoday.com. 2021-03-22 [2021-04-06]. （原始内容存档于2021-05-17）（英语）.

medicalxpress.com (Global: 8,255^th place; Chinese: low place)

Brazil approves Pfizer COVID vaccine for widespread use. [2021-02-23]. （原始内容存档于2021-02-23）.
Russia says Sputnik V vaccine does not cause blood clots. medicalxpress.com. [2021-06-11]. （原始内容存档于2021-04-19）（英语）.

medigenvac.com (Global: low place; Chinese: low place)

高端疫苗更新團結試驗疫苗三期試驗進度. 2021-11-11 [2021-12-09]. （原始内容存档于2021-11-16）.

medpagetoday.com (Global: 9,274^th place; Chinese: low place)

Unusual Variant of Guillain-Barré Syndrome Linked to COVID Vaccines. www.medpagetoday.com. 2021-06-22 [2021-08-30]. （原始内容存档于2021-07-16）（英语）.

medrxiv.org (Global: low place; Chinese: low place)

Ella, Raches; Reddy, Siddharth; Blackwelder, William; Potdar, Varsha; Yadav, Pragya; Sarangi, Vamshi; Aileni, Vinay Kumar; Kanungo, Suman; Rai, Sanjay; Reddy, Prabhakar; Verma, Savitha; Singh, Chandramani; Redkar, Sagar; Mohapatra, Satyajit; Pandey, Anil; Ranganadin, Pajanivel; Gumashta, Raghavendra; Multani, Manish; Mohammad, Shameem; Bhatt, Parul; Kumari, Laxmi; Sapkal, Gajanan; Gupta, Nivedita; Abraham, Priya; Panda, Samiran; Prasad, Sai; Bhargava, Balram; Ella, Krishna; Vadrevu, Krishna Mohan. Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial. 2021-07-02 [2021-07-03]. doi:10.1101/2021.06.30.21259439. （原始内容存档于2021-07-17）.
Heath, Paul T.; Galiza, Eva P.; Baxter, David Neil; Boffito, Marta; Browne, Duncan; Burns, Fiona; Chadwick, David R.; Clark, Rebecca; Cosgrove, Catherine; Galloway, James; Goodman, Anna L.; Heer, Amardeep; Higham, Andrew; Iyengar, Shalini; Jamal, Arham; Jeanes, Christopher; Kalra, Philip A.; Kyriakidou, Christina; McAuley, Daniel F.; Meyrick, Agnieszka; Minassian, Angela M.; Minton, Jane; Moore, Patrick; Munsoor, Imrozia; Nicholls, Helen; Osanlou, Orod; Packham, Jonathan; Pretswell, Carol H.; Ramos, Alberto San Francisco; Saralaya, Dinesh; Sheridan, Ray P.; Smith, Richard; Soiza, Roy L.; Swift, Pauline A.; Thomson, Emma C.; Turner, Jeremy; Viljoen, Marianne Elizabeth; Albert, Gary; Cho, Iksung; Dubovsky, Filip; Glenn, Greg; Rivers, Joy; Robertson, Andreana; Smith, Kathy; Toback, Seth. Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant. medRxiv. 2021-05-14 [2021-05-25]. doi:10.1101/2021.05.13.21256639. （原始内容存档于2021-05-25）.
Yeh TY, Contreras, GP. Full vaccination suppresses SARS-CoV-2 delta variant mutation frequency. medRxiv. 2021-08-10 [2021-08-15]. doi:10.1101/2021.08.08.21261768. （原始内容存档于2021-09-13）.

mingpao.com (Global: 876^th place; Chinese: 33^rd place)

news.mingpao.com

政府曾公布36針後死個案全無證據疫苗相關何栢良對不再公布無關個案感「莫名奇妙」【附死亡個案資料】 (17:35). 明報. 2021-06-03 [2021-06-09]. （原始内容存档于2022-02-17）.

minsal.cl (Global: low place; Chinese: low place)

La vacuna CoronaVac demostró ser efectiva en un 89% para evitar hospitalizaciones UCI [CoronaVac vaccine proved to be 89% effective in preventing ICU hospitalizations] (新闻稿). Santiago: Ministry of Health (Chile). 2021-04-16 [2021-04-18]. （原始内容存档于2021-06-07）（西班牙语）.
Araos, Rafael. Efectividad de la vacuna CoronaVac con virus inactivo contra SARS-CoV-2 en Chile [Effectiveness of the CoronaVac vaccine with inactivated virus against SARS-CoV-2 in Chile] (PDF) (报告). Ministry of Health (Chile): 12-13. 2021-04-16 [2021-04-18]. （原始内容存档 (PDF)于2021-05-25）（西班牙语）.

modernatx.com (Global: low place; Chinese: low place)

investors.modernatx.com

Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates. 莫德纳. 2021-02-25 [2021-03-13]. （原始内容存档于2021-05-11）.
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day. 莫德纳. 2021-04-13 [2021-05-07]. （原始内容存档于2021-05-26）.
Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel. 莫德纳. [2021-01-09]. （原始内容存档于2021-01-22）.
United Kingdom Medicines and Healthcare products Regulatory Agency Authorizes Use of COVID-19 Vaccine Moderna. 莫德纳. [2021-01-09]. （原始内容存档于2021-01-14）.

moneydj.com (Global: low place; Chinese: 1,669^th place)

浩鼎董事會決議停止BCVax、OBI-866及OBI-999三項產品研發專案開發. MoneyDJ理財網. 2023-12-20 [2024-05-03]. （原始内容存档于2024-05-03）.

naharnet.com (Global: low place; Chinese: low place)

March 2021, Naharnet Newsdesk 01. Lebanon Authorizes Use of Chinese Vaccine Sinopharm. Naharnet. [2021-04-06]. （原始内容存档于2021-03-02）.

nasdaq.com (Global: 2,740^th place; Chinese: 1,760^th place)

EU regulator looking at new possible side-effects of mRNA COVID-19 shots. [2021-08-11]. （原始内容存档于2021-08-11）.

nationalpost.com (Global: 818^th place; Chinese: 1,332^nd place)

Mexico grants emergency use approval to China's Sinopharm COVID-19 vaccine. nationalpost. [2021-08-30] （加拿大英语）.

nature.com (Global: 234^th place; Chinese: 227^th place)

Mallapaty, Smriti; Callaway, Ewen; Kozlov, Max; Ledford, Heidi; Pickrell, John; Van Noorden, Richard. How COVID vaccines shaped 2021 in eight powerful charts. Nature. 2021-12-23, 600 (7890): 580-583 [2024-08-14]. Bibcode:2021Natur.600..580M. ISSN 0028-0836. PMID 34916666. S2CID 245262732. doi:10.1038/d41586-021-03686-x. （原始内容存档于2021-12-16）（英语）.
Butler, Declan. SARS veterans tackle coronavirus. Nature. 2012-10, 490 (7418): 20–20 [2021-02-21]. ISSN 0028-0836. doi:10.1038/490020a. （原始内容存档于2021-11-06）（英语）.
Mullard, Asher. How COVID vaccines are being divvied up around the world. Nature. 2020-11-30: d41586–020–03370–6 [2021-02-21]. ISSN 0028-0836. PMID 33257891. doi:10.1038/d41586-020-03370-6. （原始内容存档于2021-02-24）（英语）.

nbcnews.com (Global: 137^th place; Chinese: 538^th place)

Sara G. Miller; Erika Edwards. J&J applies for emergency authorization; FDA expected to greenlight in coming weeks. NBC新闻. 2021-02-04 [2021-02-07]. （原始内容存档于2021-02-25）.

nbd.com.cn (Global: low place; Chinese: 390^th place)

奥地利叫停接种一批阿斯利康疫苗：1人接种后因严重凝血功能障碍死亡，1人发生肺栓塞. 每经网. [2021-04-06]. （原始内容存档于2021-03-11）.

ndtv.com (Global: 138^th place; Chinese: 1,399^th place)

Parimal Kumar; Debanish Achom. No Fresh Registrations For Healthcare Workers For Covid Vaccine: Centre. NDTV.com. 2021-04-04 [2021-05-11]. （原始内容存档于2021-05-26）（英语）.

nejm.org (Global: 2,374^th place; Chinese: 1,457^th place)

Fauci, Anthony S.; Lane, H. Clifford; Redfield, Robert R. Covid-19 — Navigating the Uncharted. New England Journal of Medicine. 2020-03-26, 382 (13): 1268–1269 [2021-02-21]. ISSN 0028-4793. PMC 7121221 . PMID 32109011. doi:10.1056/NEJMe2002387. （原始内容存档于2021-02-25）（英语）.
Gates, Bill. Responding to Covid-19 — A Once-in-a-Century Pandemic?. New England Journal of Medicine. 2020-04-30, 382 (18): 1677–1679 [2021-02-21]. ISSN 0028-4793. doi:10.1056/NEJMp2003762. （原始内容存档于2020-10-18）（英语）.
Jerald Sadoff; Glenda Gray; An Vandebosch; Vicky Cárdenas; Georgi Shukarev; Beatriz Grinsztejn; Paul A. Goepfert; Carla Truyers; Hein Fennema; Bart Spiessens; Kim Offergeld; Gert Scheper. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. 新英格兰医学杂志. 2021-04-21 [2021-05-16]. doi:10.1056/NEJMoa2101544. （原始内容存档于2021-05-16）.

news-medical.net (Global: 8,069^th place; Chinese: 8,814^th place)

CDC study shows risk of Guillain-Barré syndrome elevated after Ad.26.COV2.S COVID vaccination. [2021-12-12]. （原始内容存档于2021-12-15）.

news.cn (Global: 1,956^th place; Chinese: 86^th place)

印度累计接种新冠疫苗10亿剂次. [2021-10-21]. （原始内容存档于2021-10-21）.
法国将推进新冠疫苗加强针接种. [2021-11-10]. （原始内容存档于2021-11-10）.
智利给予中国科兴新冠疫苗在6岁至17岁人群中紧急使用许可. [2021-09-07]. （原始内容存档于2021-09-07）.

newssc.org (Global: low place; Chinese: 1,763^rd place)

scnews.newssc.org

全球首个！川大华西/威斯克生物研发的针对XBB等新冠病毒的疫苗获批紧急使用. 四川新闻网. 2023-06-08 [2023-06-11]. ^{[失效連結]}

newstracklive.com (Global: low place; Chinese: low place)

english.newstracklive.com

Nepal approves Chinese Sinopharm COVID-19 vaccine, making first purchase from India. 2021-02-18 [2021-02-18]. （原始内容存档于2021-02-18）.

nhc.gov.cn (Global: low place; Chinese: 2,074^th place)

新冠病毒疫苗接种技术指南（第一版）. ^{[失效連結]}
新冠病毒疫苗接种技术指南（第一版）. 疾病预防控制局. 2021-03-29 [2021-04-03]. ^{[失效連結]}

nhs.uk (Global: 1,989^th place; Chinese: 2,409^th place)

SARS (severe acute respiratory syndrome). National Health Service. 2020-03-05 [2020-01-31]. （原始内容存档于2020-03-09）.

nih.gov (Global: 4^th place; Chinese: 5^th place)

ncbi.nlm.nih.gov

Li, Yen-Der; Chi, Wei-Yu; Su, Jun-Han; Ferrall, Louise; Hung, Chien-Fu; Wu, T.-C. Coronavirus vaccine development: from SARS and MERS to COVID-19. Journal of Biomedical Science. 2020-12, 27 (1): 104 [2024-08-14]. ISSN 1423-0127. PMC 7749790 . PMID 33341119. doi:10.1186/s12929-020-00695-2. （原始内容存档于2021-02-19）（英语）.
Subbarao, Kanta. The success of SARS-CoV-2 vaccines and challenges ahead. Cell Host & Microbe. 2021-07, 29 (7): 1111-1123 [2024-08-14]. ISSN 1931-3128. PMC 8279572 . PMID 34265245. doi:10.1016/j.chom.2021.06.016. （原始内容存档于2025-01-16）.
Mallapaty, Smriti; Callaway, Ewen; Kozlov, Max; Ledford, Heidi; Pickrell, John; Van Noorden, Richard. How COVID vaccines shaped 2021 in eight powerful charts. Nature. 2021-12-23, 600 (7890): 580-583 [2024-08-14]. Bibcode:2021Natur.600..580M. ISSN 0028-0836. PMID 34916666. S2CID 245262732. doi:10.1038/d41586-021-03686-x. （原始内容存档于2021-12-16）（英语）.
Watson, Oliver J; Barnsley, Gregory; Toor, Jaspreet; Hogan, Alexandra B; Winskill, Peter; Ghani, Azra C. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. The Lancet Infectious Diseases. 2022-09, 22 (9): 1293-1302. ISSN 1473-3099. PMC 9225255 . PMID 35753318. doi:10.1016/s1473-3099(22)00320-6.
Wang, Hui; Xu, Ran; Qu, Shijin; Schwartz, Marlene; Adams, Aaron; Chen, Xiang. Health inequities in COVID-19 vaccination among the elderly: Case of Connecticut. Journal of Infection and Public Health. October 2021, 14 (10): 1563–1565 [29 December 2022]. PMID 34326008. S2CID 236515442. doi:10.1016/j.jiph.2021.07.013. （原始内容存档于2022-12-29）.
Cavanagh, Dave. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathology. 2003-12, 32 (6): 567–582 [2021-02-21]. ISSN 0307-9457. PMC 7154303 . PMID 14676007. doi:10.1080/03079450310001621198. （原始内容存档于2020-09-29）（英语）.
Gao, Wentao; Tamin, Azaibi; Soloff, Adam; D'Aiuto, Leonardo; Nwanegbo, Edward; Robbins, Paul D; Bellini, William J; Barratt-Boyes, Simon; Gambotto, Andrea. Effects of a SARS-associated coronavirus vaccine in monkeys. The Lancet. 2003-12, 362 (9399): 1895–1896 [2021-02-21]. PMC 7112457 . PMID 14667748. doi:10.1016/S0140-6736(03)14962-8. （原始内容存档于2020-12-20）（英语）.
Kim, Eun; Okada, Kaori; Kenniston, Tom; Raj, V. Stalin; AlHajri, Mohd M.; Farag, Elmoubasher A.B.A.; AlHajri, Farhoud; Osterhaus, Albert D.M.E.; Haagmans, Bart L. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice. Vaccine. 2014-10, 32 (45): 5975–5982 [2021-02-21]. PMC 7115510 . PMID 25192975. doi:10.1016/j.vaccine.2014.08.058. （原始内容存档于2020-12-22）（英语）.
Jiang, Shibo; Lu, Lu; Du, Lanying. Development of SARS vaccines and therapeutics is still needed. Future Virology. 2013-01, 8 (1): 1–2 [2021-02-21]. ISSN 1746-0794. PMC 7079997 . PMID 32201503. doi:10.2217/fvl.12.126. （原始内容存档于2020-10-19）（英语）.
Greenough, Thomas C.; Babcock, Gregory J.; Roberts, Anjeanette; Hernandez, Hector J.; Thomas, Jr., William D.; Coccia, Jennifer A.; Graziano, Robert F.; Srinivasan, Mohan; Lowy, Israel. Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice. The Journal of Infectious Diseases. 2005-02-15, 191 (4): 507–514 [2021-02-21]. ISSN 0022-1899. PMC 7110081 . PMID 15655773. doi:10.1086/427242. （原始内容存档于2017-07-28）（英语）.
Tripp, Ralph A.; Haynes, Lia M.; Moore, Deborah; Anderson, Barbara; Tamin, Azaibi; Harcourt, Brian H.; Jones, Les P.; Yilla, Mamadi; Babcock, Gregory J. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. Journal of Virological Methods. 2005-09, 128 (1-2): 21–28 [2021-02-21]. PMC 7112802 . PMID 15885812. doi:10.1016/j.jviromet.2005.03.021. （原始内容存档于2020-10-01）（英语）.
Roberts, Anjeanette; Thomas, William D.; Guarner, Jeannette; Lamirande, Elaine W.; Babcock, Gregory J.; Greenough, Thomas C.; Vogel, Leatrice; Hayes, Norman; Sullivan, John L. Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters. The Journal of Infectious Diseases. 2006-03, 193 (5): 685–692 [2021-02-21]. ISSN 0022-1899. PMC 7109703 . PMID 16453264. doi:10.1086/500143. （原始内容存档于2017-07-27）（英语）.
Shehata, Mahmoud M.; Gomaa, Mokhtar R.; Ali, Mohamed A.; Kayali, Ghazi. Middle East respiratory syndrome coronavirus: a comprehensive review. Frontiers of Medicine. 2016-06, 10 (2): 120–136. ISSN 2095-0217. PMC 7089261 . PMID 26791756. doi:10.1007/s11684-016-0430-6 （英语）.
Modjarrad, Kayvon; Roberts, Christine C; Mills, Kristin T; Castellano, Amy R; Paolino, Kristopher; Muthumani, Kar; Reuschel, Emma L; Robb, Merlin L; Racine, Trina. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. The Lancet Infectious Diseases. 2019-09, 19 (9): 1013–1022 [2021-02-21]. PMC 7185789 . PMID 31351922. doi:10.1016/S1473-3099(19)30266-X. （原始内容存档于2021-01-23）（英语）.
Yong, Chean Yeah; Ong, Hui Kian; Yeap, Swee Keong; Ho, Kok Lian; Tan, Wen Siang. Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus. Frontiers in Microbiology. 2019-08-02, 10: 1781. ISSN 1664-302X. PMC 6688523 . PMID 31428074. doi:10.3389/fmicb.2019.01781.
Mullard, Asher. How COVID vaccines are being divvied up around the world. Nature. 2020-11-30: d41586–020–03370–6 [2021-02-21]. ISSN 0028-0836. PMID 33257891. doi:10.1038/d41586-020-03370-6. （原始内容存档于2021-02-24）（英语）.
So, Anthony D; Woo, Joshua. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. 2020-12-15: m4750 [2021-02-21]. ISSN 1756-1833. PMC 7735431 . PMID 33323376. doi:10.1136/bmj.m4750. （原始内容存档于2020-12-16）（英语）.
Fauci, Anthony S.; Lane, H. Clifford; Redfield, Robert R. Covid-19 — Navigating the Uncharted. New England Journal of Medicine. 2020-03-26, 382 (13): 1268–1269 [2021-02-21]. ISSN 0028-4793. PMC 7121221 . PMID 32109011. doi:10.1056/NEJMe2002387. （原始内容存档于2021-02-25）（英语）.
Tanriover, Mine Durusu; Doğanay, Hamdi Levent; Akova, Murat; Güner, Hatice Rahmet; Azap, Alpay; Akhan, Sıla; Köse, Şükran; Erdinç, Fatma Şebnem; Akalın, Emin Halis. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. The Lancet. 2021-07-17, 398 (10296): 213–222. ISSN 0140-6736. PMID 34246358. doi:10.1016/S0140-6736(21)01429-X （英语）.
Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L.; Grousova, Daria M. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet (London, England). 2021-02-20, 397 (10275): 671–681 [2021-04-06]. ISSN 1474-547X. PMC 7852454 . PMID 33545094. doi:10.1016/S0140-6736(21)00234-8. （原始内容存档于2021-05-27）.
Voysey, Merryn; Costa Clemens, Sue Ann; Madhi, Shabir A; Weckx, Lily Y; Folegatti, Pedro M; Aley, Parvinder K; Angus, Brian; Baillie, Vicky L; Barnabas, Shaun L. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. 柳叶刀. 2021-03, 397 (10277): 881–891 [2021-04-06]. PMC 7894131 . PMID 33617777. doi:10.1016/S0140-6736(21)00432-3. （原始内容存档于2021-05-28）（英语）.
Singanayagam, Anika; Hakki, Seran; Dunning, Jake; Madon, Kieran J.; Crone, Michael A.; Koycheva, Aleksandra; Derqui-Fernandez, Nieves; Barnett, Jack L.; Whitfield, Michael G. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet. Infectious Diseases. 2021-10-29: S1473–3099(21)00648–4 [2021-12-04]. ISSN 1474-4457. PMC 8554486 . PMID 34756186. doi:10.1016/S1473-3099(21)00648-4. （原始内容存档于2021-12-28）.
Singanayagam, Anika; Hakki, Seran; Dunning, Jake; Madon, Kieran J.; Crone, Michael A.; Koycheva, Aleksandra; Derqui-Fernandez, Nieves; Barnett, Jack L.; Whitfield, Michael G. ” transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet Infectious Diseases. 2021-10-29, 0 (0) [2021-12-04]. ISSN 1473-3099. PMID 34756186. doi:10.1016/S1473-3099(21)00648-4. （原始内容存档于2023-07-30）（英语）.
Greinacher, Andreas; Thiele, Thomas; Warkentin, Theodore E.; Weisser, Karin; Kyrle, Paul A.; Eichinger, Sabine. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. New England Journal of Medicine. 2021-06-03, 384 (22): 2092–2101. ISSN 0028-4793. PMC 8095372 . PMID 33835769. doi:10.1056/NEJMoa2104840.
Schultz, Nina H.; Sørvoll, Ingvild H.; Michelsen, Annika E.; Munthe, Ludvig A.; Lund-Johansen, Fridtjof; Ahlen, Maria T.; Wiedmann, Markus; Aamodt, Anne-Hege; Skattør, Thor H. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. New England Journal of Medicine. 2021-06-03, 384 (22): 2124–2130. ISSN 0028-4793. PMC 8112568 . PMID 33835768. doi:10.1056/NEJMoa2104882.
Muir, Kate-Lynn; Kallam, Avyakta; Koepsell, Scott A.; Gundabolu, Krishna. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. New England Journal of Medicine. 2021-05-20, 384 (20): 1964–1965. ISSN 0028-4793. PMC 8063883 . PMID 33852795. doi:10.1056/NEJMc2105869.

dailymed.nlm.nih.gov

Moderna COVID-19 Vaccine – cx-024414 injection, suspension. DailyMed. U.S. National Institutes of Health. [2020-12-20]. （原始内容存档于2021-04-04）.
Pfizer-BioNTech COVID-19 Vaccine – rna ingredient bnt-162b2 injection, suspension. DailyMed. U.S. National Institutes of Health. [2020-12-14]. （原始内容存档于2021-01-29）.
DailyMed - JANSSEN COVID-19 VACCINE- ad26.cov2.s injection, suspension. dailymed.nlm.nih.gov. [2021-04-06]. （原始内容存档于2021-05-12）.

pubmed.ncbi.nlm.nih.gov

Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L.; Grousova, Daria M. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet (London, England). 2021-02-20, 397 (10275): 671–681 [2021-04-06]. ISSN 1474-547X. PMC 7852454 . PMID 33545094. doi:10.1016/S0140-6736(21)00234-8. （原始内容存档于2021-05-27）.
Singanayagam, Anika; Hakki, Seran; Dunning, Jake; Madon, Kieran J.; Crone, Michael A.; Koycheva, Aleksandra; Derqui-Fernandez, Nieves; Barnett, Jack L.; Whitfield, Michael G. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet. Infectious Diseases. 2021-10-29: S1473–3099(21)00648–4 [2021-12-04]. ISSN 1474-4457. PMC 8554486 . PMID 34756186. doi:10.1016/S1473-3099(21)00648-4. （原始内容存档于2021-12-28）.

nih.gov

NIH clinical trial of investigational vaccine for COVID-19 begins. US National Institutes of Health. 2020-03-16 [2020-03-17]. （原始内容存档于2020-03-19）（英语）.

novastan.org (Global: low place; Chinese: low place)

Leo Friedrich. Covid-19: Kazakhstan starts rollout of its QazVac jab. Novastan. 2021-04-27 [2021-04-28]. （原始内容存档于2021-04-30）.

novavax.com (Global: low place; Chinese: low place)

ir.novavax.com

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial. 诺瓦瓦克斯医药. 2021-06-14 [2021-06-14]. （原始内容存档于2021-06-23）.
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial. Novavax Inc. - IR Site. [2021-03-03]. （原始内容存档于2021-06-06）.

nseindia.com (Global: 9,492^nd place; Chinese: low place)

archives.nseindia.com

Zydus applies to the DCGI for EUA to launch ZyCoV-D, the world’s first Plasmid DNA vaccine for COVID-19 (PDF). Zydus Cadila. 2021-07-01 [2021-07-21]. （原始内容存档 (PDF)于2021-07-01）.

nytimes.com (Global: 7^th place; Chinese: 31^st place)

nytimes.com

Carl Zimmer; Ernesto Londoño. Turkey and Brazil Say Chinese Vaccine Effective, With Sparse Supporting Data. 纽约时报. 2020-12-25 [2021-02-27]. （原始内容存档于2021-05-09）.
Emily Schmall; Sameer Yasir. India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other. 纽约时报. 2021-01-03 [2021-02-24]. （原始内容存档于2021-01-09）.
Andrew E. Kramer. Russia Approves Coronavirus Vaccine Before Completing Tests. 纽约时报. 2020-08-11 [2021-02-25]. （原始内容存档于2021-02-18）.
Andrew E. Kramer. Russia’s Vaccine Is Safe and Effective, Published Study Shows. 纽约时报. 2021-02-02 [2021-02-25]. （原始内容存档于2021-02-24）.
Katherine J. Wu; Carl Zimmer; Sharon LaFraniere; Noah Weiland. Two Companies Restart Virus Trials in U.S. After Safety Pauses. 纽约时报. 2020-10-23 [2021-02-26]. （原始内容存档于2020-10-25）.
Carl Zimmer; Noah Weiland; Sharon LaFraniere. Johnson & Johnson’s Vaccine Works Well and May Curb Virus Spread. 纽约时报. 2021-02-24 [2021-02-26]. （原始内容存档于2021-06-05）.
Denise Grady. Moderna and Pfizer Begin Late-Stage Vaccine Trials. 纽约时报. 2020-07-27 [2021-02-20]. （原始内容存档于2020-07-27）.
Denise Grady. Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective. 纽约时报. 2020-11-16 [2021-02-20]. （原始内容存档于2021-02-24）.
Emily Schmall; Sameer Yasir. India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other. 纽约时报. 2021-01-03 [2021-01-03]. （原始内容存档于2021-01-09）.
Bryan Pietsch. Mexico approved the Oxford-AstraZeneca vaccine for emergency use.. 纽约时报. 2021-01-04 [2021-01-07]. （原始内容存档于2021-01-17）.
Anthes, Emily. The W.H.O. grants emergency authorization to the Johnson & Johnson vaccine, a boost for global vaccination efforts.. The New York Times. 2021-03-12 [2021-04-06]. ISSN 0362-4331. （原始内容存档于2021-04-28）（美国英语）.
Ian Austen. Canada approves the Moderna vaccine, paving the way for inoculations in its vast Far North.. 纽约时报. 2020-12-23 [2021-01-11]. （原始内容存档于2021-01-24）.
Ian Austen. Canada Approves Vaccine and Could Start Shots Next Week. 纽约时报. 2020-12-09 [2021-01-11]. （原始内容存档于2021-01-24）.
Carl Zimmer; Jonathan Corum; Sui-Lee Wee. Coronavirus Vaccine Tracker. 纽约时报. 2021-01-25 [2021-01-25]. （原始内容存档于2020-12-24）.
Thomas, Katie. F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away. The New York Times. 2020-11-20 [2020-12-11]. （原始内容存档于2020-12-12）.
Noah Weiland; Sharon LaFraniere. F.D.A. Clears Johnson & Johnson’s Shot, the Third Vaccine for U.S.. 纽约时报. 2021-02-27 [2021-02-27]. （原始内容存档于2021-06-06）.
Sheryl Gay Stolberg; Sharon LaFraniere. Biden Promises 100 Million Vaccine Shots in 100 Days, but Shortage Worries Rise. 纽约时报. 2020-12-08 [2021-01-27]. （原始内容存档于2021-01-29）.
Sheryl Gay Stolberg. Biden Raises Daily Vaccination Target and Extends Travel Bans. 纽约时报. 2021-01-25 [2021-02-13]. （原始内容存档于2021-02-25）.
Covid-19: Alaska Becomes First State to Open Vaccine Access to Everyone 16 and Older. 纽约时报. 2021-03-09 [2021-03-16]. （原始内容存档于2021-05-19）.
Weiland, Noah; LaFraniere, Sharon; Zimmer, Carl. U.S. Calls for Pause on Johnson & Johnson Vaccine After Clotting Cases. The New York Times. 2021-04-13 [2021-04-13]. ISSN 0362-4331. （原始内容存档于2021-06-07）（美国英语）.
LaFraniere, Sharon; Weiland, Noah. F.D.A. Will Attach Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine. The New York Times. 2021-07-12 [2021-07-12]. ISSN 0362-4331. （原始内容存档于2021-07-12）（美国英语）.
Prabhala, Achal; Jayadev, Arjun; Baker, Dean. Opinion | Want Vaccines Fast? Suspend Intellectual Property Rights. 紐約時報. 2020-12-07 [2021-05-07]. （原始内容存档于2021-06-06）（英语）.

cn.nytimes.com

简报：拜登面临对华政策难题；莫德纳疫苗有效性达94.5%. [2020-11-17]. （原始内容存档于2020-11-17）.

on.cc (Global: 495^th place; Chinese: 21^st place)

hk.on.cc

一周內多10人死前曾接種新冠疫苗　5名孕婦針後流產. 東方日報. 2021-05-26 [2021-06-04]. （原始内容存档于2021-05-26）.
疫苗監測數據欠透明　港府圖冚死亡個案　何栢良：莫名其妙. 東方日報. 2021-06-03 [2021-06-22]. （原始内容存档于2021-06-04）.
面癱列科興疫苗副作用　港府僅更新網站資訊未對外公布. 東方日報. 2021-07-15 [2021-07-21]. （原始内容存档于2021-07-21）.

oup.com (Global: 485^th place; Chinese: 489^th place)

academic.oup.com

Greenough, Thomas C.; Babcock, Gregory J.; Roberts, Anjeanette; Hernandez, Hector J.; Thomas, Jr., William D.; Coccia, Jennifer A.; Graziano, Robert F.; Srinivasan, Mohan; Lowy, Israel. Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice. The Journal of Infectious Diseases. 2005-02-15, 191 (4): 507–514 [2021-02-21]. ISSN 0022-1899. PMC 7110081 . PMID 15655773. doi:10.1086/427242. （原始内容存档于2017-07-28）（英语）.
Roberts, Anjeanette; Thomas, William D.; Guarner, Jeannette; Lamirande, Elaine W.; Babcock, Gregory J.; Greenough, Thomas C.; Vogel, Leatrice; Hayes, Norman; Sullivan, John L. Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters. The Journal of Infectious Diseases. 2006-03, 193 (5): 685–692 [2021-02-21]. ISSN 0022-1899. PMC 7109703 . PMID 16453264. doi:10.1086/500143. （原始内容存档于2017-07-27）（英语）.

ourworldindata.org (Global: 2,263^rd place; Chinese: 5,757^th place)

Coronavirus (COVID-19) Vaccinations. Our World in Data. [2021-01-01]. （原始内容存档于2021-01-24）.

people.com.cn (Global: 351^st place; Chinese: 20^th place)

world.people.com.cn

爱尔兰收紧疫情防控措施扩大加强针接种范围. [2021-11-17]. （原始内容存档于2021-11-23）.

pfizer.com (Global: low place; Chinese: 7,863^rd place)

PFIZER AND BIONTECH CONFIRM HIGH EFFICACY AND NO SERIOUS SAFETY CONCERNS THROUGH UP TO SIX MONTHS FOLLOWING SECOND DOSE IN UPDATED TOPLINE ANALYSIS OF LANDMARK COVID-19 VACCINE STUDY. 辉瑞. 2021-04-01 [2021-05-07]. （原始内容存档于2021-04-17）.
Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine. 辉瑞. 2020-11-20 [2020-11-27]. （原始内容存档于2021-01-24）.

politico.eu (Global: 1,347^th place; Chinese: 2,260^th place)

EU regulator green-lights Novavax COVID-19 vaccine. [2021-12-20]. （原始内容存档于2021-12-20）.

politifact.com (Global: 3,208^th place; Chinese: 7,644^th place)

Kertscher, Tom. No, there is no vaccine for the Wuhan coronavirus. PolitiFact. Poynter Institute. 2020-01-23 [2020-02-07]. （原始内容存档于2020-02-07）.

precisionvaccinations.com (Global: low place; Chinese: low place)

Europe Confirms mRNA Vaccines Can Cause Heart Disease. www.precisionvaccinations.com. [2021-08-30]. （原始内容存档于2021-07-23）（美国英语）.

pts.org.tw (Global: 4,825^th place; Chinese: 167^th place)

news.pts.org.tw

黃韻玲. 古巴大規模接種自製新冠疫苗有望改善拉丁美洲疫情. 公視新聞網. 2021-05-13 [2021-05-14]. （原始内容存档于2021-05-14）（中文（繁體））.

qq.com (Global: 381^st place; Chinese: 15^th place)

mp.weixin.qq.com

康希诺生物. 重磅 | 康希诺生物全球首个吸入用新冠疫苗在中国获批紧急使用. 微信公众平台. [2022-09-06].
复旦牵头研发国产新冠mRNA疫苗，取得里程碑式进展！. 复旦大学. 2023-12-01 [2023-12-01]. 复旦大学/上海蓝鹊/沃森生物联合研发的新型冠状病毒变异株mRNA疫苗（Omicron XBB.1.5）——RQ3033疫苗沃蓝安安®纳入紧急使用

new.qq.com

智飞生物与中科院微生物所合作研发的新冠疫苗获批紧急使用_腾讯新闻. new.qq.com. [2021-04-06]. （原始内容存档于2021-08-17）.
法国：明起第一批接种疫苗将在医院和养老院进行. 腾讯新闻. 2020-12-26 [2021-04-06]. （原始内容存档于2021-08-18）.

rappler.com (Global: 874^th place; Chinese: 4,417^th place)

Philippines grants emergency approval for Sinovac vaccine. [2021-02-22]. （原始内容存档于2021-02-22）.
WHO plans slew of COVID-19 vaccine approvals for global rollout – document. [2021-01-20]. （原始内容存档于2021-01-20）.

rdif.ru (Global: low place; Chinese: low place)

Belarus becomes the first foreign country to register the Sputnik V vaccine. 俄罗斯直接投资基金会. 2020-12-21 [2021-01-31]. （原始内容存档于2021-01-26）.
Palestine has become the first country in the Middle East to register Sputnik V vaccine. 俄罗斯直接投资基金会. 2021-01-11 [2021-01-11]. （原始内容存档于2021-01-13）.
Sputnik V vaccine registered in Venezuela. 俄罗斯直接投资基金会. 2021-01-13 [2021-01-19]. （原始内容存档于2021-10-06）.
Sputnik V vaccine approved in Paraguay. 俄罗斯直接投资基金会. 2021-01-15 [2021-01-19]. （原始内容存档于2021-10-06）.
Hungary becomes the first country in EU to authorize the Sputnik V vaccine. 俄罗斯直接投资基金会. 2021-01-21 [2021-01-24]. （原始内容存档于2021-10-06）.
Sputnik V vaccine authorized in the Republic of Guinea. 俄罗斯直接投资基金会. 2021-01-29 [2021-01-31]. （原始内容存档于2021-01-29）.
Single dose vaccine, Sputnik Light, authorized for use in Russia. 俄罗斯直接投资基金会. 2021-05-06 [2021-05-08]. （原始内容存档于2021-05-20）.

republicworld.com (Global: low place; Chinese: 4,863^rd place)

Iraq Approves Sinopharm, AstraZeneca COVID-19 Vaccines For Emergency Use Against COVID-19. [2021-01-20]. （原始内容存档于2021-01-22）.

reuters.com (Global: 49^th place; Chinese: 81^st place)

rfa.org (Global: 1,893^rd place; Chinese: 94^th place)

经纬. 梒青、何足 , 编. 中国悄然停止接种免费新冠疫苗. 自由亚洲电台. 2024-07-09 [202-07-11]. （原始内容存档于2024-10-02）（中文）.
全國逾2億疫苗接種「零死亡」通報　香港130萬劑25卒21人打科興. RFA. 2021-04-27 [2021-06-25]. （原始内容存档于2021-04-28）.

rferl.org (Global: 737^th place; Chinese: 997^th place)

Russia Approves CoviVac, Its Third Coronavirus Vaccine. 自由欧洲电台／自由电台. 2021-02-21 [2021-02-23]. （原始内容存档于2021-02-24）.

rfi.fr (Global: 559^th place; Chinese: 76^th place)

普京宣布俄完成全球首个新冠持久疫苗女儿也参加了接种测试. RFI - 法国国际广播电台. 2020-08-11 [2021-02-21]. （原始内容存档于2020-08-12）（中文（简体））.
俄称自家疫苗更好效率达92%. RFI - 法国国际广播电台. 2020-11-11 [2021-02-21]. （原始内容存档于2020-11-11）（中文（简体））.
印度國產Covaxin疫苗獲世衛批准效力達78%. RFI. 2021-11-03 [2021-11-26]. （原始内容存档于2021-11-26）.
Novavax疫苗入列為世衛第10支緊急使用疫苗. RFI. 2021-12-22 [2022-01-01]. （原始内容存档于2022-04-18）.
约旦授权紧急使用中国国药集团新冠疫苗. [2021-01-10]. （原始内容存档于2021-01-11）.
英国药厂阿斯利康巴西新冠疫苗测试一名志愿者死亡. [2020-10-22]. （原始内容存档于2020-10-24）.
继批准使用中国疫苗后巴林紧急批准使用辉瑞疫苗. [2020-12-07]. （原始内容存档于2020-12-06）.
接種科興疫苗後第7人死亡信心受挫致僅3%人口接種港府大擴接種群組. 法國國際廣播電台. 2021-03-16 [2021-03-16]. （原始内容存档于2021-03-17）.

rthk.hk (Global: 2,797^th place; Chinese: 109^th place)

news.rthk.hk

李克強：中國願為全球疫苗免疫聯盟籌資周期提供捐助. 香港電台. 2020-06-04 [2020-06-04]. （原始内容存档于2020-06-05）（中文（香港））.
首批國藥10萬劑疫苗周五抵澳門　料農曆新年前後接種. 香港电台. 2021-02-01 [2021-02-01]. （原始内容存档于2021-12-18）.
賀一誠和澳門主要官員接種新冠疫苗. [2021-02-09]. （原始内容存档于2021-02-12）.
美國一半成年國民已至少接種一劑疫苗　當局稱里程碑. [2021-05-14]. （原始内容存档于2021-05-14）.
英國7名曾接種阿斯利康疫苗人士出現血栓其後死亡 - RTHK. news.rthk.hk. [2021-04-06]. （原始内容存档于2021-04-03）（中文（臺灣））.
印尼總統佐科維多多公開接種中國科興新冠疫苗. 香港电台. 2021-01-13 [2021-01-14].
歐洲藥品管理局指阿斯利康疫苗安全多國恢復接種 - RTHK. news.rthk.hk. [2021-04-06] （中文（臺灣））.

gbcode.rthk.hk

法庭裁决阿斯利康9月27日前向欧盟交付5千万剂疫苗. [2021-06-19]. （原始内容存档于2021-06-24）.

rti.org.tw (Global: 5,831^st place; Chinese: 230^th place)

告別2020 輝瑞疫苗獲得世衛第一支緊急核准. 中央廣播電台. 2021-01-01 [2021-02-27]. （原始内容存档于2021-01-26）.

sciencedirect.com (Global: 149^th place; Chinese: 292^nd place)

Wang, Hui; Xu, Ran; Qu, Shijin; Schwartz, Marlene; Adams, Aaron; Chen, Xiang. Health inequities in COVID-19 vaccination among the elderly: Case of Connecticut. Journal of Infection and Public Health. October 2021, 14 (10): 1563–1565 [29 December 2022]. PMID 34326008. S2CID 236515442. doi:10.1016/j.jiph.2021.07.013. （原始内容存档于2022-12-29）.

sciencemag.org (Global: 857^th place; Chinese: 506^th place)

science.sciencemag.org

Thorp, H. Holden. Underpromise, overdeliver (PDF). American Association for the Advancement of Science. 2020-03-23 [2020-03-23]. （原始内容存档 (PDF)于2020-03-24）（英语）.

sciencemag.org

Wadman, Meredith. Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less potent in South Africa. Science. 2021-01-28 [2021-04-06]. ISSN 0036-8075. doi:10.1126/science.abg8101. （原始内容存档于2021-05-25）.

blogs.sciencemag.org

Vaccine Side Effects Q and A | In the Pipeline. blogs.sciencemag.org. 2021-04-14 [2021-06-11]. （原始内容存档于2021-04-23）（美国英语）.

semanticscholar.org (Global: 11^th place; Chinese: 332^nd place)

api.semanticscholar.org

Mallapaty, Smriti; Callaway, Ewen; Kozlov, Max; Ledford, Heidi; Pickrell, John; Van Noorden, Richard. How COVID vaccines shaped 2021 in eight powerful charts. Nature. 2021-12-23, 600 (7890): 580-583 [2024-08-14]. Bibcode:2021Natur.600..580M. ISSN 0028-0836. PMID 34916666. S2CID 245262732. doi:10.1038/d41586-021-03686-x. （原始内容存档于2021-12-16）（英语）.
Wang, Hui; Xu, Ran; Qu, Shijin; Schwartz, Marlene; Adams, Aaron; Chen, Xiang. Health inequities in COVID-19 vaccination among the elderly: Case of Connecticut. Journal of Infection and Public Health. October 2021, 14 (10): 1563–1565 [29 December 2022]. PMID 34326008. S2CID 236515442. doi:10.1016/j.jiph.2021.07.013. （原始内容存档于2022-12-29）.

shinyapps.io (Global: low place; Chinese: low place)

vac-lshtm.shinyapps.io

COVID-19 vaccine development pipeline (Refresh URL to update). Vaccine Centre, London School of Hygiene and Tropical Medicine. 2021-01-18 [2021-01-18]. （原始内容存档于2020-05-18）.

sina.com.cn (Global: 144^th place; Chinese: 3^rd place)

finance.sina.com.cn

澳官员:阿斯利康新冠疫苗开始在澳大利亚生产预计明年3月上市. [2020-11-09]. （原始内容存档于2020-11-09）.
研发新冠疫苗全球96个团队谁能跑赢？. 新浪财经. 2020-03-20 [2020-03-20]. （原始内容存档于2020-03-20）.
李潇潇. 陈薇院士团队与康希诺生物新冠疫苗附条件上市申请获受理. 澎湃新闻. 2021-02-24 [2021-02-24]. （原始内容存档于2021-08-19）.
唐唯珂. 首批50余万支！粤产首款新冠疫苗在深圳开始接种. 21世纪经济报道. 新浪网. 2021-06-01 [2021-06-01]. （原始内容存档于2021-06-02）.
万泰生物研发、国内首款鼻喷新冠疫苗获紧急使用，已有10款新冠疫苗附条件上市或紧急使用. [2022-12-16]. （原始内容存档于2022-12-21）.
中国生物重组新冠病毒疫苗获批临床试验，系其第三款新冠疫苗. [2021-04-12]. （原始内容存档于2021-04-12）.
央视. 国家卫健委：附条件上市后疫苗免费接种相关费用将由医保基金和财政共同负担. 新浪. 2021-01-09 [2021-01-09]. （原始内容存档于2021-01-11）.
界面快报. 俄罗斯批准单剂新冠疫苗“卫星-Light”，称其有效率超79%. finance.sina.com.cn. 2021-05-06 [2021-06-11]. （原始内容存档于2021-08-19）.
《巴基斯坦授权紧急使用中国科兴新冠疫苗》. 新浪. [2021-04-09].
阿联酋：目标人口100%已接种至少一剂新冠疫苗. [2021-11-28]. （原始内容存档于2021-11-28）.
印度开打新冠疫苗加强针. [2022-01-11]. （原始内容存档于2022-01-11）.
法国扩大新冠疫苗加强针接种范围. [2021-11-26]. （原始内容存档于2021-11-26）.
央视. 欧洲药监局依然推荐接种阿斯利康疫苗. finance.sina.com.cn. 2021-03-19 [2021-04-06]. （原始内容存档于2021-03-22）.
程立. 美新冠疫苗进临床阶段专家:太快了,除非更早拿到病毒株. 新浪网新闻. 北京. [2020-03-18]. （原始内容存档于2020-03-18）（中文（中国大陆））.
果壳网. 辉瑞疫苗真实有效率只有29%？这个质疑很荒谬. 新浪. 2021-01-13 [2021-01-17]. （原始内容存档于2021-01-20）. ^{[需要較佳来源]}

vip.stock.finance.sina.com.cn

神州细胞：自愿披露关于控股子公司新冠疫苗SCTV01C被纳入紧急使用的公告. [2023-02-18]. （原始内容存档于2023-02-18）.

tech.sina.com.cn

澳大利亚叫停一本土新冠疫苗研发：部分接种后出现HIV假阳. [2020-12-11]. （原始内容存档于2021-01-07）.

singtao.ca (Global: 6,710^th place; Chinese: 249^th place)

印度展開第二階段疫苗接種莫迪打第一劑. 星島日報加拿大. 2021-03-01 [2021-05-11] （中文（臺灣））.

sinovac.com (Global: low place; Chinese: low place)

Sinovac Commences Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey. 科兴生物. 2020-09-22 [2021-02-27]. （原始内容存档于2020-12-17）.

sld.cu (Global: 5,873^rd place; Chinese: low place)

rpcec.sld.cu

SOBERANA 02-FaseIII. RPCEC. [2021-03-10]. （原始内容存档于2021-03-05）.
ABDALA Clinical Study - Phase III. RPCEC. [2021-03-20]. （原始内容存档于2021-05-03）.
SOBERANA PLUS. RPCEC. [2021-04-14]. （原始内容存档于2021-04-15）.
Phase I / II, randomized, controlled, adaptive, double-blind and multicenter study to evaluate the safety, reactogenicity and immunogenicity, of the prophylactic FINLAY-FR-1 anti-SARS-CoV-2 Vaccine Candidate in a two-doses schedule. (COVID-19). RPCEC. [2021-03-03]. （原始内容存档于2021-05-13）.

sohu.com (Global: 343^rd place; Chinese: 13^th place)

辉瑞启动奥密克戎疫苗临床试验. [2022-01-26]. （原始内容存档于2022-04-18）.
石药集团(01093)：新冠病毒二价mRNA疫苗(SYS6006.32)在中国纳入紧急使用. 2023-12-01 [2023-12-01].
美国最快下月11日开始分发疫苗，欧洲多国也将于近两月启动接种_蒙西夫·斯劳伊. www.sohu.com. [2021-04-06] （英语）.
英国监管机构批准美国莫德纳公司新冠疫苗. [2021-01-09]. （原始内容存档于2021-01-11）.

springer.com (Global: 274^th place; Chinese: 320^th place)

link.springer.com

Shehata, Mahmoud M.; Gomaa, Mokhtar R.; Ali, Mohamed A.; Kayali, Ghazi. Middle East respiratory syndrome coronavirus: a comprehensive review. Frontiers of Medicine. 2016-06, 10 (2): 120–136. ISSN 2095-0217. PMC 7089261 . PMID 26791756. doi:10.1007/s11684-016-0430-6 （英语）.

sse.com.cn (Global: low place; Chinese: 1,804^th place)

上海复星医药（集团）股份有限公司关于控股子公司许可项目进展的公告 (PDF). 上海复星医药（集团）股份有限公司董事会. 2021-07-11 [2021-07-12]. （原始内容存档 (PDF)于2021-09-04）.

ssrn.com (Global: 703^rd place; Chinese: 1,016^th place)

papers.ssrn.com

Ricardo Palacios; Ana Paula Batista; Camila Santos Nascimento Albuquerque; Elizabeth González Patiño; Joane do Prado Santos; Mônica Tilli Reis Pessoa Conde; Roberta de Oliveira Piorelli; Luiz Carlos Pereira Júnior; Sonia Mara Raboni; Fabiano Ramos; Gustavo Adolfo Sierra Romero; Fábio Eudes Leal; Luis Fernando Aranha Camargo; Francisco Hideo Aoki; Eduardo Barbosa Coelho; Danise Senna Oliveira; Cor Jesus Fernandes Fontes; Gecilmara Cristina Salviato Pileggi; Ana Lúcia Lyrio de Oliveira; André Machado de Siqueira; Danielle Bruna Leal de Oliveira; Viviane Fongaro Botosso; Gang Zeng; Qianqian Xin; Mauro Martins Teixeira; Maurício Lacerda Nogueira; Esper Georges Kallas. Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study. SSRN. 2021-04-14 [2021-05-15]. （原始内容存档于2021-05-18）.

statehouse.gov.sc (Global: low place; Chinese: low place)

President Ramkalawan and First Lady receives second dose SinoPharm Vaccine. www.statehouse.gov.sc. [2021-02-05]. （原始内容存档于2021-02-01）（英语）.

statista.com (Global: 776^th place; Chinese: 1,302^nd place)

AstraZeneca, the People's Vaccine?. [2022-01-13]. （原始内容存档于2022-05-01）.

statnews.com (Global: 8,771^st place; Chinese: 9,752^nd place)

Santiago, Jahleah. A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines. STAT. 2020-12-19 [2020-12-24]. （原始内容存档于2021-01-20）.
FDA authorizes Novavax Covid vaccine, in hopes the traditional shot will convince holdouts
In puzzle of rare blood clots and Covid vaccines, researchers see clues. STAT. 2021-04-13 [2021-06-11]. （原始内容存档于2021-06-06）（美国英语）.
FDA limits use of Johnson & Johnson’s Covid-19 vaccine, citing clotting risk. [2022-05-05]. （原始内容存档于2022-05-06）.
Officials flag rare myocarditis cases after Covid vaccination. STAT. 2021-06-10 [2021-06-11]. （原始内容存档于2021-06-24）（美国英语）.
Officials note ‘likely association’ between Covid-19 vaccines and rare heart condition in young people. [2021-06-24]. （原始内容存档于2021-06-24）.
J&J Covid-19 vaccine may trigger neurological condition in rare cases. STAT. 2021-07-12 [2021-08-30]. （原始内容存档于2021-09-10）（美国英语）.

stheadline.com (Global: 1,660^th place; Chinese: 56^th place)

《新冠疫苗·美國CDC立場大轉彎——質疑安全性不建議必打醫界擔憂》，星島頭條，2025年9月20日

storm.mg (Global: 2,424^th place; Chinese: 75^th place)

陳彥鈞、林治平. BNT兒童疫苗EUA過關！5到11歲皆可打、接種2劑間隔21天…最快施打時間曝光. 中央通訊社. 2022-04-29. （原始内容存档于2022-04-29）.

swarajyamag.com (Global: low place; Chinese: low place)

India’s Total Covid-19 Vaccination Coverage Surpasses Five Crore Doses: Health Ministry. Swarajya（英语：Swarajya (magazine)）. 2021-03-24 [2021-05-11]. （原始内容存档于2021-05-13）（英语）.

swissinfo.ch (Global: 1,485^th place; Chinese: 1,674^th place)

世卫批准AZ疫苗紧急使用授权. SWI swissinfo.ch. [2021-04-06] （中文）.

swissmedic.ch (Global: low place; Chinese: low place)

Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland (新闻稿). Swiss Agency for Therapeutic Products (Swissmedic). 18 December 2020 [5 July 2022]. （原始内容存档于2 May 2021）.
Swissmedic grants authorisation for the COVID-19 vaccine from Moderna. Swissmedic. 2021-01-12 [2021-01-12]. （原始内容存档于2021-01-22）.

taihainet.com (Global: low place; Chinese: 1,635^th place)

探访莫斯科的新冠疫苗接种点_国际_天下_新闻中心_台海网. www.taihainet.com. [2021-04-06].

taiwannews.com.tw (Global: 3,205^th place; Chinese: 560^th place)

Liao, George. Taiwan's second domestic COVID vaccine's midterm performance in phase II trials inferior to local competitor: experts. Taiwan News. 2021-06-27 [2021-07-08]. （原始内容存档于2021-10-05）.

takungpao.com (Global: 5,624^th place; Chinese: 219^th place)

港府刊宪：引入符合要求的新冠疫苗作紧急使用 _大公网. www.takungpao.com. [2021-04-06]. （原始内容存档于2020-12-24）.
土耳其总统接种科兴疫苗. [2021-01-15]. （原始内容存档于2021-01-21）.

tandfonline.com (Global: 507^th place; Chinese: 610^th place)

Cavanagh, Dave. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathology. 2003-12, 32 (6): 567–582 [2021-02-21]. ISSN 0307-9457. PMC 7154303 . PMID 14676007. doi:10.1080/03079450310001621198. （原始内容存档于2020-09-29）（英语）.

tass.com (Global: 1,763^rd place; Chinese: 1,901^st place)

Russian Health Ministry issues permit for post-registration trials of CoviVac. 俄通社-塔斯社. 2021-06-08 [2021-06-12]. （原始内容存档于2021-06-13）.
Russian Sputnik V anti-coronavirus vaccine registered in Algeria. 俄通社-塔斯社. 2021-01-10 [2021-01-11]. （原始内容存档于2021-01-12）.

technews.tw (Global: low place; Chinese: 454^th place)

林妤柔. 台積電、鴻海買到 BNT 疫苗！費用、抵達時間重點一次看. TechNews. 2021-07-12 [2021-07-12]. （原始内容存档于2021-07-12）.

telesurenglish.net (Global: low place; Chinese: low place)

Iran's Version of Cuba's Soberana 02 Approved for Emergency Use. 南方电视台. 2021-06-29 [2021-07-01]. （原始内容存档于2021-07-11）.

theglobalherald.com (Global: low place; Chinese: low place)

Serbia approves China's Sinopharm COVID-19 vaccine - The Global Herald. [2021-04-06]. （原始内容存档于2021-04-22）（美国英语）.

theguardian.com (Global: 12^th place; Chinese: 60^th place)

Beaumont P. Covid-19 vaccine: who are countries prioritising for first doses?. The Guardian. 18 November 2020 [26 December 2020]. ISSN 0261-3077. （原始内容存档于18 January 2021）.
Beaumont, Peter. Covid-19 vaccine: who are countries prioritising for first doses?. The Guardian. 2020-11-18 [2020-12-26]. ISSN 0261-3077. （原始内容存档于2021-01-18）.
Spinney, Laura. When will a coronavirus vaccine be ready?. The Guardian. 2020-03-18 [2020-03-18]. （原始内容存档于2020-03-20）.
Devlin, Hannah. Lessons from SARS outbreak help in race for coronavirus vaccine. The Guardian. 2020-01-24 [2020-01-25]. （原始内容存档于2020-01-25）.
Devlin, Hannah; Sample, Ian. Hopes rise over experimental drug's effectiveness against coronavirus. The Guardian. 2020-03-10 [2020-03-19]. （原始内容存档于2020-03-19）.

thehill.com (Global: 476^th place; Chinese: 1,277^th place)

Celine Castronuovo. Russia gives over 800,000 people its COVID-19 vaccine. The Hill. 2021-01-02 [2021-01-02]. （原始内容存档于2021-01-16）.

thejournal.ie (Global: 2,703^rd place; Chinese: 8,910^th place)

AFP. No deaths in Europe directly linked to Covid vaccine, experts say. TheJournal.ie. [2021-01-27]. （原始内容存档于2021-01-26）（英语）.

thelancet.com (Global: 2,393^rd place; Chinese: 1,199^th place)

Tanriover, Mine Durusu; Doğanay, Hamdi Levent; Akova, Murat; Güner, Hatice Rahmet; Azap, Alpay; Akhan, Sıla; Köse, Şükran; Erdinç, Fatma Şebnem; Akalın, Emin Halis. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. The Lancet. 2021-07-17, 398 (10296): 213–222. ISSN 0140-6736. PMID 34246358. doi:10.1016/S0140-6736(21)01429-X （英语）.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial. [2022-02-05]. （原始内容存档于2022-01-28）.
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
Singanayagam, Anika; Hakki, Seran; Dunning, Jake; Madon, Kieran J.; Crone, Michael A.; Koycheva, Aleksandra; Derqui-Fernandez, Nieves; Barnett, Jack L.; Whitfield, Michael G. ” transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet Infectious Diseases. 2021-10-29, 0 (0) [2021-12-04]. ISSN 1473-3099. PMID 34756186. doi:10.1016/S1473-3099(21)00648-4. （原始内容存档于2023-07-30）（英语）.

thepaper.cn (Global: 1,497^th place; Chinese: 54^th place)

四川新冠疫苗分三批打，普通人最快明年初可接种_政务_澎湃新闻-The Paper. www.thepaper.cn. [2021-04-06].
世卫专家：接种新冠疫苗后仍需戴口罩和保持社交距离|我国将加快推动信用立法进程|2020年版市场准入…_政务_澎湃新闻-The Paper. www.thepaper.cn. [2021-04-06]. （原始内容存档于2021-08-19）.
克宫新闻发言人：普京将接种“卫星-V”新冠疫苗. 澎湃新闻. [2020-12-28]. （原始内容存档于2020-12-28）.
《匈牙利日增新冠死亡病例数创纪录，已批准七款疫苗使用》. 澎湃新闻. [2021-04-01].

thestandnews.com (Global: 4,504^th place; Chinese: 168^th place)

美國撐開放武漢肺炎疫苗專利　引發憂慮中俄輕易取得尖端生物製藥技術. 立場新聞. 2021-05-10 [2021-05-10]. （原始内容存档于2021-05-13）.

thestar.com.my (Global: 574^th place; Chinese: 461^st place)

Morocco approves Chinese Sinopharm COVID-19 vaccine. The Star. [2021-04-06].
Laos declares Covid-19 vaccinations safe, more to be inoculated next week. The Star. [2021-04-06]. （原始内容存档于2021-01-09）.

trackvaccines.org (Global: low place; Chinese: low place)

covid19.trackvaccines.org

Bharat Biotech: Covaxin. [2021-11-06]. （原始内容存档于2021-12-13）.
Vaccines – COVID19 Vaccine Tracker. covid19.trackvaccines.org. [2021-06-12]. （原始内容存档于2020-10-29）.

trend.az (Global: 4,569^th place; Chinese: 9,681^st place)

en.trend.az

Elnur Baghishov. Iran issues license on its coronavirus vaccine. Trend News Agency. 2021-06-14 [2021-06-15]. （原始内容存档于2021-06-14）.

trust.org (Global: 9,070^th place; Chinese: 9,930^th place)

news.trust.org

BRIEF-WHO Says It Granted Emergency Use Listing To India's Covaxin For Prevention Of COVID-19 - Tweet
Foundation, Thomson Reuters. WHO gives emergency approval to Sinopharm, first Chinese COVID-19 vaccine. news.trust.org. [2021-08-30].

twitter.com (Global: 23^rd place; Chinese: 34^th place)

In our endeavour to bring out an effective solution to fight the COVID-19 pandemic, we are pleased to announce that Bharat Biotech has received DCGI approval to initiate Phase-3 clinical trials for COVAXIN.. Twitter. [2021-02-24]. （原始内容存档于2021-01-22）.

twse.com.tw (Global: low place; Chinese: 2,435^th place)

mops.twse.com.tw

本公司與永齡基金會共同捐贈五百萬劑BNT162b2疫苗予行政院衛生福利部疾病管制署作為新型冠狀病毒（COVID-19）防疫使用. 公開資訊觀測站. 臺灣證券交易所. [2021-07-12]. （原始内容存档于2021-09-27）.
本公司捐贈五百萬劑BNT162b2疫苗予行政院衛生福利部疾病管制署作為新型冠狀病毒肺炎（COVID-19）防疫使用. 公開資訊觀測站. 臺灣證券交易所. [2021-07-12]. （原始内容存档于2021-09-27）.

udn.com (Global: 392^nd place; Chinese: 10^th place)

udn.com

印度將躍新冠疫苗第二大產國。僅次於美國 | 聯合新聞網：最懂你的新聞網站，. 聯合新聞網. 20210216T003448Z [2021-03-12]. （原始内容存档于2021-02-17）（中文（臺灣））. 请检查|date=中的日期值 (帮助)
大陸宣布首款新冠疫苗有條件上市保護率近八成. 聯合新聞網. 2020-12-31 [2020-12-31]. （原始内容存档于2021-06-28）（中文（繁體））.
陳言喬. 台灣有人建議引進中國大陸疫苗陸國台辦：存在政治障礙. 聯合新聞網. 2021-01-27 [2021-01-27]. （原始内容存档于2021-10-22）（中文（臺灣））.
鄭超文. 影／首批莫德納抵達桃園機場工作人員小心運送. 聯合新聞網. 2021-05-28 [2021-05-28]. （原始内容存档于2021-08-17）.
王燕華. 買到了！慈濟宣布簽訂500萬劑BNT採購全捐給民眾施打. 聯合報 (聯合新聞網). 2021-07-21 [2021-07-21]. （原始内容存档于2021-07-21）.
首批93.2萬劑BNT疫苗抵台張淑芬、顏博文接機陳時中連說多次「感謝」. 聯合新聞網. [2021-09-02]. （原始内容存档于2021-09-02）.
文在寅：韓國全民可免費施打新冠肺炎疫苗. 中央通讯社. 2021-01-11 [2021-01-11]. （原始内容存档于2021-01-13）.

money.udn.com

謝柏宏. 陳時中：已購新冠疫苗2,000萬劑. 經濟日報. 2020-12-31 [2021-01-27]. （原始内容存档于2021-02-05）（中文（臺灣））.

un.org (Global: 97^th place; Chinese: 122^nd place)

news.un.org

世卫组织将第十种新冠疫苗列入紧急使用清单. 聯合國新聞. 2021-12-21 [2022-01-01]. （原始内容存档于2022-04-17）.
世卫组织：全球新冠疫苗接种人数已超过感染病例总数. [2021-02-06]. （原始内容存档于2021-02-18）.
临时豁免世界卫生组织称其为“里程碑时刻”. 聯合國新聞. 2021-05-05 [2021-05-07]. （原始内容存档于2021-05-13）.
世卫组织批准第九款新冠疫苗紧急使用. 聯合國新聞. 2021-12-17 [2022-01-01]. （原始内容存档于2022-03-12）.
世卫组织：莫德纳新冠疫苗接种后应至少观察15分钟暂不建议18岁以下人群及孕妇接种. [2021-01-27]. （原始内容存档于2021-01-27）.

uol.com.br (Global: 74^th place; Chinese: 1,700^th place)

noticias.uol.com.br

Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19. noticias.uol.com.br. [2021-01-06]. （原始内容存档于2021-01-10）（巴西葡萄牙语）.

upmedia.mg (Global: 3,392^nd place; Chinese: 112^th place)

美國「真朋友」贈250萬劑莫德納疫苗16:31抵台　陳時中親接機. 上報. 2021-06-20 [2021-06-20]. （原始内容存档于2021-06-29）.

uschamber.com (Global: low place; Chinese: low place)

Proposal at WTO to Waive Intellectual Property Would Set Harmful Precedent. www.uschamber.com. [2022-06-19]. （原始内容存档于2022-06-15）（英语）.

vietnamplus.vn (Global: 5,113^th place; Chinese: 883^rd place)

zh.vietnamplus.vn

越南成为新冠疫苗接种率最高的6个国家之一. [2022-11-29]. （原始内容存档于2022-11-29）.

voachinese.com (Global: 2,382^nd place; Chinese: 72^nd place)

欧盟与英国药监机构发现阿斯利康新冠疫苗与罕见血栓有关联. 美国之音. [2021-06-11]. （原始内容存档于2021-04-08）（中文）.

washingtonpost.com (Global: 34^th place; Chinese: 129^th place)

Taylor, Adam. WHO grants emergency use authorization for Chinese-made Sinopharm coronavirus vaccine. The Washington Post. 2021-05-07 [2021-05-07]. （原始内容存档于2021-05-07）.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

Li, Yen-Der; Chi, Wei-Yu; Su, Jun-Han; Ferrall, Louise; Hung, Chien-Fu; Wu, T.-C. Coronavirus vaccine development: from SARS and MERS to COVID-19. Journal of Biomedical Science. 2020-12, 27 (1): 104 [2024-08-14]. ISSN 1423-0127. PMC 7749790 . PMID 33341119. doi:10.1186/s12929-020-00695-2. （原始内容存档于2021-02-19）（英语）.
Subbarao, Kanta. The success of SARS-CoV-2 vaccines and challenges ahead. Cell Host & Microbe. 2021-07, 29 (7): 1111-1123 [2024-08-14]. ISSN 1931-3128. PMC 8279572 . PMID 34265245. doi:10.1016/j.chom.2021.06.016. （原始内容存档于2025-01-16）.
Padilla TB. No one is safe unless everyone is safe. BusinessWorld. 24 February 2021 [24 February 2021]. （原始内容存档于23 February 2021）.
Rogers K. COVID-19 vaccine. Encyclopædia Britannica. 11 May 2022 [12 June 2022]. （原始内容存档于12 June 2022）.
Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland (新闻稿). Swiss Agency for Therapeutic Products (Swissmedic). 18 December 2020 [5 July 2022]. （原始内容存档于2 May 2021）.
EMA recommends first COVID-19 vaccine for authorisation in the EU. European Medicines Agency (EMA) (新闻稿). 21 December 2020 [21 December 2020]. （原始内容存档于30 January 2021）.
Mallapaty, Smriti; Callaway, Ewen; Kozlov, Max; Ledford, Heidi; Pickrell, John; Van Noorden, Richard. How COVID vaccines shaped 2021 in eight powerful charts. Nature. 2021-12-23, 600 (7890): 580-583 [2024-08-14]. Bibcode:2021Natur.600..580M. ISSN 0028-0836. PMID 34916666. S2CID 245262732. doi:10.1038/d41586-021-03686-x. （原始内容存档于2021-12-16）（英语）.
COVID-19 vaccines saved nearly 20 million lives in a year, study says. CBS News. 24 June 2022 [27 June 2022]. （原始内容存档于29 June 2022）.
Beaumont P. Covid-19 vaccine: who are countries prioritising for first doses?. The Guardian. 18 November 2020 [26 December 2020]. ISSN 0261-3077. （原始内容存档于18 January 2021）.
Wang, Hui; Xu, Ran; Qu, Shijin; Schwartz, Marlene; Adams, Aaron; Chen, Xiang. Health inequities in COVID-19 vaccination among the elderly: Case of Connecticut. Journal of Infection and Public Health. October 2021, 14 (10): 1563–1565 [29 December 2022]. PMID 34326008. S2CID 236515442. doi:10.1016/j.jiph.2021.07.013. （原始内容存档于2022-12-29）.
Cavanagh, Dave. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathology. 2003-12, 32 (6): 567–582 [2021-02-21]. ISSN 0307-9457. PMC 7154303 . PMID 14676007. doi:10.1080/03079450310001621198. （原始内容存档于2020-09-29）（英语）.
Gao, Wentao; Tamin, Azaibi; Soloff, Adam; D'Aiuto, Leonardo; Nwanegbo, Edward; Robbins, Paul D; Bellini, William J; Barratt-Boyes, Simon; Gambotto, Andrea. Effects of a SARS-associated coronavirus vaccine in monkeys. The Lancet. 2003-12, 362 (9399): 1895–1896 [2021-02-21]. PMC 7112457 . PMID 14667748. doi:10.1016/S0140-6736(03)14962-8. （原始内容存档于2020-12-20）（英语）.
Kim, Eun; Okada, Kaori; Kenniston, Tom; Raj, V. Stalin; AlHajri, Mohd M.; Farag, Elmoubasher A.B.A.; AlHajri, Farhoud; Osterhaus, Albert D.M.E.; Haagmans, Bart L. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice. Vaccine. 2014-10, 32 (45): 5975–5982 [2021-02-21]. PMC 7115510 . PMID 25192975. doi:10.1016/j.vaccine.2014.08.058. （原始内容存档于2020-12-22）（英语）.
Jiang, Shibo; Lu, Lu; Du, Lanying. Development of SARS vaccines and therapeutics is still needed. Future Virology. 2013-01, 8 (1): 1–2 [2021-02-21]. ISSN 1746-0794. PMC 7079997 . PMID 32201503. doi:10.2217/fvl.12.126. （原始内容存档于2020-10-19）（英语）.
SARS (severe acute respiratory syndrome). National Health Service. 2020-03-05 [2020-01-31]. （原始内容存档于2020-03-09）.
Greenough, Thomas C.; Babcock, Gregory J.; Roberts, Anjeanette; Hernandez, Hector J.; Thomas, Jr., William D.; Coccia, Jennifer A.; Graziano, Robert F.; Srinivasan, Mohan; Lowy, Israel. Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice. The Journal of Infectious Diseases. 2005-02-15, 191 (4): 507–514 [2021-02-21]. ISSN 0022-1899. PMC 7110081 . PMID 15655773. doi:10.1086/427242. （原始内容存档于2017-07-28）（英语）.
Tripp, Ralph A.; Haynes, Lia M.; Moore, Deborah; Anderson, Barbara; Tamin, Azaibi; Harcourt, Brian H.; Jones, Les P.; Yilla, Mamadi; Babcock, Gregory J. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. Journal of Virological Methods. 2005-09, 128 (1-2): 21–28 [2021-02-21]. PMC 7112802 . PMID 15885812. doi:10.1016/j.jviromet.2005.03.021. （原始内容存档于2020-10-01）（英语）.
Roberts, Anjeanette; Thomas, William D.; Guarner, Jeannette; Lamirande, Elaine W.; Babcock, Gregory J.; Greenough, Thomas C.; Vogel, Leatrice; Hayes, Norman; Sullivan, John L. Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters. The Journal of Infectious Diseases. 2006-03, 193 (5): 685–692 [2021-02-21]. ISSN 0022-1899. PMC 7109703 . PMID 16453264. doi:10.1086/500143. （原始内容存档于2017-07-27）（英语）.
Butler, Declan. SARS veterans tackle coronavirus. Nature. 2012-10, 490 (7418): 20–20 [2021-02-21]. ISSN 0028-0836. doi:10.1038/490020a. （原始内容存档于2021-11-06）（英语）.
Modjarrad, Kayvon; Roberts, Christine C; Mills, Kristin T; Castellano, Amy R; Paolino, Kristopher; Muthumani, Kar; Reuschel, Emma L; Robb, Merlin L; Racine, Trina. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. The Lancet Infectious Diseases. 2019-09, 19 (9): 1013–1022 [2021-02-21]. PMC 7185789 . PMID 31351922. doi:10.1016/S1473-3099(19)30266-X. （原始内容存档于2021-01-23）（英语）.
COVID-19 vaccine development pipeline (Refresh URL to update). Vaccine Centre, London School of Hygiene and Tropical Medicine. 2021-01-18 [2021-01-18]. （原始内容存档于2020-05-18）.
Santiago, Jahleah. A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines. STAT. 2020-12-19 [2020-12-24]. （原始内容存档于2021-01-20）.
A Chinese mRNA COVID vaccine is approved for the first time - in Indonesia. [2022-10-01]. （原始内容存档于2022-11-28）.
Kangtai Biological's COVID-19 vaccine gets emergency use approval in China. [2021-05-14]. （原始内容存档于2021-06-06）.
高端疫苗通過EUA 衛福部核准專案製造. 中央社. 2021-07-19 [2021-07-19]. （原始内容存档于2021-07-23）.
Novavax COVID-19 vaccine receives first emergency use authorization. [2021-11-01]. （原始内容存档于2021-12-24）.
世卫组织将第十种新冠疫苗列入紧急使用清单. 聯合國新聞. 2021-12-21 [2022-01-01]. （原始内容存档于2022-04-17）.
Coronavirus Disease (COVID-19): COVID-19 vaccine EUL issued. [2021-05-08]. （原始内容存档于2021-06-04）.
WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries. [2021-12-17]. （原始内容存档于2021-12-24）.
WHO adds CanSino's COVID-19 vaccine to list of validated shots. [2022-05-19]. （原始内容存档于2022-05-19）.
Dan Vergano. COVID-19 Vaccines Work Way Better Than We Had Ever Expected. Scientists Are Still Figuring Out Why.. BuzzFeed News. 2021-06-05 [2021-08-12]. （原始内容存档于2021-10-06）.
Beaumont, Peter. Covid-19 vaccine: who are countries prioritising for first doses?. The Guardian. 2020-11-18 [2020-12-26]. ISSN 0261-3077. （原始内容存档于2021-01-18）.
Coronavirus (COVID-19) Vaccinations. Our World in Data. [2021-01-01]. （原始内容存档于2021-01-24）.
施予. 5000多名人大代表、政協委員接種國藥新冠疫苗. 香港01. 2021-03-04 [2021-04-06]. （原始内容存档于2021-03-10）（中文（香港））.
Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates. 莫德纳. 2021-02-25 [2021-03-13]. （原始内容存档于2021-05-11）.
印度將躍新冠疫苗第二大產國。僅次於美國 | 聯合新聞網：最懂你的新聞網站，. 聯合新聞網. 20210216T003448Z [2021-03-12]. （原始内容存档于2021-02-17）（中文（臺灣））. 请检查|date=中的日期值 (帮助)
Mullard, Asher. How COVID vaccines are being divvied up around the world. Nature. 2020-11-30: d41586–020–03370–6 [2021-02-21]. ISSN 0028-0836. PMID 33257891. doi:10.1038/d41586-020-03370-6. （原始内容存档于2021-02-24）（英语）.
So, Anthony D; Woo, Joshua. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. 2020-12-15: m4750 [2021-02-21]. ISSN 1756-1833. PMC 7735431 . PMID 33323376. doi:10.1136/bmj.m4750. （原始内容存档于2020-12-16）（英语）.
Factbox: Vaccines delivered under COVAX sharing scheme for poorer countries. Reuters. 2022-03-28 [2022-04-01]. （原始内容存档于2022-05-02）.
Fauci, Anthony S.; Lane, H. Clifford; Redfield, Robert R. Covid-19 — Navigating the Uncharted. New England Journal of Medicine. 2020-03-26, 382 (13): 1268–1269 [2021-02-21]. ISSN 0028-4793. PMC 7121221 . PMID 32109011. doi:10.1056/NEJMe2002387. （原始内容存档于2021-02-25）（英语）.
Gates, Bill. Responding to Covid-19 — A Once-in-a-Century Pandemic?. New England Journal of Medicine. 2020-04-30, 382 (18): 1677–1679 [2021-02-21]. ISSN 0028-4793. doi:10.1056/NEJMp2003762. （原始内容存档于2020-10-18）（英语）.
Steenhuysen, Julie; Kelland, Kate. With Wuhan virus genetic code in hand, scientists begin work on a vaccine (vanc). Reuters. 2020-01-24 [2020-01-25]. （原始内容存档于2020-01-25）.
Praveen Duddu. Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19 （页面存档备份，存于互联网档案馆）. [clinicaltrialsarena.com clinicaltrialsarena.com] 19 February 2020.
Lee, Jaimy. These nine companies are working on coronavirus treatments or vaccines — here's where things stand. MarketWatch. 2020-03-07 [2020-03-07]. （原始内容存档于2020-03-18）.
Spinney, Laura. When will a coronavirus vaccine be ready?. The Guardian. 2020-03-18 [2020-03-18]. （原始内容存档于2020-03-20）.
Ziady, Hanna. Biotech company Moderna says its coronavirus vaccine is ready for first tests. CNN. 2020-02-26 [2020-03-02]. （原始内容存档于2020-02-28）.
Devlin, Hannah. Lessons from SARS outbreak help in race for coronavirus vaccine. The Guardian. 2020-01-24 [2020-01-25]. （原始内容存档于2020-01-25）.
Devlin, Hannah; Sample, Ian. Hopes rise over experimental drug's effectiveness against coronavirus. The Guardian. 2020-03-10 [2020-03-19]. （原始内容存档于2020-03-19）.
Shankland, Stephen. Sixteen supercomputers tackle coronavirus cures in US. CNET. [2020-03-23]. （原始内容存档于2020-07-26）（英语）.
CEPI welcomes UK Government's funding and highlights need for $2 billion to develop a vaccine against COVID-19. Coalition for Epidemic Preparedness Innovations, Oslo, Norway. 2020-03-06 [2020-03-23]. （原始内容存档于2020-03-22）.
多维新闻. 【新冠肺炎】习近平推重磅举措中国疫苗将为全球公共产品. 多维新闻. 2020-05-18 [2021-02-21]. （原始内容存档于2021-10-23）（中文（中国大陆））.
李克強：中國願為全球疫苗免疫聯盟籌資周期提供捐助. 香港電台. 2020-06-04 [2020-06-04]. （原始内容存档于2020-06-05）（中文（香港））.
宋岩. 李克强出席澜沧江—湄公河合作第三次领导人会议. 中国政府网. 2020-08-24 [2020-08-24]. （原始内容存档于2020-08-31）.
普京宣布俄完成全球首个新冠持久疫苗女儿也参加了接种测试. RFI - 法国国际广播电台. 2020-08-11 [2021-02-21]. （原始内容存档于2020-08-12）（中文（简体））.
Kate Kelland. Scientists ask: Without trial data, how can we trust Russia's COVID vaccine?. 路透社. 2020-08-11 [2020-08-12]. （原始内容存档于2020-08-11）.
Welle (www.dw.com), Deutsche. 让世界公平接种疫苗？Covax雄心难实现. DW.COM. [2021-02-21]. （原始内容存档于2020-11-24）（中文（中国大陆））.
中国宣布加入冠病疫苗实施计划. [2020-10-09]. （原始内容存档于2020-11-07）.
COVAX：致力于全球公平获取2019冠状病毒病（COVID-19）疫苗. [2020-10-09]. （原始内容存档于2020-10-19）.
澳官员:阿斯利康新冠疫苗开始在澳大利亚生产预计明年3月上市. [2020-11-09]. （原始内容存档于2020-11-09）.
Hopkins, Jared S. 临床试验显示辉瑞新冠疫苗有效性超过90%. 华尔街日报中文网. [2021-02-21]. （原始内容存档于2020-11-29）（中文（中国大陆））.
俄称自家疫苗更好效率达92%. RFI - 法国国际广播电台. 2020-11-11 [2021-02-21]. （原始内容存档于2020-11-11）（中文（简体））.
简报：拜登面临对华政策难题；莫德纳疫苗有效性达94.5%. [2020-11-17]. （原始内容存档于2020-11-17）.
阿斯利康&牛津疫苗有效性可达90%. [2020-11-24]. （原始内容存档于2020-12-12）.
Draft landscape of COVID-19 candidate vaccines. 世界卫生组织. [2021-01-06]. （原始内容存档于2020-07-29）.
新冠疫苗：英国率先批准辉瑞疫苗大规模使用，高危人群几天内开始接种. [2020-12-02]. （原始内容存档于2020-12-24）.
英國正式開啟疫苗接種「值得紀念但挑戰巨大」. BBC. 2020-12-09 [2021-03-16]. （原始内容存档于2021-01-02）.
日本通过《预防接种法》民众可免费接种新冠疫苗. [2020-12-02]. （原始内容存档于2020-12-08）.
Pfizer-BioNTech COVID-19 Vaccine. www.fda.gov. Food and Drug Administration. [2021-03-16]. （原始内容存档于2021-01-14）.
Swissmedic autorise un premier vaccin contre le coronavirus. Le Temps. 2020-12-19 [2020-12-19]. （原始内容存档于2021-01-10）（法语）.
世卫专家：接种新冠疫苗后仍需戴口罩和保持社交距离|我国将加快推动信用立法进程|2020年版市场准入…_政务_澎湃新闻-The Paper. www.thepaper.cn. [2021-04-06]. （原始内容存档于2021-08-19）.
告別2020 輝瑞疫苗獲得世衛第一支緊急核准. 中央廣播電台. 2021-01-01 [2021-02-27]. （原始内容存档于2021-01-26）.
大陸宣布首款新冠疫苗有條件上市保護率近八成. 聯合新聞網. 2020-12-31 [2020-12-31]. （原始内容存档于2021-06-28）（中文（繁體））.
Loftus, Peter. 强生新冠疫苗后期试验有效性66%，有望数周内在美国部署. 华尔街日报中文网. [2021-02-21]. （原始内容存档于2021-01-30）（中文（中国大陆））.
强生称其单剂新冠疫苗全球有效性为66% 对多种变异病毒有效. [2021-01-30]. （原始内容存档于2021-01-30）.
新冠肺炎｜外交部：中國正式加入世衛COVAX 將提供1000萬劑疫苗. 香港01. 2021-02-03 [2021-02-04]. （原始内容存档于2021-02-09）（中文（香港））.
世卫组织：全球新冠疫苗接种人数已超过感染病例总数. [2021-02-06]. （原始内容存档于2021-02-18）.
WHO authorizes AstraZeneca's COVID vaccine for emergency use. [2021-02-15]. （原始内容存档于2021-02-23）.
陈静; 徐谦. 芬兰研发出鼻喷式新冠疫苗. 新华网. 2021-03-09 [2021-03-09]. （原始内容存档于2021-03-11）.
世界卫生组织批准强生单剂量新冠肺炎疫苗的紧急使用清单申请. [2021-03-19]. （原始内容存档于2021-11-20）.
临时豁免世界卫生组织称其为“里程碑时刻”. 聯合國新聞. 2021-05-05 [2021-05-07]. （原始内容存档于2021-05-13）.
WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations (新闻稿). World Health Organization (WHO). 2021-05-07 [2021-05-07]. （原始内容存档于2021-05-08）.
Taylor, Adam. WHO grants emergency use authorization for Chinese-made Sinopharm coronavirus vaccine. The Washington Post. 2021-05-07 [2021-05-07]. （原始内容存档于2021-05-07）.
深圳康泰生物新冠灭活疫苗被纳入紧急使用. 新华网. 2021-05-15 [2021-05-15]. （原始内容存档于2021-05-15）.
WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations. www.who.int. [2021-06-02]. （原始内容存档于2021-06-05）（英语）.
中国科兴新冠疫苗获世卫组织紧急使用授权-新华网. [2021-06-02]. （原始内容存档于2021-06-03）.
奧克蘭動物園開打新冠疫苗！老虎雪貂都打了「下批輪到豬和蝙蝠」. ETtoday新聞雲. [2021-08-30]. （原始内容存档于2021-07-11）（中文（繁體））.
中国吸入用新冠疫苗试验获认可各国积极研发口服形式. DW.COM. 2021-08-02 [2021-08-30]. （原始内容存档于2021-08-05）（中文（中国大陆））.
世卫：接种中国疫苗的长者应打加强针. DW. 2021-10-12 [2021-10-13]. （原始内容存档于2021-10-27）.
新冠疫苗面世一年，中国疫苗外交使智利、柬埔寨接种率接近八成--经济学人智库. [2021-11-12]. （原始内容存档于2021-11-12）.
印度國產Covaxin疫苗獲世衛批准效力達78%. RFI. 2021-11-03 [2021-11-26]. （原始内容存档于2021-11-26）.
世卫组织批准第九款新冠疫苗紧急使用. 聯合國新聞. 2021-12-17 [2022-01-01]. （原始内容存档于2022-03-12）.
Novavax疫苗入列為世衛第10支緊急使用疫苗. RFI. 2021-12-22 [2022-01-01]. （原始内容存档于2022-04-18）.
辉瑞启动奥密克戎疫苗临床试验. [2022-01-26]. （原始内容存档于2022-04-18）.
重大进展！中国生物二代重组蛋白新冠疫苗获批临床. [2022-04-04]. （原始内容存档于2022-04-18）.
〈高端股東會〉WHO新冠疫苗三期試驗已達解盲條件隨時公布數據. Anue鉅亨. 2022-06-30 [2022-09-06]. （原始内容存档于2022-07-12）（中文（臺灣））.
中央社記者張良知. 高端：COVID-19疫苗將申請WHO緊急使用授權. 中央社. 2022-06-30 [2022-09-06]. （原始内容存档于2022-07-18）（中文（臺灣））.
美加英相继批准新冠二价疫苗日本新冠感染下降｜大流行手记（9月3日）. [2022-09-07]. （原始内容存档于2022-09-24）.
中国研发的新冠mRNA疫苗开始试生产. [2023-01-07]. （原始内容存档于2023-01-09）.
中国生物奥密克戎株新冠mRNA疫苗获国家药监局临床批件. [2023-01-20]. （原始内容存档于2023-01-20）.
Sinovac Commences Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey. 科兴生物. 2020-09-22 [2021-02-27]. （原始内容存档于2020-12-17）.
Stanley Widianto; Roxanne Liu. Sinovac launches Phase 3 trial for COVID-19 vaccine in Indonesia, reports Phase 2 details. 路透社. 2020-08-10 [2021-02-27]. （原始内容存档于2021-06-06）.
Carl Zimmer; Ernesto Londoño. Turkey and Brazil Say Chinese Vaccine Effective, With Sparse Supporting Data. 纽约时报. 2020-12-25 [2021-02-27]. （原始内容存档于2021-05-09）.
Jinshan Hong. China’s Covid Shot Has Four Wildly Different Efficacy Rates. 彭博新闻社. 2021-01-12 [2021-02-27]. （原始内容存档于2021-02-19）.
宫若涵. 巴西公布科兴新冠疫苗Ⅲ期临床试验最终研究结果. 新华社. 2021-04-12 [2021-04-12]. （原始内容存档于2021-05-11）.
India's first COVID-19 vaccine candidate approved for human trials. 路透社. 2020-06-29 [2021-02-24]. （原始内容存档于2021-02-08）.
In our endeavour to bring out an effective solution to fight the COVID-19 pandemic, we are pleased to announce that Bharat Biotech has received DCGI approval to initiate Phase-3 clinical trials for COVAXIN.. Twitter. [2021-02-24]. （原始内容存档于2021-01-22）.
Emily Schmall; Sameer Yasir. India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other. 纽约时报. 2021-01-03 [2021-02-24]. （原始内容存档于2021-01-09）.
Bharat Biotech Announces Phase 3 Results of COVAXIN®: India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81% (PDF). 巴拉特生技. 2021-03-03 [2021-03-16]. （原始内容存档 (PDF)于2021-05-29）.
Bharat Biotech and ICMR Announce Interim Results from Phase 3 trials of COVAXIN®; Demonstrates overall Interim Clinical Efficacy of 78% and 100% efficacy against Severe COVID-19 disease (PDF). Bharat Biotech. 2021-04-21 [2021-05-08]. （原始内容存档 (PDF)于2021-04-21）.
Assel Satubaldina. Human Trials for Kazakh COVID-19 Vaccine to Start in September. Astana Times. 2020-08-06 [2021-07-09]. （原始内容存档于2021-05-25）.
Kazakhstan to vaccinate 3,000 volunteers with domestic QazCovid-in. 哈萨克国际通讯社. 2020-12-19 [2021-07-09]. （原始内容存档于2021-04-19）.
Kazakhstan starts using indigenous COVID-19 vaccine. Meiramgul Kussainova. Anadolu Agency. 2021-04-26 [2021-07-09]. （原始内容存档于2021-05-10）.
Elise Mak. China approves first homegrown COVID-19 vaccine to enter clinical trials. BioWorld. 2020-03-18 [2020-03-24]. （原始内容存档于2020-03-28）.
A Phase I Clinical Trial in 18-60 Adults - Full Text View - ClinicalTrials.gov. clinicaltrials.gov. US National Library of Medicine, National Institutes of Health. [2020-03-25]. （原始内容存档于2020-03-24）（英语）.
研发新冠疫苗全球96个团队谁能跑赢？. 新浪财经. 2020-03-20 [2020-03-20]. （原始内容存档于2020-03-20）.
李潇潇. 陈薇院士团队与康希诺生物新冠疫苗附条件上市申请获受理. 澎湃新闻. 2021-02-24 [2021-02-24]. （原始内容存档于2021-08-19）.
国家药监局附条件批准两家公司新冠疫苗注册申请. 中央广电总台央视新闻客户端. 2021-02-25 [2021-02-25]. （原始内容存档于2021-08-17）.
Huizhong Wu. China approves two more COVID-19 vaccines for wider use. 美联社. 2020-02-25 [2021-03-16]. （原始内容存档于2021-05-16）.
Andrew E. Kramer. Russia Approves Coronavirus Vaccine Before Completing Tests. 纽约时报. 2020-08-11 [2021-02-25]. （原始内容存档于2021-02-18）.
Andrew E. Kramer. Russia’s Vaccine Is Safe and Effective, Published Study Shows. 纽约时报. 2021-02-02 [2021-02-25]. （原始内容存档于2021-02-24）.
Katherine J. Wu; Carl Zimmer; Sharon LaFraniere; Noah Weiland. Two Companies Restart Virus Trials in U.S. After Safety Pauses. 纽约时报. 2020-10-23 [2021-02-26]. （原始内容存档于2020-10-25）.
Carl Zimmer; Noah Weiland; Sharon LaFraniere. Johnson & Johnson’s Vaccine Works Well and May Curb Virus Spread. 纽约时报. 2021-02-24 [2021-02-26]. （原始内容存档于2021-06-05）.
A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19. ClinicalTrials.gov, US National Library of Medicine. 2020-11-30 [2021-03-06]. （原始内容存档于2021-04-30）.
SOBERANA 02-FaseIII. RPCEC. [2021-03-10]. （原始内容存档于2021-03-05）.
Nelson Acosta. Cuba encouraged by early efficacy results of homegrown COVID-19 vaccine. 路透社. 2021-06-19 [2021-06-22]. （原始内容存档于2021-06-24）.
NIH clinical trial of investigational vaccine for COVID-19 begins. US National Institutes of Health. 2020-03-16 [2020-03-17]. （原始内容存档于2020-03-19）（英语）.
Kaiser Permanente launches first coronavirus vaccine trial. Kaiser Permanente, Washington Health Research Institute, Seattle. 2020-03-16 [2020-03-23]. （原始内容存档于2020-03-25）.
Andrew Dunn. The first study of a potential coronavirus vaccine will soon start recruiting healthy volunteers in Georgia at Emory University. Business Insider. 2020-03-24 [2020-03-24]. （原始内容存档于2020-03-25）.
Denise Grady. Moderna and Pfizer Begin Late-Stage Vaccine Trials. 纽约时报. 2020-07-27 [2021-02-20]. （原始内容存档于2020-07-27）.
Denise Grady. Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective. 纽约时报. 2020-11-16 [2021-02-20]. （原始内容存档于2021-02-24）.
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day. 莫德纳. 2021-04-13 [2021-05-07]. （原始内容存档于2021-05-26）.
浙江省人民政府门户网站浙江省新冠肺炎疫情防控工作新闻发布会（第七十一场）. www.zj.gov.cn. [2021-05-13]. （原始内容存档于2021-05-13）.
Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV). ClinicalTrials.gov, US National Library of Medicine. 2020-07-02 [2021-03-07]. （原始内容存档于2020-10-20）.
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine (COVID-19). ClinicalTrials.gov, US National Library of Medicine. 2020-08-11 [2021-03-07]. （原始内容存档于2020-10-20）.
Clinical Trial For SARS-CoV-2 Vaccine (COVID-19). ClinicalTrials.gov, US National Library of Medicine. 2020-10-09 [2021-03-07]. （原始内容存档于2020-10-20）.
Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults. ClinicalTrials.gov, US National Library of Medicine. 2020-11-05 [2021-03-07]. （原始内容存档于2020-11-12）.
Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults (CoronaVac3CL). ClinicalTrials.gov, US National Library of Medicine. 2020-12-03 [2021-03-07]. （原始内容存档于2021-05-01）.
Ricardo Palacios; Ana Paula Batista; Camila Santos Nascimento Albuquerque; Elizabeth González Patiño; Joane do Prado Santos; Mônica Tilli Reis Pessoa Conde; Roberta de Oliveira Piorelli; Luiz Carlos Pereira Júnior; Sonia Mara Raboni; Fabiano Ramos; Gustavo Adolfo Sierra Romero; Fábio Eudes Leal; Luis Fernando Aranha Camargo; Francisco Hideo Aoki; Eduardo Barbosa Coelho; Danise Senna Oliveira; Cor Jesus Fernandes Fontes; Gecilmara Cristina Salviato Pileggi; Ana Lúcia Lyrio de Oliveira; André Machado de Siqueira; Danielle Bruna Leal de Oliveira; Viviane Fongaro Botosso; Gang Zeng; Qianqian Xin; Mauro Martins Teixeira; Maurício Lacerda Nogueira; Esper Georges Kallas. Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study. SSRN. 2021-04-14 [2021-05-15]. （原始内容存档于2021-05-18）.
WHO approves Sinovac COVID vaccine, the second Chinese-made dose listed. [2021-06-01]. （原始内容存档于2021-06-05）.
Stanley Widianto. Indonesia approves China's Sinovac vaccine as infections surge. 路透社. 2021-01-11 [2021-01-11]. （原始内容存档于2021-01-23）.
Susan Fraser. Turkey approves China-based Sinovac vaccine’s emergency use. 美联社. 2021-01-13 [2021-01-13]. （原始内容存档于2021-01-24）.
Jamie McGeever; Pedro Fonseca. Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin. 路透社. 2021-01-17 [2021-01-18]. （原始内容存档于2021-01-21）.
Aislinn Laing; Fabian Cambero. Chile regulator greenlights Sinovac COVID-19 vaccine for emergency use. 路透社. 2021-01-20 [2021-01-20]. （原始内容存档于2021-01-23）.
Aliyev, Jeyhun. Azerbaijan kicks off COVID-19 vaccination. Anadolu Agency. [2021-02-07]. （原始内容存档于2021-02-06）.
Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19. noticias.uol.com.br. [2021-01-06]. （原始内容存档于2021-01-10）（巴西葡萄牙语）.
Liu, Roxanne. China approves Sinovac Biotech COVID-19 vaccine for general public use. Reuters. 2021-02-06 [2021-02-07]. （原始内容存档于2021-02-23）（英语）.
Mexico approves China's CanSino and Sinovac COVID-19 vaccines. 路透社. 2021-02-10 [2021-02-10]. （原始内容存档于2021-02-11）.
Rinith, Taing. Health Ministry grants Emergency Use Authorization to China's Sinopharm vaccine. Khmer Times. 2021-02-04 [2021-02-04]. （原始内容存档于2024-05-16）.
Philippines grants emergency approval for Sinovac vaccine. [2021-02-22]. （原始内容存档于2021-02-22）.
Chinese Covid-19 vaccine Sinovac gets local emergency use in Thailand. [2021-02-23]. （原始内容存档于2021-02-23）.
Staff, Reuters. Ukraine approves China's Sinovac COVID-19 vaccine. Reuters. 2021-03-09 [2021-04-06]. （原始内容存档于2021-03-16）（英语）.
Pakistan allows third Chinese vaccine for emergency use. [2021-04-09]. （原始内容存档于2021-04-09）.
Panama approves use of China's Sinovac vaccine against COVID-19. [2021-04-09]. （原始内容存档于2021-04-09）.
Egypt approves China's Sinovac coronavirus vaccine for emergency use. [2021-04-27]. （原始内容存档于2021-06-05）.
Nepal gives emergency use approval to China's Sinovac Covid-19 vaccine. [2021-06-06]. （原始内容存档于2021-06-06）.
Bangladesh Approves Sinovac Vaccine for Emergency Use. [2021-06-06]. （原始内容存档于2021-06-06）.
South Africa approves China's Sinovac COVID-19 vaccine - health ministry. news.yahoo.com. [2021-08-30]. （原始内容存档于2021-07-12）（美国英语）.
Saudi Arabia approves Sinovac and Sinopharm vaccines. [2021-08-25]. （原始内容存档于2021-08-25）.
Unvaccinated barred from workplaces from Jan 1, 2022; Singapore approves Sinovac use. [2021-10-23]. （原始内容存档于2021-10-23）.
AstraZeneca, the People's Vaccine?. [2022-01-13]. （原始内容存档于2022-05-01）.
China approves Sinovac Biotech COVID-19 vaccine for general public use. 路透社. 2021-02-06 [2021-02-06]. （原始内容存档于2021-02-23）.
兩間藥物製造商供應的新冠疫苗獲註冊為香港藥劑製品. www.info.gov.hk. [2023-01-13]. （原始内容存档于2022-12-23）.
新型冠状病毒肺炎(COVID-19)灭活疫苗（Vero细胞）III期临床试验. 中国临床试验注册中心. 2020-11-28 [2020-12-11]. （原始内容存档于2021-01-11）.
A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above (COVID-19). ClinicalTrials.gov. 2020-10-30 [2020-12-21]. （原始内容存档于2020-09-14）.
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Adult Population In Peru (Cov-Peru). ClinicalTrials.gov. 2020-11-03 [2020-12-21]. （原始内容存档于2021-01-14）.
Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M.; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults. JAMA. 2021-05-26 [2021-05-26]. ISSN 0098-7484. doi:10.1001/jama.2021.8565. （原始内容存档于2021-06-04）（英语）.
中国国家药监局附条件批准国药集团武汉和康希诺两公司新冠疫苗注册申请. 路透社. 2021-02-25 [2021-02-28]. （原始内容存档于2021-06-28）.
Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19). ClinicalTrials.gov. 美国临床试验注册中心. 2020-09-23 [2020-09-30]. （原始内容存档于2021-10-09）.
Muhammad Abu Zaid. Egypt approves Chinese Sinopharm COVID-19 vaccine. Arab News. 2021-01-03 [2021-01-04]. （原始内容存档于2021-01-19）.
Jordan approves China's Sinopharm Covid vaccine. [2021-01-09]. （原始内容存档于2021-01-09）.
约旦授权紧急使用中国国药集团新冠疫苗. [2021-01-10]. （原始内容存档于2021-01-11）.
Asif Shahzad. UPDATE 1-Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use. 路透社. 2021-01-18 [2021-01-18]. （原始内容存档于2021-01-19）.
Serbia approves China's Sinopharm COVID-19 vaccine - The Global Herald. [2021-04-06]. （原始内容存档于2021-04-22）（美国英语）.
Iraq Approves Sinopharm, AstraZeneca COVID-19 Vaccines For Emergency Use Against COVID-19. [2021-01-20]. （原始内容存档于2021-01-22）.
Staff, Reuters. Hungary's drug regulator approved Sinopharm's vaccine - surgeon general. Reuters. 2021-01-29 [2021-04-06]. （原始内容存档于2021-02-08）（英语）.
Health Ministry grants Emergency Use Authorization to China’s Sinopharm vaccine - Khmer Times. 2021-02-04 [2021-04-06]. （原始内容存档于2024-05-16）（美国英语）.
Laos declares Covid-19 vaccinations safe, more to be inoculated next week. The Star. [2021-04-06]. （原始内容存档于2021-01-09）.
Peru grants 'exceptional' approval for Sinopharm COVID-19 vaccine - government sources. Reuters. 2021-01-27 [2021-02-08]. （原始内容存档于2021-02-02）.
Nepal approves Chinese Sinopharm COVID-19 vaccine, making first purchase from India. 2021-02-18 [2021-02-18]. （原始内容存档于2021-02-18）.
Staff, Reuters. Venezuela approves use of China's Sinopharm coronavirus vaccine. Reuters. 2021-03-01 [2021-04-06]. （原始内容存档于2021-03-03）（英语）.
\Staff, Reuters. Argentina approves Sinopharm COVID-19 vaccine for emergency use. Reuters. 2021-02-21 [2021-04-06]. （原始内容存档于2021-02-22）（英语）.
March 2021, Naharnet Newsdesk 01. Lebanon Authorizes Use of Chinese Vaccine Sinopharm. Naharnet. [2021-04-06]. （原始内容存档于2021-03-02）.
956. Iran issues permit for emergency use of Sinopharm vaccine. IRNA English. 2021-03-10 [2021-04-06]. （原始内容存档于2021-04-19）（英语）.
Maldives approves China's Sinopharm vaccine for emergency use. Xinhua. [2021-04-06]. （原始内容存档于2021-03-16）.
NMRA approves sinopharm vaccine for emergency use. Colombo Gazette. 2021-03-19 [2021-04-06]. （原始内容存档于2021-03-19）（英国英语）.
Bangladesh approves China's Sinopharm coronavirus vaccine. [2021-04-29]. （原始内容存档于2021-05-25）.
Indonesia approves Sinopharm COVID-19 vaccine for emergency use. [2021-05-01]. （原始内容存档于2021-05-14）.
Royal academy seeks 1 mln vaccines as Thailand approves Sinopharm. Reuters. 2021-05-28 [2021-08-30]. （原始内容存档于2021-08-30）（英语）.
South African regulator approves Sinopharm COVID vaccine. [2022-02-07]. （原始内容存档于2022-04-18）.
President Ramkalawan and First Lady receives second dose SinoPharm Vaccine. www.statehouse.gov.sc. [2021-02-05]. （原始内容存档于2021-02-01）（英语）.
林嘉欣. 首批10萬劑國藥疫苗抵澳特區政府順利接收. 力報. 2021-02-06 [2021-02-07]. （原始内容存档于2021-10-23）.
An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers. ClinicalTrials.gov, US National Library of Medicine. 2020-11-23 [2021-03-06]. （原始内容存档于2020-11-26）.
Ella, Raches; Reddy, Siddharth; Blackwelder, William; Potdar, Varsha; Yadav, Pragya; Sarangi, Vamshi; Aileni, Vinay Kumar; Kanungo, Suman; Rai, Sanjay; Reddy, Prabhakar; Verma, Savitha; Singh, Chandramani; Redkar, Sagar; Mohapatra, Satyajit; Pandey, Anil; Ranganadin, Pajanivel; Gumashta, Raghavendra; Multani, Manish; Mohammad, Shameem; Bhatt, Parul; Kumari, Laxmi; Sapkal, Gajanan; Gupta, Nivedita; Abraham, Priya; Panda, Samiran; Prasad, Sai; Bhargava, Balram; Ella, Krishna; Vadrevu, Krishna Mohan. Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial. 2021-07-02 [2021-07-03]. doi:10.1101/2021.06.30.21259439. （原始内容存档于2021-07-17）.
Emily Schmall; Sameer Yasir. India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other. 纽约时报. 2021-01-03 [2021-01-03]. （原始内容存档于2021-01-09）.
Iran issues permit for emergency use for three other COVID-19 vaccines: Official. IRNA English. 2021-02-17 [2021-04-19]. （原始内容存档于2021-02-27）（英语）.
Manral, Karan. Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine. Hindustan Times. 2021-03-04 [2021-03-06]. （原始内容存档于2021-03-05）.
Dr Jagutpal: Une cargaison de 200 000 vaccins Covaxin débarque demain. L'Express. 2021-03-19 [2021-04-19]. （原始内容存档于2021-04-21）.
Sharma, Gopal. Nepal becomes third country to give emergency nod to Indian vaccine COVAXIN. Reuters. 2021-03-19 [2021-03-19]. （原始内容存档于2021-04-25）（英语）.
India provides 100,000 doses of Covaxin vaccine to Paraguay. Hindustan Times. 2021-03-30 [2021-04-19]. （原始内容存档于2021-05-04）.
Staff, Reuters. Mexico authorizes emergency use of Indian COVID-19 vaccine. Reuters. 2021-04-07 [2021-04-07]. （原始内容存档于2021-04-07）（英语）.
Bharat Biotech: Covaxin. [2021-11-06]. （原始内容存档于2021-12-13）.
Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine. ClinicalTrials.gov. [2021-01-06]. （原始内容存档于2021-01-14）.
Leo Friedrich. Covid-19: Kazakhstan starts rollout of its QazVac jab. Novastan. 2021-04-27 [2021-04-28]. （原始内容存档于2021-04-30）.
唐唯珂. 首批50余万支！粤产首款新冠疫苗在深圳开始接种. 21世纪经济报道. 新浪网. 2021-06-01 [2021-06-01]. （原始内容存档于2021-06-02）.
A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19). ClinicalTrials.gov. [2021-05-18]. （原始内容存档于2021-05-03）.
Russian Health Ministry issues permit for post-registration trials of CoviVac. 俄通社-塔斯社. 2021-06-08 [2021-06-12]. （原始内容存档于2021-06-13）.
Russia Approves CoviVac, Its Third Coronavirus Vaccine. 自由欧洲电台／自由电台. 2021-02-21 [2021-02-23]. （原始内容存档于2021-02-24）.
The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19. ClinicalTrials.gov, US National Library of Medicine. 2020-12-09 [2021-01-12]. （原始内容存档于2021-01-21）.
Leng Shumei. China approves 7th self-developed COVID-19 vaccine, can cross-neutralize variants. 环球时报. 2021-06-09 [2021-06-15]. （原始内容存档于2021-06-24）.
Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above. ClinicalTrials.gov. 2021-01-08 [2021-01-21]. （原始内容存档于2020-09-18）.
CanSinoBIO's COVID-19 vaccine 65.7% effective in global trials, Pakistan official says. Reuters. 2021-02-08 [2021-02-08]. （原始内容存档于2021-03-24）.
China's CanSino COVID-19 vaccine approved for emergency use in Hungary. www.ecns.cn. [2021-04-06]. （原始内容存档于2021-03-23）.
Cambero, Fabian. Chilean health regulator approves CanSino COVID-19 vaccine for emergency use. Reuters. 2021-04-07 [2021-08-30]. （原始内容存档于2021-10-07）（英语）.
Argentina issues emergency approval to China's single-dose Cansino COVID-19 vaccine. Reuters. 2021-06-11 [2021-08-30]. （原始内容存档于2021-07-12）（英语）.
Malaysia grants conditional approval for CanSino, J&J COVID-19 vaccines. Reuters. 2021-06-15 [2021-08-30]. （原始内容存档于2021-06-15）（英语）.
Ecuador authorizes use of China's CanSino vaccine against COVID-19. [2021-06-16]. （原始内容存档于2021-06-16）.
Indonesia approves J&J, Cansino COVID-19 vaccines for emergency use. [2021-09-07]. （原始内容存档于2021-10-06）.
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 (RESIST). ClinicalTrials.gov. 2020-08-28 [2020-09-17]. （原始内容存档于2020-09-12）.
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus. ClinicalTrials.gov. 2020-10-01 [2020-10-26]. （原始内容存档于2020-11-29）.
Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela (VENEZUELA). ClinicalTrials.gov. [2021-01-19]. （原始内容存档于2021-01-17）.
A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE (SPUTNIK-UAE). ClinicalTrials.gov, US National Library of Medicine. 2020-12-07 [2021-03-07]. （原始内容存档于2021-04-11）.
Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L.; Grousova, Daria M. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet (London, England). 2021-02-20, 397 (10275): 671–681 [2021-04-06]. ISSN 1474-547X. PMC 7852454 . PMID 33545094. doi:10.1016/S0140-6736(21)00234-8. （原始内容存档于2021-05-27）.
Belarus becomes the first foreign country to register the Sputnik V vaccine. 俄罗斯直接投资基金会. 2020-12-21 [2021-01-31]. （原始内容存档于2021-01-26）.
Bolivia has registered Sputnik V vaccine based on Russian clinical trial data. Yahoo！Finance. 2021-01-06 [2021-01-07]. （原始内容存档于2021-01-12）.
Russian Sputnik V anti-coronavirus vaccine registered in Algeria. 俄通社-塔斯社. 2021-01-10 [2021-01-11]. （原始内容存档于2021-01-12）.
Palestine has become the first country in the Middle East to register Sputnik V vaccine. 俄罗斯直接投资基金会. 2021-01-11 [2021-01-11]. （原始内容存档于2021-01-13）.
Sputnik V vaccine registered in Venezuela. 俄罗斯直接投资基金会. 2021-01-13 [2021-01-19]. （原始内容存档于2021-10-06）.
Sputnik V vaccine approved in Paraguay. 俄罗斯直接投资基金会. 2021-01-15 [2021-01-19]. （原始内容存档于2021-10-06）.
Turkmenistan registers Russia's Sputnik V vaccine, says RDIF. 路透社. 2021-01-18 [2021-01-18]. （原始内容存档于2021-01-20）.
Hungary becomes the first country in EU to authorize the Sputnik V vaccine. 俄罗斯直接投资基金会. 2021-01-21 [2021-01-24]. （原始内容存档于2021-10-06）.
UAE approves Russia's Sputnik V COVID-19 vaccine for emergency use. 路透社. 2021-01-21 [2021-01-24]. （原始内容存档于2021-01-21）.
Sputnik V vaccine authorized in the Republic of Guinea. 俄罗斯直接投资基金会. 2021-01-29 [2021-01-31]. （原始内容存档于2021-01-29）.
India approves Russia's Sputnik V COVID-19 vaccine. [2021-04-30]. （原始内容存档于2021-05-25）.
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults. ClinicalTrials.gov. 2021-01-12 [2021-01-21]. （原始内容存档于2020-08-23）.
A Study of a Candidate COVID-19 Vaccine (COV003). ClinicalTrials.gov, US National Library of Medicine. 2020-09-02 [2021-03-08]. （原始内容存档于2021-05-26）.
Voysey, Merryn; Costa Clemens, Sue Ann; Madhi, Shabir A; Weckx, Lily Y; Folegatti, Pedro M; Aley, Parvinder K; Angus, Brian; Baillie, Vicky L; Barnabas, Shaun L. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. 柳叶刀. 2021-03, 397 (10277): 881–891 [2021-04-06]. PMC 7894131 . PMID 33617777. doi:10.1016/S0140-6736(21)00432-3. （原始内容存档于2021-05-28）（英语）.
AstraZeneca-Oxford Covid vaccine approved for use by European regulator. [2021-01-29]. （原始内容存档于2021-01-29）.
Aislinn Laing. Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine -AstraZeneca. 路透社. 2020-12-30 [2021-01-01]. （原始内容存档于2021-01-24）.
El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine. 路透社. 2020-12-30 [2021-01-08]. （原始内容存档于2021-01-24）.
Nigam Prusty; Shilpa Jamkhandikar. India drug regulator approves AstraZeneca COVID vaccine, country's first - sources. 路透社. 2021-01-01 [2021-01-01]. （原始内容存档于2021-01-01）.
Bryan Pietsch. Mexico approved the Oxford-AstraZeneca vaccine for emergency use.. 纽约时报. 2021-01-04 [2021-01-07]. （原始内容存档于2021-01-17）.
Sahidul Hasan Khokon. Bangladesh drug regulator approves Oxford-SII's Covid vaccine for emergency use. India Today. 2021-01-08 [2021-01-10]. （原始内容存档于2021-01-13）.
Gopal Sharma; Alasdair Pal. Nepal approves AstraZeneca COVID-19 vaccine for emergency use. 路透社. 2021-01-15 [2021-01-24]. （原始内容存档于2021-01-31）.
Asif Shahzad. Pakistan approves AstraZeneca COVID-19 vaccine for emergency use. 路透社. 2021-01-16 [2021-01-18]. （原始内容存档于2021-01-22）.
Taiwan grants emergency AstraZeneca COVID-19 vaccine authorization and orders 10 million doses. [2021-02-20]. （原始内容存档于2021-02-24）.
Japan gives preliminary OK to 2 more COVID-19 vaccines. [2021-05-20]. （原始内容存档于2021-05-21）.
Australia approves Pfizer vaccine, warns of limited global AstraZeneca supply. 路透社. 2021-01-24 [2021-01-26]. （原始内容存档于2021-01-26）.
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants (ENSEMBLE). ClinicalTrials.gov, US National Library of Medicine. 2020-08-10 [2020-09-24]. （原始内容存档于2021-10-24）.
Jerald Sadoff; Glenda Gray; An Vandebosch; Vicky Cárdenas; Georgi Shukarev; Beatriz Grinsztejn; Paul A. Goepfert; Carla Truyers; Hein Fennema; Bart Spiessens; Kim Offergeld; Gert Scheper. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. 新英格兰医学杂志. 2021-04-21 [2021-05-16]. doi:10.1056/NEJMoa2101544. （原始内容存档于2021-05-16）.
Anthes, Emily. The W.H.O. grants emergency authorization to the Johnson & Johnson vaccine, a boost for global vaccination efforts.. The New York Times. 2021-03-12 [2021-04-06]. ISSN 0362-4331. （原始内容存档于2021-04-28）（美国英语）.
Commissioner, Office of the. FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine. FDA. 2021-03-02 [2021-04-06]. （原始内容存档于2021-03-18）（英语）.
Ellyatt, Holly. Johnson & Johnson's one-shot Covid vaccine cleared for use in the EU. CNBC. 2021-03-11 [2021-04-06]. （原始内容存档于2021-03-26）（英语）.
Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021 (PDF). Government of Saint Vincent and the Grenadines. 2021-02-11 [2021-02-12]. （原始内容 (PDF)存档于2021-02-13）.
Coronavirus: South Africa rolls out vaccination programme. 2021-02-17 [2021-02-19]. （原始内容存档于2021-02-22） –通过www.bbc.com.
Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use: regulator. news.yahoo.com. [2021-04-06]. （原始内容存档于2021-02-25）（美国英语）.
News, A. B. C. Canada clears Johnson & Johnson vaccine, first to approve 4. ABC News. [2021-04-06]. （原始内容存档于2021-03-10）（英语）.
Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light (SPUTNIK-LIGHT). ClinicalTrials.gov. [2021-05-08]. （原始内容存档于2021-05-08）.
Single dose vaccine, Sputnik Light, authorized for use in Russia. 俄罗斯直接投资基金会. 2021-05-06 [2021-05-08]. （原始内容存档于2021-05-20）.
Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19. ClinicalTrials.gov, US National Library of Medicine. 2021-03-03 [2021-03-06]. （原始内容存档于2021-04-24）.
Russia approves second COVID-19 vaccine after preliminary trials. 路透社. 2020-10-14 [2021-01-14]. （原始内容存档于2020-10-19）.
Turkmenistan: Master Berdymukhamedov goes to Moscow. Eurasianet. [2021-04-25]. （原始内容存档于2021-04-28）（英语）.
智飞生物与中科院微生物所合作研发的新冠疫苗获批紧急使用_腾讯新闻. new.qq.com. [2021-04-06]. （原始内容存档于2021-08-17）.
Uzbekistan approves Chinese-developed COVID-19 vaccine. Reuters. 2021-03-01 [2021-03-01]. （原始内容存档于2021-03-10）.
Indonesia approves COVID-19 vaccine of China's Zhifei unit. [2021-10-07]. （原始内容存档于2021-10-08）.
中国智飞生物子公司重组新冠病毒疫苗在哥伦比亚获批紧急使用许可. [2022-01-28]. （原始内容存档于2022-01-28）.
Iran's Version of Cuba's Soberana 02 Approved for Emergency Use. 南方电视台. 2021-06-29 [2021-07-01]. （原始内容存档于2021-07-11）.
ABDALA Clinical Study - Phase III. RPCEC. [2021-03-20]. （原始内容存档于2021-05-03）.
Cuba says Abdala vaccine 92.28% effective against coronavirus. 路透社. 2021-06-21 [2021-06-22]. （原始内容存档于2021-06-24）.
Aprueba el CECMED el Autorizo de Uso de Emergencia del candidato vacunal cubano ABDALA. CECMED. 2021-07-09 [2021-07-09]. （原始内容存档于2021-07-17）.
A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19. ClinicalTrials.gov. 美国临床试验注册中心. 2020-09-28 [2020-10-02]. （原始内容存档于2020-07-29）.
WHO gives emergency use listing to Moderna's COVID-19 vaccine. 路透社. [2021-04-30]. （原始内容存档于2021-05-12）.
Ian Austen. Canada approves the Moderna vaccine, paving the way for inoculations in its vast Far North.. 纽约时报. 2020-12-23 [2021-01-11]. （原始内容存档于2021-01-24）.
Bart H. Meijer. Europe prepares for Moderna vaccine rollout as fears grow over virus variants. 路透社. 2021-01-06 [2021-01-06]. （原始内容存档于2021-01-13）.
Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel. 莫德纳. [2021-01-09]. （原始内容存档于2021-01-22）.
Vaccines – COVID19 Vaccine Tracker. covid19.trackvaccines.org. [2021-06-12]. （原始内容存档于2020-10-29）.
Swissmedic grants authorisation for the COVID-19 vaccine from Moderna. Swissmedic. 2021-01-12 [2021-01-12]. （原始内容存档于2021-01-22）.
莫德納疫苗獲緊急授權自費AZ疫苗供應不間斷. [2021-05-07]. （原始内容存档于2021-05-07）.
United Kingdom Medicines and Healthcare products Regulatory Agency Authorizes Use of COVID-19 Vaccine Moderna. 莫德纳. [2021-01-09]. （原始内容存档于2021-01-14）.
A double-blind, randomized, placebo-controlled Phase II/III Clinical trial to evaluate the safety and efficacy of COVID-19 inactivated vaccine (Shifa-Pharmed) in a population aged 18 to 75 years. Iranian Registry of Clinical Trials. [2021-04-23]. （原始内容存档于2021-04-23）.
Elnur Baghishov. Iran issues license on its coronavirus vaccine. Trend News Agency. 2021-06-14 [2021-06-15]. （原始内容存档于2021-06-14）.
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals. ClinicalTrials.gov, US National Library of Medicine. 2020-04-30 [2021-03-06]. （原始内容存档于2020-10-11）.
PFIZER AND BIONTECH CONFIRM HIGH EFFICACY AND NO SERIOUS SAFETY CONCERNS THROUGH UP TO SIX MONTHS FOLLOWING SECOND DOSE IN UPDATED TOPLINE ANALYSIS OF LANDMARK COVID-19 VACCINE STUDY. 辉瑞. 2021-04-01 [2021-05-07]. （原始内容存档于2021-04-17）.
WHO plans slew of COVID-19 vaccine approvals for global rollout – document. [2021-01-20]. （原始内容存档于2021-01-20）.
Ian Austen. Canada Approves Vaccine and Could Start Shots Next Week. 纽约时报. 2020-12-09 [2021-01-11]. （原始内容存档于2021-01-24）.
Saeed Azhar. Dubai to begin inoculations with Pfizer-BioNTech vaccine from Wednesday. 路透社. 2020-12-22 [2021-01-03]. （原始内容存档于2021-01-12）.
Iraq grants emergency approval for Pfizer COVID-19 vaccine. Arab News. 2020-12-27 [2021-01-20]. （原始内容存档于2021-12-22）.
Colombia regulator approves Pfizer-BioNTech vaccine for emergency use. 路透社. 2021-01-05 [2021-01-20]. （原始内容存档于2021-03-02）.
PH authorizes Pfizer's COVID-19 vaccine for emergency use. CNN菲律宾. 2021-01-14 [2021-01-14]. （原始内容存档于2021-01-21）.
存档副本. [2021-02-14]. （原始内容存档于2021-02-17）.
Brazil approves Pfizer COVID vaccine for widespread use. [2021-02-23]. （原始内容存档于2021-02-23）.
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults. ClinicalTrials.gov. United States National Library of Medicine. 2021-10-06 [2021-12-09]. （原始内容存档于2021-01-21）.
高端疫苗更新團結試驗疫苗三期試驗進度. 2021-11-11 [2021-12-09]. （原始内容存档于2021-11-16）.
Omicron蔓延非洲台灣贈索馬利蘭15萬劑高端疫苗. 中央社. 2021-12-28. （原始内容存档于2021-12-28）.
Taiwan to donate domestic COVID-19 vaccines to Somaliland. Focus Taiwan. 2021-12-28 [2022-01-07]. （原始内容存档于2022-04-18）.
A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2. ClinicalTrials.gov, US National Library of Medicine. 2020-11-02 [2021-03-27]. （原始内容存档于2021-05-10）.
A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom. ClinicalTrials.gov, US National Library of Medicine. 2020-10-12 [2021-03-27]. （原始内容存档于2021-05-25）.
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial. 诺瓦瓦克斯医药. 2021-06-14 [2021-06-14]. （原始内容存档于2021-06-23）.
Heath, Paul T.; Galiza, Eva P.; Baxter, David Neil; Boffito, Marta; Browne, Duncan; Burns, Fiona; Chadwick, David R.; Clark, Rebecca; Cosgrove, Catherine; Galloway, James; Goodman, Anna L.; Heer, Amardeep; Higham, Andrew; Iyengar, Shalini; Jamal, Arham; Jeanes, Christopher; Kalra, Philip A.; Kyriakidou, Christina; McAuley, Daniel F.; Meyrick, Agnieszka; Minassian, Angela M.; Minton, Jane; Moore, Patrick; Munsoor, Imrozia; Nicholls, Helen; Osanlou, Orod; Packham, Jonathan; Pretswell, Carol H.; Ramos, Alberto San Francisco; Saralaya, Dinesh; Sheridan, Ray P.; Smith, Richard; Soiza, Roy L.; Swift, Pauline A.; Thomson, Emma C.; Turner, Jeremy; Viljoen, Marianne Elizabeth; Albert, Gary; Cho, Iksung; Dubovsky, Filip; Glenn, Greg; Rivers, Joy; Robertson, Andreana; Smith, Kathy; Toback, Seth. Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant. medRxiv. 2021-05-14 [2021-05-25]. doi:10.1101/2021.05.13.21256639. （原始内容存档于2021-05-25）.
EU regulator green-lights Novavax COVID-19 vaccine. [2021-12-20]. （原始内容存档于2021-12-20）.
Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine (COV-COMPARE). ClinicalTrials.gov, US National Library of Medicine. [2021-05-14]. （原始内容存档于2021-05-20）.
Britain gives first European approval to Valneva COVID shot. [2022-04-14]. （原始内容存档于2022-04-14）.
A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above. ClinicalTrials.gov, US National Library of Medicine. [2021-06-01]. （原始内容存档于2021-04-23）.
鼻喷流感病毒载体新冠肺炎(COVID-19)疫苗（DelNS1-2019-nCoV-RBD- OPT1）II期临床试验. 中国临床试验注册中心. 2020-11-06 [2020-11-14]. （原始内容存档于2020-11-19）.
万泰生物研发、国内首款鼻喷新冠疫苗获紧急使用，已有10款新冠疫苗附条件上市或紧急使用. [2022-12-16]. （原始内容存档于2022-12-21）.
神州细胞：自愿披露关于控股子公司新冠疫苗SCTV01C被纳入紧急使用的公告. [2023-02-18]. （原始内容存档于2023-02-18）.
石药集团mRNA疫苗在江苏开打. 石藥集團. 2023-05-31 [2023-06-11]. （原始内容存档于2023-06-11）. 石药集团丘远征博士就《中国首个新冠mRNA疫苗（度恩泰）研究进展》做报告
石药集团(01093):自愿公告 - 新型冠状病毒MRNA疫苗 (SYS6006) 在中国纳入紧急使用. 2023-03-22 [2023-04-14]. （原始内容存档于2023-04-14）.
北京神州细胞生物技术集团股份公司自愿披露关于控股子公司新冠疫苗SCTV01E被纳入紧急使用的公告. 上海证券报. 2023-03-23 [2023-04-14]. （原始内容存档于2023-04-17）. 公司自主研发的重组新冠病毒4价（Alpha/Beta/Delta/Omicron变异株）S三聚体蛋白疫苗（项目代号：SCTV01E）经国家有关部门论证被纳入紧急使用
中国生物重组新冠病毒疫苗获批临床试验，系其第三款新冠疫苗. [2021-04-12]. （原始内容存档于2021-04-12）.
Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine. ClinicalTrials.gov. United States National Library of Medicine. [2021-06-29]. （原始内容存档于2021-07-09）.
Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older (VAT00008). ClinicalTrials.gov, US National Library of Medicine. [2021-05-29]. （原始内容存档于2021-06-02）.
A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells). ClinicalTrials.gov, US National Library of Medicine. [2021-06-01]. （原始内容存档于2021-06-03）.
Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19. ClinicalTrials.gov. [2021-06-14]. （原始内容存档于2021-06-12）.
A phase III, randomized, multi-centre, double blind, placebo controlled, study to evaluate efficacy, safety and immunogenicity of Novel Corona Virus -2019-nCov vaccine candidate of M/s Cadila Healthcare Limited.. Clinical Trials Registry - India. [2021-06-14]. （原始内容存档于2021-06-15）.
Zydus applies to the DCGI for EUA to launch ZyCoV-D, the world’s first Plasmid DNA vaccine for COVID-19 (PDF). Zydus Cadila. 2021-07-01 [2021-07-21]. （原始内容存档 (PDF)于2021-07-01）.
A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers. ClinicalTrials.gov. 2021-02-26 [2021-03-20]. NCT04773067. （原始内容存档于2021-05-21）.
A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine. ClinicalTrials.gov. 2020-12-24 [2021-03-20]. NCT04683224. （原始内容存档于2021-05-06）.
Liao, George. Taiwan's second domestic COVID vaccine's midterm performance in phase II trials inferior to local competitor: experts. Taiwan News. 2021-06-27 [2021-07-08]. （原始内容存档于2021-10-05）.
Study of GRAd-COV2 for the Prevention of COVID-19 in Adults (COVITAR). ClinicalTrials.gov. 2020-03-10 [2021-03-12]. （原始内容存档于2021-04-30）.
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19 (SCB-2019). ClinicalTrials.gov. United States National Library of Medicine. 2021-01-08 [2021-01-09]. （原始内容存档于2021-01-11）.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial. [2022-02-05]. （原始内容存档于2022-01-28）.
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults. 美国临床试验注册中心. 2020-11-19 [2020-11-28]. （原始内容存档于2021-01-23）.
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure. 美国临床试验注册中心. 2020-11-24 [2020-11-28]. （原始内容存档于2021-01-18）.
Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19). ClinicalTrials.gov. 2020-12-07 [2021-01-06]. （原始内容存档于2021-01-21）.
COVID-19: A Phase 2b/3, Randomized, Observer-Blinded, Placebo Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older. EU Clinical Trials Register. [2021-05-08]. （原始内容存档于2021-02-13）.
CureVac Provides Update on Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV. CureVac. 2021-06-16 [2021-06-17]. （原始内容存档于2021-06-24）.
Phase 2 trial of safety and immunogenicity of 10 micro gram inactivated SARS-CoV-2 vaccine (FAKHRAVAC), two doses two weeks apart in adults aged 18-70 years: a randomized, double-blind, placebo-controlled, clinical trial. Iranian Registry of Clinical Trials. [2021-06-22]. （原始内容存档于2021-06-16）.
SARS-CoV-2 Vaccine (COH04S1) Versus Emergency Use Authorization SARS-COV-2 Vaccine for the Treatment of COVID-19 in Patients With Blood Cancer. ClinicalTrials.gov. United States National Library of Medicine. [2021-08-03]. （原始内容存档于2021-10-06）.
Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells). ClinicalTrials.gov. United States National Library of Medicine. 2021-03-24 [2021-03-25]. （原始内容存档于2021-05-06）.
SOBERANA PLUS. RPCEC. [2021-04-14]. （原始内容存档于2021-04-15）.
Phase II, Safety and Immunogenicity of RAZI SARS-CoV-2 recombinant Spike protein vaccine (RAZI Cov Pars) in adults aged 18-70 years; a Randomised, double blind, parallel 2 arms clinical trial. Iranian Registry of Clinical Trials. [2021-04-23]. （原始内容存档于2021-05-25）.
A phase II, Randomized, Two-armed, Double-blind, Placebo controlled trial to evaluate efficacy and safety of an adjuvanted recombinant SARS-CoV-2 spike (S) protein subunit vaccine (SpikoGen®) produced by CinnaGen Co. (Two doses of 25µg with dosing interval of 21 days). Iranian Registry of Clinical Trials. [2021-05-28]. （原始内容存档于2021-06-02）.
Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell). ClinicalTrials.gov, US National Library of Medicine. [2021-08-09]. （原始内容存档于2021-10-06）.
Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine (COVID-19). ClinicalTrials.gov, US National Library of Medicine. [2021-07-15]. （原始内容存档于2021-07-20）.
A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults. ClinicalTrials.gov, US National Library of Medicine. 2020-12-16 [2021-01-07]. （原始内容存档于2021-01-13）.
Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine. ClinicalTrials.gov, US National Library of Medicine. 2020-11-03 [2020-11-09]. （原始内容存档于2020-12-07）.
Biological E’s novel Covid-19 vaccine of SARS-CoV-2 for protection against Covid-19 disease.. 印度临床试验注册中心. 2020-11-12 [2020-11-14]. （原始内容存档于2020-12-01）.
KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers. ClinicalTrials.gov. 2021-01-11 [2021-01-12]. （原始内容存档于2020-10-02）.
A Clinical Trial of COVAC Vaccines in Healthy Adults. ClinicalTrials.gov. 2021-01-29 [2021-02-19]. （原始内容存档于2021-02-12）.
Phase I / II, randomized, controlled, adaptive, double-blind and multicenter study to evaluate the safety, reactogenicity and immunogenicity, of the prophylactic FINLAY-FR-1 anti-SARS-CoV-2 Vaccine Candidate in a two-doses schedule. (COVID-19). RPCEC. [2021-03-03]. （原始内容存档于2021-05-13）.
신형코로나비루스후보왁찐을 새로 개발. 朝鮮國家科學技術委員會. 2020-07-18 [2021-05-03]. （原始内容存档于2021-05-03）.
Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19). ClinicalTrials.gov. 2021-02-08 [2021-05-11]. （原始内容存档于2021-05-24）.
Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19). ClinicalTrials.gov. [2021-05-12]. （原始内容存档于2021-05-24）.
B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency (B-pVAC). ClinicalTrials.gov. United States National Library of Medicine. [2021-07-16]. （原始内容存档于2021-07-19）.
Trial registered on ANZCTR. 澳大利亚-新西兰临床试验注册中心. 2020-09-08 [2020-09-25]. （原始内容存档于2021-10-06）.
Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults. ClinicalTrials.gov. 2021-01-20 [2021-01-21]. （原始内容存档于2021-05-03）.
GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19). ClinicalTrials.gov. 2020-12-24 [2021-02-11]. （原始内容存档于2021-02-07）.
Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19. 美国临床试验注册中心. 2020-11-06 [2020-12-06]. （原始内容存档于2021-01-22）.
Study of the Safety of Prophylactic Vaccination With 2nd Generation E1/E2B/E3-Deleted Adenoviral-COVID-19 in Normal Healthy Volunteers. 美国临床试验注册中心. 2020-10-22 [2020-11-10]. （原始内容存档于2020-11-11）.
Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults. ClinicalTrials.gov (Registry). United States National Library of Medicine. 2020-09-24 [2020-09-25]. NCT04563702. （原始内容存档于2021-12-23）.
Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19. ClinicalTrials.gov. United States National Library of Medicine. 2020-09-29 [2020-09-30]. （原始内容存档于2021-11-21）.
A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine. ClinicalTrials.gov. United States National Library of Medicine. 2020-09-24 [2020-12-17]. （原始内容存档于2021-10-09）.
Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19). ClinicalTrials.gov. 2021-02-18 [2021-05-11]. （原始内容存档于2021-05-25）.
Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19. 美国临床试验注册中心. 2020-10-27 [2020-11-09]. （原始内容存档于2021-01-02）.
CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) (CORVax12). 美国临床试验注册中心. 2020-11-13 [2020-12-06]. （原始内容存档于2021-01-21）.
A Clinical Trial of a Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults. ClinicalTrials.gov. 2020-11-24 [2021-01-03]. （原始内容存档于2021-01-22）.
ChulaCov19 mRNA Vaccine in Healthy Adults. ClinicalTrials.gov. United States National Library of Medicine. 2020-10-06 [2020-12-19]. （原始内容存档于2021-01-01）.
An interventional study to evaluate the safety and immune response of a vaccine against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2, the virus that causes COVID-19 infection) when given to healthy adult participants.. 澳大利亚-新西兰临床试验注册中心. 2020-07-24 [2020-11-10]. （原始内容存档于2020-12-09）.
澳大利亚叫停一本土新冠疫苗研发：部分接种后出现HIV假阳. [2020-12-11]. （原始内容存档于2021-01-07）.
Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine (COVID-19-101). ClinicalTrials.gov. United States National Library of Medicine. 2020-09-28 [2020-11-23]. （原始内容存档于2020-12-08）.
Carl Zimmer; Jonathan Corum; Sui-Lee Wee. Coronavirus Vaccine Tracker. 纽约时报. 2021-01-25 [2021-01-25]. （原始内容存档于2020-12-24）.
Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001). ClinicalTrials.gov. United States National Library of Medicine. 2020-11-13 [2020-11-19]. （原始内容存档于2020-11-28）.
Andrew Scheuber. Imperial vaccine tech to target COVID mutations and booster doses. 伦敦帝国学院. 2021-01-26 [2021-01-29]. （原始内容存档于2021-01-26）.
Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study). ClinicalTrials.gov. United States National Library of Medicine. 2021-01-19 [2021-02-10]. （原始内容存档于2021-02-25）.
Altimmune Announces Update On AdCOVID™ Phase 1 Clinical Trial. Altimmune. 2021-06-29 [2021-07-03]. （原始内容存档于2021-07-20）.
浩鼎董事會決議停止BCVax、OBI-866及OBI-999三項產品研發專案開發. MoneyDJ理財網. 2023-12-20 [2024-05-03]. （原始内容存档于2024-05-03）.
Thorp, H. Holden. Underpromise, overdeliver (PDF). American Association for the Advancement of Science. 2020-03-23 [2020-03-23]. （原始内容存档 (PDF)于2020-03-24）（英语）.
Clinical Development Success Rates 2006-2015 (PDF). BIO Industry Analysis. June 2016 [2020-03-27]. （原始内容存档 (PDF)于2019-09-12）.
阿斯利康在美国获批恢复新冠疫苗临床试验. [2020-10-24]. （原始内容存档于2020-11-12）.
COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India. 阿斯利康. [2020-10-11]. （原始内容存档于2020-12-19）.
英国药厂阿斯利康巴西新冠疫苗测试一名志愿者死亡. [2020-10-22]. （原始内容存档于2020-10-24）.
陸製疫苗出現嚴重不良反應巴西停止臨床試驗. 今日新聞NOWnews. [2020-11-10]. （原始内容存档于2020-11-10）.
巴西卫生监管机构恢复在该国进行中国科兴生物新冠疫苗三期临床试验. [2020-11-12]. （原始内容存档于2020-11-12）.
一受试者患病秘鲁暂停中国疫苗临床试验. DW.COM. 2020-12-12 [2021-04-06]. （原始内容存档于2020-12-14）（中文（中国大陆））.
秘鲁允许重启之前暂停的中国国药集团新冠疫苗试验. [2020-12-20]. （原始内容存档于2020-12-17）.
Moderna COVID-19 Vaccine – cx-024414 injection, suspension. DailyMed. U.S. National Institutes of Health. [2020-12-20]. （原始内容存档于2021-04-04）.
Pfizer-BioNTech COVID-19 Vaccine – rna ingredient bnt-162b2 injection, suspension. DailyMed. U.S. National Institutes of Health. [2020-12-14]. （原始内容存档于2021-01-29）.
AZD1222 US Phase III primary analysis confirms safety and efficacy. www.astrazeneca.com. [2021-04-06]. （原始内容存档于2021-06-03）（英语）.
Wadman, Meredith. Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less potent in South Africa. Science. 2021-01-28 [2021-04-06]. ISSN 0036-8075. doi:10.1126/science.abg8101. （原始内容存档于2021-05-25）.
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial. Novavax Inc. - IR Site. [2021-03-03]. （原始内容存档于2021-06-06）.
La vacuna CoronaVac demostró ser efectiva en un 89% para evitar hospitalizaciones UCI [CoronaVac vaccine proved to be 89% effective in preventing ICU hospitalizations] (新闻稿). Santiago: Ministry of Health (Chile). 2021-04-16 [2021-04-18]. （原始内容存档于2021-06-07）（西班牙语）.
Araos, Rafael. Efectividad de la vacuna CoronaVac con virus inactivo contra SARS-CoV-2 en Chile [Effectiveness of the CoronaVac vaccine with inactivated virus against SARS-CoV-2 in Chile] (PDF) (报告). Ministry of Health (Chile): 12-13. 2021-04-16 [2021-04-18]. （原始内容存档 (PDF)于2021-05-25）（西班牙语）.
Estudio "Efectividad de la vacuna CoronaVac con virus inactivado contra SARS-CoV-2 en Chile"tran [Study "Effectiveness of the CoronaVac vaccine with inactivated virus against SARS-CoV-2 in Chile"] (Online video). Ministry of Health (Chile). 事件发生在 10:12-13:42, 16:59-17:45. 2021-04-16 [2021-04-18]. （原始内容存档于2021-06-02）（西班牙语）.
China's Coronavac 80% effective at preventing Covid deaths: Chile results. Santiago: France 24. Agence France-Presse. 2021-04-16 [2021-04-18]. （原始内容存档于2021-04-27）.
DailyMed - JANSSEN COVID-19 VACCINE- ad26.cov2.s injection, suspension. dailymed.nlm.nih.gov. [2021-04-06]. （原始内容存档于2021-05-12）.
2019冠状病毒病（COVID-19）：疫苗. www.who.int. [2021-12-04]. （原始内容存档于2021-12-04）（中文）.
陈丹妮. 警惕！完成疫苗接种者依然会传播新冠病毒. language.chinadaily.com.cn. [2021-12-04]. （原始内容存档于2021-12-04）.
Singanayagam, Anika; Hakki, Seran; Dunning, Jake; Madon, Kieran J.; Crone, Michael A.; Koycheva, Aleksandra; Derqui-Fernandez, Nieves; Barnett, Jack L.; Whitfield, Michael G. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet. Infectious Diseases. 2021-10-29: S1473–3099(21)00648–4 [2021-12-04]. ISSN 1474-4457. PMC 8554486 . PMID 34756186. doi:10.1016/S1473-3099(21)00648-4. （原始内容存档于2021-12-28）.
Singanayagam, Anika; Hakki, Seran; Dunning, Jake; Madon, Kieran J.; Crone, Michael A.; Koycheva, Aleksandra; Derqui-Fernandez, Nieves; Barnett, Jack L.; Whitfield, Michael G. ” transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet Infectious Diseases. 2021-10-29, 0 (0) [2021-12-04]. ISSN 1473-3099. PMID 34756186. doi:10.1016/S1473-3099(21)00648-4. （原始内容存档于2023-07-30）（英语）.
国家卫健委官员：下一步考虑适度扩大新冠疫苗紧急使用的范围-中新网. www.chinanews.com. [2021-04-25]. （原始内容存档于2021-04-25）.
央视. 国家卫健委：附条件上市后疫苗免费接种相关费用将由医保基金和财政共同负担. 新浪. 2021-01-09 [2021-01-09]. （原始内容存档于2021-01-11）.
权威快报丨全国新冠疫苗接种剂次超11亿. china.huanqiu.com. [2021-06-27]. （原始内容存档于2021-06-27）.
经纬. 梒青、何足 , 编. 中国悄然停止接种免费新冠疫苗. 自由亚洲电台. 2024-07-09 [202-07-11]. （原始内容存档于2024-10-02）（中文）.
周禮希, 林劍, 翟睿敏. 林鄭月娥：接種疫苗後「感覺很好」可站立半小時不停答問題. 香港01. 2021-02-22 [2021-04-06]. （原始内容存档于2021-08-03）（中文（香港））.
、香港今日正式啟動新冠疫苗接種 - 兩岸. 中時新聞網. [2021-04-06]. （原始内容存档于2021-02-26）（中文（臺灣））.
香港新冠疫苗接種資料概覽. 香港衛生防護中心. [2021-04-28]. （原始内容存档 (PDF)于2021-03-14）.
全國逾2億疫苗接種「零死亡」通報　香港130萬劑25卒21人打科興. RFA. 2021-04-27 [2021-06-25]. （原始内容存档于2021-04-28）.
一周內多10人死前曾接種新冠疫苗　5名孕婦針後流產. 東方日報. 2021-05-26 [2021-06-04]. （原始内容存档于2021-05-26）.
專家委員會:沒個案與接種疫苗有因果關係. 信报财经新闻. 2021-06-01 [2021-06-26]. （原始内容存档于2021-08-17）.
疫苗監測數據欠透明　港府圖冚死亡個案　何栢良：莫名其妙. 東方日報. 2021-06-03 [2021-06-22]. （原始内容存档于2021-06-04）.
澳门拟采购140万剂新冠疫苗三类人员优先接种→. world.huanqiu.com. [2021-04-06]. （原始内容存档于2021-08-18）.
首批國藥10萬劑疫苗周五抵澳門　料農曆新年前後接種. 香港电台. 2021-02-01 [2021-02-01]. （原始内容存档于2021-12-18）.
賀一誠和澳門主要官員接種新冠疫苗. [2021-02-09]. （原始内容存档于2021-02-12）.
國藥疫苗｜澳門下周二打第一針衛生局：內地批准上市澳門都准用. 香港01. 2021-02-06 [2021-02-06]. （原始内容存档于2021-02-14）（中文（香港））.
新型冠狀病毒感染應變協調中心. 首批10萬劑國藥集團新型冠狀病毒滅活疫苗抵澳社會文化司歐陽瑜司長、中聯辦嚴植嬋副主任見證接收. 澳門特別行政區政府入口網站. 2020-02-08 [2021-02-08]. （原始内容存档于2021-02-14）（中文（繁體））.
謝柏宏. 陳時中：已購新冠疫苗2,000萬劑. 經濟日報. 2020-12-31 [2021-01-27]. （原始内容存档于2021-02-05）（中文（臺灣））.
陳言喬. 台灣有人建議引進中國大陸疫苗陸國台辦：存在政治障礙. 聯合新聞網. 2021-01-27 [2021-01-27]. （原始内容存档于2021-10-22）（中文（臺灣））.
台灣為什麼不買中國疫苗？指揮中心QA一次看. 中央通讯社. 2021-01-27 [2021-01-27]. （原始内容存档于2021-01-28）（中文（臺灣））.
台灣搶新冠疫苗「另找3家疫苗廠談」　陳時中證實接洽. ETtoday新聞雲. 2021-02-03 [2021-02-04]. （原始内容存档于2021-02-09）.
莫德納將供台灣500萬劑COVID-19疫苗年中交付. [2021-02-10]. （原始内容存档于2021-02-18）.
鄭超文. 影／首批莫德納抵達桃園機場工作人員小心運送. 聯合新聞網. 2021-05-28 [2021-05-28]. （原始内容存档于2021-08-17）.
率先施打AZ疫苗蘇貞昌：沒有任何痠痛不舒服[影]CNA. 中央社. [2021-04-06]. （原始内容存档于2021-04-20）（中文（臺灣））.
共同社. 详讯：日本宣布向台湾提供124万剂疫苗. 共同网. [2021-06-05]. （原始内容存档于2021-06-05）.
贈台250萬劑莫德納美官員：我們的疫苗沒有附加條件. 自由時報. 2021-06-19 [2021-06-20]. （原始内容存档于2021-06-28）.
美國「真朋友」贈250萬劑莫德納疫苗16:31抵台　陳時中親接機. 上報. 2021-06-20 [2021-06-20]. （原始内容存档于2021-06-29）.
上海复星医药（集团）股份有限公司关于控股子公司许可项目进展的公告 (PDF). 上海复星医药（集团）股份有限公司董事会. 2021-07-11 [2021-07-12]. （原始内容存档 (PDF)于2021-09-04）.
林妤柔. 台積電、鴻海買到 BNT 疫苗！費用、抵達時間重點一次看. TechNews. 2021-07-12 [2021-07-12]. （原始内容存档于2021-07-12）.
本公司與永齡基金會共同捐贈五百萬劑BNT162b2疫苗予行政院衛生福利部疾病管制署作為新型冠狀病毒（COVID-19）防疫使用. 公開資訊觀測站. 臺灣證券交易所. [2021-07-12]. （原始内容存档于2021-09-27）.
本公司捐贈五百萬劑BNT162b2疫苗予行政院衛生福利部疾病管制署作為新型冠狀病毒肺炎（COVID-19）防疫使用. 公開資訊觀測站. 臺灣證券交易所. [2021-07-12]. （原始内容存档于2021-09-27）.
王燕華. 買到了！慈濟宣布簽訂500萬劑BNT採購全捐給民眾施打. 聯合報 (聯合新聞網). 2021-07-21 [2021-07-21]. （原始内容存档于2021-07-21）.
首批93.2萬劑BNT疫苗抵台張淑芬、顏博文接機陳時中連說多次「感謝」. 聯合新聞網. [2021-09-02]. （原始内容存档于2021-09-02）.
18到22歲納BNT優先接種族群陳時中：確保每個年紀打到疫苗. 自由時報. 2021-09-01 [2021-09-03]. （原始内容存档于2021-10-07）.
衛福部食藥署核准莫德納疫苗用於6至11歲兒童接種. 衛生福利部食品藥物管理署. 2022-04-17. （原始内容存档于2022-04-17）.
陳彥鈞、林治平. 台灣核准莫德納用於6至11歲各國兒童疫苗政策一次看. 中央通訊社. 2022-04-18. （原始内容存档于2022-04-18）.
林惠琴. 6-11歲打莫德納專家拍板：2劑間隔拉長12週. 自由時報. 2022-04-20. （原始内容存档于2022-04-22）.
6~11歲新冠疫苗最快下周一5/2接種. 大愛電視. 2022-04-26 [2022-05-03]. （原始内容存档于2022-05-03）.
陳彥鈞、林治平. BNT兒童疫苗EUA過關！5到11歲皆可打、接種2劑間隔21天…最快施打時間曝光. 中央通訊社. 2022-04-29. （原始内容存档于2022-04-29）.
Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine. 辉瑞. 2020-11-20 [2020-11-27]. （原始内容存档于2021-01-24）.
Thomas, Katie. F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away. The New York Times. 2020-11-20 [2020-12-11]. （原始内容存档于2020-12-12）.
Ivan Pereira. US administers 1st doses of Pfizer coronavirus vaccine. ABC News. [2020-12-14]. （原始内容存档于2021-01-19）.
Kate Sullivan. Biden receives first dose of Covid-19 vaccine on live television. CNN. 2020-12-21 [2021-02-07]. （原始内容存档于2021-02-18）.
新冠疫情：美国批准第二种疫苗莫德纳　彭斯夫妇接种疫苗. [2020-12-19]. （原始内容存档于2020-12-19）.
Madeline Holcombe; Holly Yan; Steve Almasy. The Moderna vaccine is now in some Americans' arms as Covid-19 cases in the US pass 18 million. CNN. 2020-12-21 [2020-12-22]. （原始内容存档于2021-01-22）.
世卫组织：莫德纳新冠疫苗接种后应至少观察15分钟暂不建议18岁以下人群及孕妇接种. [2021-01-27]. （原始内容存档于2021-01-27）.
Sara G. Miller; Erika Edwards. J&J applies for emergency authorization; FDA expected to greenlight in coming weeks. NBC新闻. 2021-02-04 [2021-02-07]. （原始内容存档于2021-02-25）.
Noah Weiland; Sharon LaFraniere. F.D.A. Clears Johnson & Johnson’s Shot, the Third Vaccine for U.S.. 纽约时报. 2021-02-27 [2021-02-27]. （原始内容存档于2021-06-06）.
US vaccine roll-out falls short of 20 million jabs by end of 2020. Al Jazeera. 2020-12-31 [2021-01-05]. （原始内容存档于2021-01-24）.
Sheryl Gay Stolberg; Sharon LaFraniere. Biden Promises 100 Million Vaccine Shots in 100 Days, but Shortage Worries Rise. 纽约时报. 2020-12-08 [2021-01-27]. （原始内容存档于2021-01-29）.
Sheryl Gay Stolberg. Biden Raises Daily Vaccination Target and Extends Travel Bans. 纽约时报. 2021-01-25 [2021-02-13]. （原始内容存档于2021-02-25）.
Covid-19: Alaska Becomes First State to Open Vaccine Access to Everyone 16 and Older. 纽约时报. 2021-03-09 [2021-03-16]. （原始内容存档于2021-05-19）.
Justin Gomez. In address, Biden directs that all adults be eligible for COVID-19 vaccine by May 1. ABC新闻. 2021-03-11 [2021-03-14]. （原始内容存档于2021-05-16）.
美國一半成年國民已至少接種一劑疫苗　當局稱里程碑. [2021-05-14]. （原始内容存档于2021-05-14）.
英国批准辉瑞疫苗上市后美国疫苗注射进入倒计时. [2020-12-06]. （原始内容存档于2020-12-15）.
新冠战“疫”迎来“胜利日”！英国展开大规模疫苗接种. [2020-12-09]. （原始内容存档于2021-01-23）.
焦点：英国警告有严重过敏史的人不要接种辉瑞疫苗此前两人出现不良反应. [2020-12-10]. （原始内容存档于2020-12-15）.
英国批准牛津和阿斯利康研发的新冠疫苗紧急使用. [2021-01-03]. （原始内容存档于2020-12-30）.
英国监管机构批准美国莫德纳公司新冠疫苗. [2021-01-09]. （原始内容存档于2021-01-11）.
趙蔡州. 快訊／英國女王夫婦接種「新冠疫苗」　白金漢宮曝光細節. ETtoday新聞雲. 2021-01-09 [2021-01-09]. （原始内容存档于2021-01-11）.
英國7名曾接種阿斯利康疫苗人士出現血栓其後死亡 - RTHK. news.rthk.hk. [2021-04-06]. （原始内容存档于2021-04-03）（中文（臺灣））.
Celine Castronuovo. Russia gives over 800,000 people its COVID-19 vaccine. The Hill. 2021-01-02 [2021-01-02]. （原始内容存档于2021-01-16）.
界面快报. 俄罗斯批准单剂新冠疫苗“卫星-Light”，称其有效率超79%. finance.sina.com.cn. 2021-05-06 [2021-06-11]. （原始内容存档于2021-08-19）.
疫情燒　聖彼得堡強制打針　俄人跑鄰國接種. [2021-11-11]. （原始内容存档于2021-11-11）.
法国病例每周以两位数百分比增长当局不排除再次封城. [2021-11-22]. （原始内容存档于2021-11-22）.
India’s Total Covid-19 Vaccination Coverage Surpasses Five Crore Doses: Health Ministry. Swarajya（英语：Swarajya (magazine)）. 2021-03-24 [2021-05-11]. （原始内容存档于2021-05-13）（英语）.
India giving COVID-19 vaccines to more people as cases rise. ABC新聞. 2021-03-01 [2021-05-11]. （原始内容存档于2021-05-13）（英语）.
Parimal Kumar; Debanish Achom. No Fresh Registrations For Healthcare Workers For Covid Vaccine: Centre. NDTV.com. 2021-04-04 [2021-05-11]. （原始内容存档于2021-05-26）（英语）.
Divya Goyal. Explained: Supply chain of Covid-19 vaccines and how they reach districts. 印度快報. 2021-05-08 [2021-05-11]. （原始内容存档于2021-05-14）（英语）.
Sumeysh Srivastava. CoWIN app quirks show just how Phase 4 of India's vaccination programme excludes entire class of Indians. Firstpost. 2021-05-10 [2021-05-11]. （原始内容存档于2021-05-13）（英语）.
印度将免费为成年人接种新冠疫苗. [2021-06-09]. （原始内容存档于2021-06-10）.
印度累计接种新冠疫苗10亿剂次. [2021-10-21]. （原始内容存档于2021-10-21）.
新冠疫苗：欧美欢呼两款产品现曙光，中国品牌出海面临审视. [2020-12-07]. （原始内容存档于2020-12-18）.
继批准使用中国疫苗后巴林紧急批准使用辉瑞疫苗. [2020-12-07]. （原始内容存档于2020-12-06）.
阿联酋正式批准使用中国新冠疫苗. [2020-12-10]. （原始内容存档于2020-12-18）.
印度批准紧急使用两种新冠疫苗的授权申请. [2021-01-03]. （原始内容存档于2021-01-09）.
文在寅：韓國全民可免費施打新冠肺炎疫苗. 中央通讯社. 2021-01-11 [2021-01-11]. （原始内容存档于2021-01-13）.
土耳其总统接种科兴疫苗. [2021-01-15]. （原始内容存档于2021-01-21）.
以色列近半人口已接种疫苗商场等场所重新开放. [2021-02-22]. （原始内容存档于2021-02-23）.
Welle (www.dw.com), Deutsche. 新冠疫情升温以色列率先施打第三针. DW.COM. 2021-08-01 [2021-08-02]. （原始内容存档于2021-08-09）（中文（中国大陆））.
视频｜全球：严防疫情卷土重来多国“开打”疫苗加强针菲律宾：批准中国科兴疫苗作为加强针接种. [2021-11-17]. （原始内容存档于2021-11-17）.
阿联酋：目标人口100%已接种至少一剂新冠疫苗. [2021-11-28]. （原始内容存档于2021-11-28）.
越南成为新冠疫苗接种率最高的6个国家之一. [2022-11-29]. （原始内容存档于2022-11-29）.
印度开打新冠疫苗加强针. [2022-01-11]. （原始内容存档于2022-01-11）.
法国：明起第一批接种疫苗将在医院和养老院进行. 腾讯新闻. 2020-12-26 [2021-04-06]. （原始内容存档于2021-08-18）.
法国逾8万人本周接种新冠疫苗民众接种疫苗意愿上升. 中新网. 2021-01-09 [2021-04-06]. （原始内容存档于2021-01-09）.
《匈牙利批准中国疫苗紧急使用授权匈总理：我对中国疫苗最为信任》. 央视网. [2021-01-30]. （原始内容存档于2021-08-18）.
欧盟批准阿斯利康疫苗附条件上市-. 新华网. 2021-01-30 [2021-04-06]. （原始内容存档于2021-02-04）.
奥地利叫停接种一批阿斯利康疫苗：1人接种后因严重凝血功能障碍死亡，1人发生肺栓塞. 每经网. [2021-04-06]. （原始内容存档于2021-03-11）.
德国或9月开始接种新冠疫苗加强针. 新华网. 2021-08-03 [2021-08-30]. （原始内容存档于2021-08-03）.
意大利疫苗接种率接近80% 伦巴第大区率先完成目标. [2021-10-10]. （原始内容存档于2021-09-16）.
德国新冠疫苗完全接种者比例近66%. [2021-10-24]. （原始内容存档于2021-11-03）.
法国扩大新冠疫苗加强针接种范围. [2021-11-26]. （原始内容存档于2021-11-26）.
法国将推进新冠疫苗加强针接种. [2021-11-10]. （原始内容存档于2021-11-10）.
爱尔兰收紧疫情防控措施扩大加强针接种范围. [2021-11-17]. （原始内容存档于2021-11-23）.
德国通过医护人员义务接种新冠疫苗法案. [2021-12-11]. （原始内容存档于2021-12-11）.
奥地利将成为欧洲首个强制接种疫苗的国家. [2021-11-20]. （原始内容存档于2021-11-22）.
西班牙80岁以上高龄人群将接种第四剂加强针. [2022-07-27]. （原始内容存档于2022-07-28）.
朱婉君. 通讯：“我感到非常自豪”——记古巴医务工作者接种本土候选新冠疫苗. 新华网. 新华社. [2021-05-14]. （原始内容存档于2021-03-25）（中文（简体））.
黃韻玲. 古巴大規模接種自製新冠疫苗有望改善拉丁美洲疫情. 公視新聞網. 2021-05-13 [2021-05-14]. （原始内容存档于2021-05-14）（中文（繁體））.
中国康希诺新冠疫苗在智利获紧急使用许可. [2021-09-07]. （原始内容存档于2021-09-07）.
智利给予中国科兴新冠疫苗在6岁至17岁人群中紧急使用许可. [2021-09-07]. （原始内容存档于2021-09-07）.
智利批准科兴新冠疫苗在3至6岁人群中紧急使用. [2021-11-26]. （原始内容存档于2021-11-26）.
阿根廷批准国药新冠疫苗在3至11岁儿童中紧急使用. [2021-10-17]. （原始内容存档于2021-10-19）.
埃及开始为医护人员接种中国国药集团新冠疫苗. [2021-01-25]. （原始内容存档于2021-01-26）.
澳大利亚批准12至15岁青少年接种辉瑞新冠疫苗. [2022-01-10]. （原始内容存档于2022-04-21）.
澳大利亚累计新冠病例逾百万半数上周出现. [2022-01-10]. （原始内容存档于2022-04-22）.
What are the side effects of COVID-19 vaccines, and should you worry?. www.medicalnewstoday.com. 2021-03-22 [2021-04-06]. （原始内容存档于2021-05-17）（英语）.
AFP. No deaths in Europe directly linked to Covid vaccine, experts say. TheJournal.ie. [2021-01-27]. （原始内容存档于2021-01-26）（英语）.
EU regulator looking at new possible side-effects of mRNA COVID-19 shots. [2021-08-11]. （原始内容存档于2021-08-11）.
EU reviewing risk of rare inflammation after COVID-19 vaccinations. [2021-09-04]. （原始内容存档于2021-09-17）.
疫苗副作用──面癱？. 信報. 2020-12-29 [2021-04-21]. （原始内容存档于2020-12-31）.
科興接種須知更新　政府列「貝爾面癱」為副作用. AM730. 2021-07-15 [2021-07-21]. （原始内容存档于2021-07-21）.
面癱列科興疫苗副作用　港府僅更新網站資訊未對外公布. 東方日報. 2021-07-15 [2021-07-21]. （原始内容存档于2021-07-21）.
Higher risk of Bell's palsy after Sinovac's Covid-19 vaccine: Study. AsiaOne. 2021-08-17 [2021-08-30]. （原始内容存档于2021-08-17）（英语）.
AIFA imposes ban of use of AstraZeneca batch. Investigations in progress in coordination with EMA. 意大利药品管理局. [2021-03-11]. （原始内容存档于2021-03-11）（意大利语）.
出现血栓及死亡事件！德法意紧急停用阿斯利康疫苗欧洲有15国停用. news.ifeng.com. [2021-04-06]. （原始内容存档于2021-06-06）.
央视. 欧洲药监局依然推荐接种阿斯利康疫苗. finance.sina.com.cn. 2021-03-19 [2021-04-06]. （原始内容存档于2021-03-22）.
欧盟与英国药监机构发现阿斯利康新冠疫苗与罕见血栓有关联. 美国之音. [2021-06-11]. （原始内容存档于2021-04-08）（中文）.
Medical Director of AstraZeneca AB. Direct healthcare professional communication (DHPC): Vaxzevria (previously COVID-19 Vaccine AstraZeneca): link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia (PDF). 欧洲药品管理局. 2021-04-13 [2021-04-13]. （原始内容存档 (PDF)于2022-07-18）.
COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. [2021-04-20]. （原始内容存档于2021-06-06）.
In puzzle of rare blood clots and Covid vaccines, researchers see clues. STAT. 2021-04-13 [2021-06-11]. （原始内容存档于2021-06-06）（美国英语）.
CNN, Ben Tinker and Elizabeth Cohen. CDC and FDA recommend US pause use of Johnson & Johnson's Covid-19 vaccine over blood clot concerns. CNN. [2021-04-13]. （原始内容存档于2021-06-07）.
Weiland, Noah; LaFraniere, Sharon; Zimmer, Carl. U.S. Calls for Pause on Johnson & Johnson Vaccine After Clotting Cases. The New York Times. 2021-04-13 [2021-04-13]. ISSN 0362-4331. （原始内容存档于2021-06-07）（美国英语）.
Health officials lift pause on Johnson & Johnson vaccine following panel recommendation. The Associated Press. 2021-04-23 [2021-04-24]. （原始内容存档于2021-05-05）.
Vaccine Side Effects Q and A | In the Pipeline. blogs.sciencemag.org. 2021-04-14 [2021-06-11]. （原始内容存档于2021-04-23）（美国英语）.
Russia says Sputnik V vaccine does not cause blood clots. medicalxpress.com. [2021-06-11]. （原始内容存档于2021-04-19）（英语）.
CanSinoBIO says no serious blood clots from its vaccine. Reuters. 2021-04-14 [2021-06-11]. （原始内容存档于2021-04-18）.
英国接种阿斯利康疫苗后死于血栓者升至32人-新华网. www.xinhuanet.com. [2021-06-11]. （原始内容存档于2021-04-28）.
加拿大发生首起接种阿斯利康疫苗后血栓致死案例. [2021-04-28]. （原始内容存档于2021-04-30）.
FDA limits use of Johnson & Johnson’s Covid-19 vaccine, citing clotting risk. [2022-05-05]. （原始内容存档于2022-05-06）.
Heller, Jeffrey. Israel sees probable link between Pfizer vaccine and myocarditis cases. Reuters. 2021-06-02 [2021-06-03]. （原始内容存档于2021-06-25）.
Officials flag rare myocarditis cases after Covid vaccination. STAT. 2021-06-10 [2021-06-11]. （原始内容存档于2021-06-24）（美国英语）.
Officials note ‘likely association’ between Covid-19 vaccines and rare heart condition in young people. [2021-06-24]. （原始内容存档于2021-06-24）.
Europe Confirms mRNA Vaccines Can Cause Heart Disease. www.precisionvaccinations.com. [2021-08-30]. （原始内容存档于2021-07-23）（美国英语）.
CDC study shows risk of Guillain-Barré syndrome elevated after Ad.26.COV2.S COVID vaccination. [2021-12-12]. （原始内容存档于2021-12-15）.
LaFraniere, Sharon; Weiland, Noah. F.D.A. Will Attach Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine. The New York Times. 2021-07-12 [2021-07-12]. ISSN 0362-4331. （原始内容存档于2021-07-12）（美国英语）.
J&J Covid-19 vaccine may trigger neurological condition in rare cases. STAT. 2021-07-12 [2021-08-30]. （原始内容存档于2021-09-10）（美国英语）.
Unusual Variant of Guillain-Barré Syndrome Linked to COVID Vaccines. www.medpagetoday.com. 2021-06-22 [2021-08-30]. （原始内容存档于2021-07-16）（英语）.
Mrinalika Roy. EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot. Reuters. 2022-01-14 [2022-01-17]. （原始内容存档于2022-04-18）.
Welle (www.dw.com), Deutsche. 偏心？违约？欧盟与阿斯利康的疫苗供货之争. DW.COM. 2021-01-28. （原始内容存档于2021-01-30）（中文（中国大陆））.
新冠疫苗缺口巨大，欧盟愤怒要求阿斯利康英国工厂提高供应. [2021-01-30]. （原始内容存档于2021-02-03）.
新冠疫苗：世卫组织批评欧盟疫苗出口管制计划. [2021-01-30]. （原始内容存档于2021-01-30）.
疫苗严重交付不足欧盟正式起诉阿斯利康. [2021-04-27]. （原始内容存档于2021-05-27）.
法庭裁决阿斯利康9月27日前向欧盟交付5千万剂疫苗. [2021-06-19]. （原始内容存档于2021-06-24）.
歐盟告AZ疫苗延誤交貨法院裁定9月底前補貨即可. 中央通訊社. 2021-06-19 [2021-06-24]. （原始内容存档于2021-06-24）.
程立. 美新冠疫苗进临床阶段专家:太快了,除非更早拿到病毒株. 新浪网新闻. 北京. [2020-03-18]. （原始内容存档于2020-03-18）（中文（中国大陆））.
Staff, Reuters. 俄罗斯率先批准新冠疫苗专家质疑其批准速度（更新版）. Reuters. 2020-08-12 [2020-11-28]. （原始内容存档于2021-09-09）（英语）.
Fact check: Six people have not died from the Pfizer-BioNTech COVID-19 vaccine. 路透社. 2020-12-16 [2021-01-15]. （原始内容存档于2021-01-05）.
蔡添成. 挪威23名逾80岁老人接种疫苗后死亡公卫局：高龄与患末期重症者或有高风险. 联合早报. 2021-01-16 [2021-01-17]. （原始内容存档于2021-01-24）.
Fact check: Discussion of deaths in elderly vaccine recipients in Norway lacks context. 路透社. 2021-01-20 [2021-01-23]. （原始内容存档于2021-01-24）.
果壳网. 辉瑞疫苗真实有效率只有29%？这个质疑很荒谬. 新浪. 2021-01-13 [2021-01-17]. （原始内容存档于2021-01-20）. ^{[需要較佳来源]}
Carlton, Jim. Moderna一批新冠疫苗引发潜在过敏反应后暂停接种，待接受评估. 华尔街日报中文网. [2021-02-21]. （原始内容存档于2021-01-19）（中文（中国大陆））.
疫苗全球速报：以色列有民众接种首剂疫苗后确诊香港未放弃采购科兴疫苗. [2021-01-23]. （原始内容存档于2021-01-23）.
陈慧璋, 文 /. 菲给予科兴疫苗使用授权但不建议医护人员使用. 早报. 2021-02-22 [2021-03-11]. （原始内容存档于2021-02-22）（中文（简体））.
政府曾公布36針後死個案全無證據疫苗相關何栢良對不再公布無關個案感「莫名奇妙」【附死亡個案資料】 (17:35). 明報. 2021-06-03 [2021-06-09]. （原始内容存档于2022-02-17）.
接種科興疫苗後第7人死亡信心受挫致僅3%人口接種港府大擴接種群組. 法國國際廣播電台. 2021-03-16 [2021-03-16]. （原始内容存档于2021-03-17）.
AstraZeneca Defends Dosing Error in Covid-19 Vaccine Trial. 华尔街日报. 2020-11-25 [2020-11-26]. （原始内容存档于2021-10-22）.
Kertscher, Tom. No, there is no vaccine for the Wuhan coronavirus. PolitiFact. Poynter Institute. 2020-01-23 [2020-02-07]. （原始内容存档于2020-02-07）.
McDonald, Jessica. Social Media Posts Spread Bogus Coronavirus Conspiracy Theory. FactCheck.org. Annenberg Public Policy Center. 2020-01-24 [2020-02-08]. （原始内容存档于2020-02-06）.
Yeh TY, Contreras, GP. Full vaccination suppresses SARS-CoV-2 delta variant mutation frequency. medRxiv. 2021-08-10 [2021-08-15]. doi:10.1101/2021.08.08.21261768. （原始内容存档于2021-09-13）.
Prabhala, Achal; Jayadev, Arjun; Baker, Dean. Opinion | Want Vaccines Fast? Suspend Intellectual Property Rights. 紐約時報. 2020-12-07 [2021-05-07]. （原始内容存档于2021-06-06）（英语）.
综述：欧盟支持讨论新冠疫苗专利豁免提议批评人士称无法解决短缺问题. 路透社. 2021-05-07 [2021-05-07]. （原始内容存档于2021-05-07）（中文）.
Pfizer begins exporting U.S.-made COVID-19 vaccine to Mexico. Reuters. 2021-04-30 [2021-05-24]. （原始内容存档于2021-05-24）.
“非常时期，非常手段”：美国喊出终结新冠疫情策略. 路透社. 2021-06-11 [2021-06-11]. （原始内容存档于2021-06-11）（中文（简体））.
拜登稱支持新冠疫苗知識產權豁免，世衛稱是抗疫的"不朽時刻". BBC. 2021-05-06 [2021-05-08]. （原始内容存档于2021-05-08）.
美國撐開放武漢肺炎疫苗專利　引發憂慮中俄輕易取得尖端生物製藥技術. 立場新聞. 2021-05-10 [2021-05-10]. （原始内容存档于2021-05-13）.
世貿總幹事：期望年底達成解決方案. 商業電台. [2021-05-16]. （原始内容存档于2021-05-16）.
王盼盼. 外交部：发展中国家希望豁免新冠疫苗知识产权的诉求，中方完全理解并支持. 环球网. [2021-05-17]. （原始内容存档于2021-05-17）（中文（简体））.
WTO agrees partial patent waiver for Covid-19 vaccines. Financial Times. 2022-06-17 [2022-06-19]. （原始内容存档于2022-06-17）.
Board, The Editorial. Opinion | Biden’s Patent Gift to Beijing. Wall Street Journal. 2022-06-17 [2022-06-19]. ISSN 0099-9660. （原始内容存档于2022-06-19）（美国英语）.
Proposal at WTO to Waive Intellectual Property Would Set Harmful Precedent. www.uschamber.com. [2022-06-19]. （原始内容存档于2022-06-15）（英语）.
中国国药冠病特异性治疗药物获批临床试验. [2021-09-04]. （原始内容存档于2021-09-13）.

who.int (Global: 195^th place; Chinese: 179^th place)

who.int

WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries. [2021-12-17]. （原始内容存档于2021-12-24）.
COVAX：致力于全球公平获取2019冠状病毒病（COVID-19）疫苗. [2020-10-09]. （原始内容存档于2020-10-19）.
Draft landscape of COVID-19 candidate vaccines. 世界卫生组织. [2021-01-06]. （原始内容存档于2020-07-29）.
WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations (新闻稿). World Health Organization (WHO). 2021-05-07 [2021-05-07]. （原始内容存档于2021-05-08）.
WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations. www.who.int. [2021-06-02]. （原始内容存档于2021-06-05）（英语）.
2019冠状病毒病（COVID-19）：疫苗. www.who.int. [2021-12-04]. （原始内容存档于2021-12-04）（中文）.

extranet.who.int

Coronavirus Disease (COVID-19): COVID-19 vaccine EUL issued. [2021-05-08]. （原始内容存档于2021-06-04）.

wikipedia.org (Global: low place; Chinese: low place)

en.wikipedia.org

India’s Total Covid-19 Vaccination Coverage Surpasses Five Crore Doses: Health Ministry. Swarajya（英语：Swarajya (magazine)）. 2021-03-24 [2021-05-11]. （原始内容存档于2021-05-13）（英语）.

worldcat.org (Global: 5^th place; Chinese: 12^th place)

Li, Yen-Der; Chi, Wei-Yu; Su, Jun-Han; Ferrall, Louise; Hung, Chien-Fu; Wu, T.-C. Coronavirus vaccine development: from SARS and MERS to COVID-19. Journal of Biomedical Science. 2020-12, 27 (1): 104 [2024-08-14]. ISSN 1423-0127. PMC 7749790 . PMID 33341119. doi:10.1186/s12929-020-00695-2. （原始内容存档于2021-02-19）（英语）.
Subbarao, Kanta. The success of SARS-CoV-2 vaccines and challenges ahead. Cell Host & Microbe. 2021-07, 29 (7): 1111-1123 [2024-08-14]. ISSN 1931-3128. PMC 8279572 . PMID 34265245. doi:10.1016/j.chom.2021.06.016. （原始内容存档于2025-01-16）.
Mallapaty, Smriti; Callaway, Ewen; Kozlov, Max; Ledford, Heidi; Pickrell, John; Van Noorden, Richard. How COVID vaccines shaped 2021 in eight powerful charts. Nature. 2021-12-23, 600 (7890): 580-583 [2024-08-14]. Bibcode:2021Natur.600..580M. ISSN 0028-0836. PMID 34916666. S2CID 245262732. doi:10.1038/d41586-021-03686-x. （原始内容存档于2021-12-16）（英语）.
Watson, Oliver J; Barnsley, Gregory; Toor, Jaspreet; Hogan, Alexandra B; Winskill, Peter; Ghani, Azra C. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. The Lancet Infectious Diseases. 2022-09, 22 (9): 1293-1302. ISSN 1473-3099. PMC 9225255 . PMID 35753318. doi:10.1016/s1473-3099(22)00320-6.
Beaumont P. Covid-19 vaccine: who are countries prioritising for first doses?. The Guardian. 18 November 2020 [26 December 2020]. ISSN 0261-3077. （原始内容存档于18 January 2021）.
Cavanagh, Dave. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathology. 2003-12, 32 (6): 567–582 [2021-02-21]. ISSN 0307-9457. PMC 7154303 . PMID 14676007. doi:10.1080/03079450310001621198. （原始内容存档于2020-09-29）（英语）.
Jiang, Shibo; Lu, Lu; Du, Lanying. Development of SARS vaccines and therapeutics is still needed. Future Virology. 2013-01, 8 (1): 1–2 [2021-02-21]. ISSN 1746-0794. PMC 7079997 . PMID 32201503. doi:10.2217/fvl.12.126. （原始内容存档于2020-10-19）（英语）.
Greenough, Thomas C.; Babcock, Gregory J.; Roberts, Anjeanette; Hernandez, Hector J.; Thomas, Jr., William D.; Coccia, Jennifer A.; Graziano, Robert F.; Srinivasan, Mohan; Lowy, Israel. Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice. The Journal of Infectious Diseases. 2005-02-15, 191 (4): 507–514 [2021-02-21]. ISSN 0022-1899. PMC 7110081 . PMID 15655773. doi:10.1086/427242. （原始内容存档于2017-07-28）（英语）.
Roberts, Anjeanette; Thomas, William D.; Guarner, Jeannette; Lamirande, Elaine W.; Babcock, Gregory J.; Greenough, Thomas C.; Vogel, Leatrice; Hayes, Norman; Sullivan, John L. Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters. The Journal of Infectious Diseases. 2006-03, 193 (5): 685–692 [2021-02-21]. ISSN 0022-1899. PMC 7109703 . PMID 16453264. doi:10.1086/500143. （原始内容存档于2017-07-27）（英语）.
Shehata, Mahmoud M.; Gomaa, Mokhtar R.; Ali, Mohamed A.; Kayali, Ghazi. Middle East respiratory syndrome coronavirus: a comprehensive review. Frontiers of Medicine. 2016-06, 10 (2): 120–136. ISSN 2095-0217. PMC 7089261 . PMID 26791756. doi:10.1007/s11684-016-0430-6 （英语）.
Butler, Declan. SARS veterans tackle coronavirus. Nature. 2012-10, 490 (7418): 20–20 [2021-02-21]. ISSN 0028-0836. doi:10.1038/490020a. （原始内容存档于2021-11-06）（英语）.
Yong, Chean Yeah; Ong, Hui Kian; Yeap, Swee Keong; Ho, Kok Lian; Tan, Wen Siang. Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus. Frontiers in Microbiology. 2019-08-02, 10: 1781. ISSN 1664-302X. PMC 6688523 . PMID 31428074. doi:10.3389/fmicb.2019.01781.
Beaumont, Peter. Covid-19 vaccine: who are countries prioritising for first doses?. The Guardian. 2020-11-18 [2020-12-26]. ISSN 0261-3077. （原始内容存档于2021-01-18）.
Mullard, Asher. How COVID vaccines are being divvied up around the world. Nature. 2020-11-30: d41586–020–03370–6 [2021-02-21]. ISSN 0028-0836. PMID 33257891. doi:10.1038/d41586-020-03370-6. （原始内容存档于2021-02-24）（英语）.
So, Anthony D; Woo, Joshua. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. 2020-12-15: m4750 [2021-02-21]. ISSN 1756-1833. PMC 7735431 . PMID 33323376. doi:10.1136/bmj.m4750. （原始内容存档于2020-12-16）（英语）.
Fauci, Anthony S.; Lane, H. Clifford; Redfield, Robert R. Covid-19 — Navigating the Uncharted. New England Journal of Medicine. 2020-03-26, 382 (13): 1268–1269 [2021-02-21]. ISSN 0028-4793. PMC 7121221 . PMID 32109011. doi:10.1056/NEJMe2002387. （原始内容存档于2021-02-25）（英语）.
Gates, Bill. Responding to Covid-19 — A Once-in-a-Century Pandemic?. New England Journal of Medicine. 2020-04-30, 382 (18): 1677–1679 [2021-02-21]. ISSN 0028-4793. doi:10.1056/NEJMp2003762. （原始内容存档于2020-10-18）（英语）.
Tanriover, Mine Durusu; Doğanay, Hamdi Levent; Akova, Murat; Güner, Hatice Rahmet; Azap, Alpay; Akhan, Sıla; Köse, Şükran; Erdinç, Fatma Şebnem; Akalın, Emin Halis. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. The Lancet. 2021-07-17, 398 (10296): 213–222. ISSN 0140-6736. PMID 34246358. doi:10.1016/S0140-6736(21)01429-X （英语）.
Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M.; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults. JAMA. 2021-05-26 [2021-05-26]. ISSN 0098-7484. doi:10.1001/jama.2021.8565. （原始内容存档于2021-06-04）（英语）.
Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L.; Grousova, Daria M. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet (London, England). 2021-02-20, 397 (10275): 671–681 [2021-04-06]. ISSN 1474-547X. PMC 7852454 . PMID 33545094. doi:10.1016/S0140-6736(21)00234-8. （原始内容存档于2021-05-27）.
Anthes, Emily. The W.H.O. grants emergency authorization to the Johnson & Johnson vaccine, a boost for global vaccination efforts.. The New York Times. 2021-03-12 [2021-04-06]. ISSN 0362-4331. （原始内容存档于2021-04-28）（美国英语）.
Wadman, Meredith. Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.—but is less potent in South Africa. Science. 2021-01-28 [2021-04-06]. ISSN 0036-8075. doi:10.1126/science.abg8101. （原始内容存档于2021-05-25）.
Singanayagam, Anika; Hakki, Seran; Dunning, Jake; Madon, Kieran J.; Crone, Michael A.; Koycheva, Aleksandra; Derqui-Fernandez, Nieves; Barnett, Jack L.; Whitfield, Michael G. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet. Infectious Diseases. 2021-10-29: S1473–3099(21)00648–4 [2021-12-04]. ISSN 1474-4457. PMC 8554486 . PMID 34756186. doi:10.1016/S1473-3099(21)00648-4. （原始内容存档于2021-12-28）.
Singanayagam, Anika; Hakki, Seran; Dunning, Jake; Madon, Kieran J.; Crone, Michael A.; Koycheva, Aleksandra; Derqui-Fernandez, Nieves; Barnett, Jack L.; Whitfield, Michael G. ” transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet Infectious Diseases. 2021-10-29, 0 (0) [2021-12-04]. ISSN 1473-3099. PMID 34756186. doi:10.1016/S1473-3099(21)00648-4. （原始内容存档于2023-07-30）（英语）.
Greinacher, Andreas; Thiele, Thomas; Warkentin, Theodore E.; Weisser, Karin; Kyrle, Paul A.; Eichinger, Sabine. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. New England Journal of Medicine. 2021-06-03, 384 (22): 2092–2101. ISSN 0028-4793. PMC 8095372 . PMID 33835769. doi:10.1056/NEJMoa2104840.
Schultz, Nina H.; Sørvoll, Ingvild H.; Michelsen, Annika E.; Munthe, Ludvig A.; Lund-Johansen, Fridtjof; Ahlen, Maria T.; Wiedmann, Markus; Aamodt, Anne-Hege; Skattør, Thor H. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. New England Journal of Medicine. 2021-06-03, 384 (22): 2124–2130. ISSN 0028-4793. PMC 8112568 . PMID 33835768. doi:10.1056/NEJMoa2104882.
Weiland, Noah; LaFraniere, Sharon; Zimmer, Carl. U.S. Calls for Pause on Johnson & Johnson Vaccine After Clotting Cases. The New York Times. 2021-04-13 [2021-04-13]. ISSN 0362-4331. （原始内容存档于2021-06-07）（美国英语）.
Muir, Kate-Lynn; Kallam, Avyakta; Koepsell, Scott A.; Gundabolu, Krishna. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. New England Journal of Medicine. 2021-05-20, 384 (20): 1964–1965. ISSN 0028-4793. PMC 8063883 . PMID 33852795. doi:10.1056/NEJMc2105869.
LaFraniere, Sharon; Weiland, Noah. F.D.A. Will Attach Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine. The New York Times. 2021-07-12 [2021-07-12]. ISSN 0362-4331. （原始内容存档于2021-07-12）（美国英语）.
Board, The Editorial. Opinion | Biden’s Patent Gift to Beijing. Wall Street Journal. 2022-06-17 [2022-06-19]. ISSN 0099-9660. （原始内容存档于2022-06-19）（美国英语）.

wsj.com (Global: 79^th place; Chinese: 143^rd place)

cn.wsj.com

Hopkins, Jared S. 临床试验显示辉瑞新冠疫苗有效性超过90%. 华尔街日报中文网. [2021-02-21]. （原始内容存档于2020-11-29）（中文（中国大陆））.
Loftus, Peter. 强生新冠疫苗后期试验有效性66%，有望数周内在美国部署. 华尔街日报中文网. [2021-02-21]. （原始内容存档于2021-01-30）（中文（中国大陆））.
中国研发的新冠mRNA疫苗开始试生产. [2023-01-07]. （原始内容存档于2023-01-09）.
秘鲁允许重启之前暂停的中国国药集团新冠疫苗试验. [2020-12-20]. （原始内容存档于2020-12-17）.
英国批准牛津和阿斯利康研发的新冠疫苗紧急使用. [2021-01-03]. （原始内容存档于2020-12-30）.
Carlton, Jim. Moderna一批新冠疫苗引发潜在过敏反应后暂停接种，待接受评估. 华尔街日报中文网. [2021-02-21]. （原始内容存档于2021-01-19）（中文（中国大陆））.

wsj.com

AstraZeneca Defends Dosing Error in Covid-19 Vaccine Trial. 华尔街日报. 2020-11-25 [2020-11-26]. （原始内容存档于2021-10-22）.
Board, The Editorial. Opinion | Biden’s Patent Gift to Beijing. Wall Street Journal. 2022-06-17 [2022-06-19]. ISSN 0099-9660. （原始内容存档于2022-06-19）（美国英语）.

xhby.net (Global: low place; Chinese: 739^th place)

xhby.net

重大进展！中国生物二代重组蛋白新冠疫苗获批临床. [2022-04-04]. （原始内容存档于2022-04-18）.

news.xhby.net

阿根廷批准国药新冠疫苗在3至11岁儿童中紧急使用. [2021-10-17]. （原始内容存档于2021-10-19）.

xinhuanet.com (Global: 309^th place; Chinese: 19^th place)

陈静; 徐谦. 芬兰研发出鼻喷式新冠疫苗. 新华网. 2021-03-09 [2021-03-09]. （原始内容存档于2021-03-11）.
深圳康泰生物新冠灭活疫苗被纳入紧急使用. 新华网. 2021-05-15 [2021-05-15]. （原始内容存档于2021-05-15）.
中国科兴新冠疫苗获世卫组织紧急使用授权-新华网. [2021-06-02]. （原始内容存档于2021-06-03）.
宫若涵. 巴西公布科兴新冠疫苗Ⅲ期临床试验最终研究结果. 新华社. 2021-04-12 [2021-04-12]. （原始内容存档于2021-05-11）.
Maldives approves China's Sinopharm vaccine for emergency use. Xinhua. [2021-04-06]. （原始内容存档于2021-03-16）.
阿斯利康在美国获批恢复新冠疫苗临床试验. [2020-10-24]. （原始内容存档于2020-11-12）.
印度将免费为成年人接种新冠疫苗. [2021-06-09]. （原始内容存档于2021-06-10）.
印度批准紧急使用两种新冠疫苗的授权申请. [2021-01-03]. （原始内容存档于2021-01-09）.
泰国与中国企业签署新冠疫苗订购协议. 新华网. [2021-01-05]. （原始内容存档于2021-01-05）.
欧盟批准阿斯利康疫苗附条件上市-. 新华网. 2021-01-30 [2021-04-06]. （原始内容存档于2021-02-04）.
德国或9月开始接种新冠疫苗加强针. 新华网. 2021-08-03 [2021-08-30]. （原始内容存档于2021-08-03）.
朱婉君. 通讯：“我感到非常自豪”——记古巴医务工作者接种本土候选新冠疫苗. 新华网. 新华社. [2021-05-14]. （原始内容存档于2021-03-25）（中文（简体））.
埃及开始为医护人员接种中国国药集团新冠疫苗. [2021-01-25]. （原始内容存档于2021-01-26）.
澳大利亚批准12至15岁青少年接种辉瑞新冠疫苗. [2022-01-10]. （原始内容存档于2022-04-21）.
英国接种阿斯利康疫苗后死于血栓者升至32人-新华网. www.xinhuanet.com. [2021-06-11]. （原始内容存档于2021-04-28）.

xmnn.cn (Global: low place; Chinese: 1,840^th place)

news.xmnn.cn

古巴将于下月开始推进接种新冠疫苗加强针.
加拿大发生首起接种阿斯利康疫苗后血栓致死案例. [2021-04-28]. （原始内容存档于2021-04-30）.

yahoo.com (Global: 38^th place; Chinese: 9^th place)

news.yahoo.com

A Chinese mRNA COVID vaccine is approved for the first time - in Indonesia. [2022-10-01]. （原始内容存档于2022-11-28）.
South Africa approves China's Sinovac COVID-19 vaccine - health ministry. news.yahoo.com. [2021-08-30]. （原始内容存档于2021-07-12）（美国英语）.
Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use: regulator. news.yahoo.com. [2021-04-06]. （原始内容存档于2021-02-25）（美国英语）.

tw.news.yahoo.com

陸製疫苗出現嚴重不良反應巴西停止臨床試驗. 今日新聞NOWnews. [2020-11-10]. （原始内容存档于2020-11-10）.
6~11歲新冠疫苗最快下周一5/2接種. 大愛電視. 2022-04-26 [2022-05-03]. （原始内容存档于2022-05-03）.
韓國展開疫苗接種 200間療養設施優先. tw.news.yahoo.com. [2021-04-06] （中文（臺灣））.

finance.yahoo.com

Panama approves use of China's Sinovac vaccine against COVID-19. [2021-04-09]. （原始内容存档于2021-04-09）.
Bolivia has registered Sputnik V vaccine based on Russian clinical trial data. Yahoo！Finance. 2021-01-06 [2021-01-07]. （原始内容存档于2021-01-12）.

yicai.com (Global: low place; Chinese: 482^nd place)

沃森生物：新型冠状病毒变异株mRNA疫苗获批纳入紧急使用. 第一财经. 2023-12-01 [2023-12-01].
英国开始大规模接种新冠肺炎疫苗. 第一财经. [2020-12-09]. （原始内容存档于2020-12-09）.
泰国总理：年内将为半数国内民众免费接种疫苗. 第一财经. 2021-01-06 [2021-01-06].

youtube.com (Global: 9^th place; Chinese: 2^nd place)

Estudio "Efectividad de la vacuna CoronaVac con virus inactivado contra SARS-CoV-2 en Chile"tran [Study "Effectiveness of the CoronaVac vaccine with inactivated virus against SARS-CoV-2 in Chile"] (Online video). Ministry of Health (Chile). 事件发生在 10:12-13:42, 16:59-17:45. 2021-04-16 [2021-04-18]. （原始内容存档于2021-06-02）（西班牙语）.

zaobao.com (Global: 5,400^th place; Chinese: 195^th place)

zaobao.com.sg (Global: 2,796^th place; Chinese: 104^th place)

中国宣布加入冠病疫苗实施计划. [2020-10-09]. （原始内容存档于2020-11-07）.
蔡添成. 挪威23名逾80岁老人接种疫苗后死亡公卫局：高龄与患末期重症者或有高风险. 联合早报. 2021-01-16 [2021-01-17]. （原始内容存档于2021-01-24）.
陈慧璋, 文 /. 菲给予科兴疫苗使用授权但不建议医护人员使用. 早报. 2021-02-22 [2021-03-11]. （原始内容存档于2021-02-22）（中文（简体））.
中国国药冠病特异性治疗药物获批临床试验. [2021-09-04]. （原始内容存档于2021-09-13）.

zj.gov.cn (Global: low place; Chinese: 1,732^nd place)

浙江省人民政府门户网站浙江省新冠肺炎疫情防控工作新闻发布会（第七十一场）. www.zj.gov.cn. [2021-05-13]. （原始内容存档于2021-05-13）.

zytzb.gov.cn (Global: low place; Chinese: 4,270^th place)

澳门市民将自愿及免费接种新冠疫苗. 中共中央统一战线工作社. [2020-12-08]. （原始内容存档于2020-12-08）.

2019冠状病毒病疫苗 (Chinese Wikipedia)

246.250 (Global: low place; Chinese: low place)

202.100.246.250

881903.com (Global: low place; Chinese: 409th place)

8world.com (Global: low place; Chinese: 711th place)

aa.com.tr (Global: 754th place; Chinese: 2,412th place)

aastocks.com (Global: low place; Chinese: 2,162nd place)

aca.kp (Global: low place; Chinese: low place)

mirae.aca.kp

ahyouth.com (Global: low place; Chinese: low place)

aifa.gov.it (Global: low place; Chinese: low place)

aljazeera.com (Global: 268th place; Chinese: 470th place)

altimmune.com (Global: low place; Chinese: low place)

ir.altimmune.com

am730.com.hk (Global: 3,427th place; Chinese: 119th place)

anzctr.org.au (Global: low place; Chinese: low place)

apnews.com (Global: 129th place; Chinese: 436th place)

arabnews.com (Global: 1,365th place; Chinese: 3,762nd place)

asiaone.com (Global: 2,155th place; Chinese: 1,370th place)

astanatimes.com (Global: 8,381st place; Chinese: 9,590th place)

astrazeneca.com (Global: low place; Chinese: low place)

bbc.com (Global: 20th place; Chinese: 41st place)

bharatbiotech.com (Global: low place; Chinese: low place)

bio.org (Global: low place; Chinese: low place)

biomedcentral.com (Global: 2,747th place; Chinese: 1,988th place)

jbiomedsci.biomedcentral.com

bioworld.com (Global: low place; Chinese: low place)

bjnews.com.cn (Global: 1,192nd place; Chinese: 44th place)

bloomberg.com (Global: 99th place; Chinese: 225th place)

bmj.com (Global: 1,226th place; Chinese: 890th place)

bostonglobe.com (Global: 553rd place; Chinese: 1,930th place)

brecorder.com (Global: 4,490th place; Chinese: low place)

britannica.com (Global: 40th place; Chinese: 100th place)

businessinsider.com (Global: 140th place; Chinese: 399th place)

businesstimes.com.sg (Global: 9,172nd place; Chinese: 8,607th place)

buzzfeednews.com (Global: 1,368th place; Chinese: 4,144th place)

bworldonline.com (Global: 5,578th place; Chinese: low place)

caixin.com (Global: 7,276th place; Chinese: 307th place)

cbsnews.com (Global: 108th place; Chinese: 449th place)

cctv.com (Global: 2,386th place; Chinese: 101st place)

news.cctv.com

m.news.cctv.com

cecmed.cu (Global: low place; Chinese: low place)

cepi.net (Global: low place; Chinese: low place)

cfi.cn (Global: low place; Chinese: low place)

chictr.org.cn (Global: low place; Chinese: low place)

chinacourt.org (Global: low place; Chinese: 1,121st place)

chinadaily.com.cn (Global: 831st place; Chinese: 134th place)

language.chinadaily.com.cn

chinanews.com (Global: 1,432nd place; Chinese: 50th place)

chinanews.com.cn (Global: 2,979th place; Chinese: 106th place)

chinaqw.com (Global: low place; Chinese: 1,427th place)

chinatimes.com (Global: 440th place; Chinese: 14th place)

cincainews.com (Global: low place; Chinese: 1,806th place)

clinicaltrials.gov (Global: 5,225th place; Chinese: 4,888th place)

clinicaltrialsarena.com (Global: low place; Chinese: low place)

clinicaltrialsregister.eu (Global: low place; Chinese: low place)

cna.com.tw (Global: 527th place; Chinese: 24th place)

cnbc.com (Global: 220th place; Chinese: 426th place)

cnet.com (Global: 272nd place; Chinese: 459th place)

cnn.com (Global: 28th place; Chinese: 71st place)

cnnphilippines.com (Global: 2,993rd place; Chinese: 8,965th place)

cnstock.com (Global: low place; Chinese: 1,045th place)

news.cnstock.com

paper.cnstock.com

cnyes.com (Global: low place; Chinese: 371st place)

news.cnyes.com

colombogazette.com (Global: low place; Chinese: low place)

covidvaccine.gov.hk (Global: low place; Chinese: low place)

cri.cn (Global: 2,251st place; Chinese: 164th place)

news.cri.cn

ctri.nic.in (Global: low place; Chinese: low place)

curevac.com (Global: low place; Chinese: low place)

dailytimes.com.pk (Global: 1,625th place; Chinese: 3,690th place)

dhakatribune.com (Global: 2,157th place; Chinese: low place)

doi.org (Global: 2nd place; Chinese: 23rd place)

dw.com (Global: 204th place; Chinese: 124th place)

dwnews.com (Global: 4,516th place; Chinese: 180th place)

e-cspc.com (Global: low place; Chinese: low place)

ecns.cn (Global: low place; Chinese: low place)

881903.com (Global: low place; Chinese: 409^th place)

8world.com (Global: low place; Chinese: 711^th place)

aa.com.tr (Global: 754^th place; Chinese: 2,412^th place)

aastocks.com (Global: low place; Chinese: 2,162^nd place)

aljazeera.com (Global: 268^th place; Chinese: 470^th place)

am730.com.hk (Global: 3,427^th place; Chinese: 119^th place)

apnews.com (Global: 129^th place; Chinese: 436^th place)

arabnews.com (Global: 1,365^th place; Chinese: 3,762^nd place)

asiaone.com (Global: 2,155^th place; Chinese: 1,370^th place)

astanatimes.com (Global: 8,381^st place; Chinese: 9,590^th place)

bbc.com (Global: 20^th place; Chinese: 41^st place)

biomedcentral.com (Global: 2,747^th place; Chinese: 1,988^th place)

bjnews.com.cn (Global: 1,192^nd place; Chinese: 44^th place)

bloomberg.com (Global: 99^th place; Chinese: 225^th place)

bmj.com (Global: 1,226^th place; Chinese: 890^th place)

bostonglobe.com (Global: 553^rd place; Chinese: 1,930^th place)

brecorder.com (Global: 4,490^th place; Chinese: low place)

britannica.com (Global: 40^th place; Chinese: 100^th place)

businessinsider.com (Global: 140^th place; Chinese: 399^th place)

businesstimes.com.sg (Global: 9,172^nd place; Chinese: 8,607^th place)

buzzfeednews.com (Global: 1,368^th place; Chinese: 4,144^th place)

bworldonline.com (Global: 5,578^th place; Chinese: low place)

caixin.com (Global: 7,276^th place; Chinese: 307^th place)

cbsnews.com (Global: 108^th place; Chinese: 449^th place)

cctv.com (Global: 2,386^th place; Chinese: 101^st place)

chinacourt.org (Global: low place; Chinese: 1,121^st place)

chinadaily.com.cn (Global: 831^st place; Chinese: 134^th place)

chinanews.com (Global: 1,432^nd place; Chinese: 50^th place)

chinanews.com.cn (Global: 2,979^th place; Chinese: 106^th place)

chinaqw.com (Global: low place; Chinese: 1,427^th place)

chinatimes.com (Global: 440^th place; Chinese: 14^th place)

cincainews.com (Global: low place; Chinese: 1,806^th place)

clinicaltrials.gov (Global: 5,225^th place; Chinese: 4,888^th place)

cna.com.tw (Global: 527^th place; Chinese: 24^th place)

cnbc.com (Global: 220^th place; Chinese: 426^th place)

cnet.com (Global: 272^nd place; Chinese: 459^th place)

cnn.com (Global: 28^th place; Chinese: 71^st place)

cnnphilippines.com (Global: 2,993^rd place; Chinese: 8,965^th place)

cnstock.com (Global: low place; Chinese: 1,045^th place)

cnyes.com (Global: low place; Chinese: 371^st place)

cri.cn (Global: 2,251^st place; Chinese: 164^th place)

dailytimes.com.pk (Global: 1,625^th place; Chinese: 3,690^th place)

dhakatribune.com (Global: 2,157^th place; Chinese: low place)

doi.org (Global: 2^nd place; Chinese: 23^rd place)

dw.com (Global: 204^th place; Chinese: 124^th place)

dwnews.com (Global: 4,516^th place; Chinese: 180^th place)

elsevier.com (Global: 610^th place; Chinese: 388^th place)

ettoday.net (Global: 371^st place; Chinese: 7^th place)

eurasianet.org (Global: 3,649^th place; Chinese: 4,238^th place)

europa.eu (Global: 68^th place; Chinese: 209^th place)

exmoo.com (Global: low place; Chinese: 707^th place)

factcheck.org (Global: 7,075^th place; Chinese: low place)

fda.gov (Global: 447^th place; Chinese: 581^st place)

fda.gov.tw (Global: low place; Chinese: 1,125^th place)

firstpost.com (Global: 283^rd place; Chinese: 2,869^th place)

focustaiwan.tw (Global: 3,164^th place; Chinese: 1,453^rd place)

france24.com (Global: 481^st place; Chinese: 798^th place)

freezepage.com (Global: 5,120^th place; Chinese: 545^th place)

frontiersin.org (Global: 4,679^th place; Chinese: 2,220^th place)

ft.com (Global: 210^th place; Chinese: 353^rd place)

ftvnews.com.tw (Global: 6,057^th place; Chinese: 213^th place)

fx168.com (Global: low place; Chinese: 8,191^st place)

globaltimes.cn (Global: low place; Chinese: 1,577^th place)

go.com (Global: 48^th place; Chinese: 146^th place)

gov.cn (Global: 1,676^th place; Chinese: 62^nd place)

gov.mo (Global: low place; Chinese: 677^th place)

guancha.cn (Global: 4,433^rd place; Chinese: 170^th place)

harvard.edu (Global: 18^th place; Chinese: 57^th place)

hindustantimes.com (Global: 71^st place; Chinese: 1,063^rd place)

hk01.com (Global: 379^th place; Chinese: 11^th place)

hkej.com (Global: 8,654^th place; Chinese: 328^th place)

huanqiu.com (Global: 2,206^th place; Chinese: 65^th place)

ifeng.com (Global: 542^nd place; Chinese: 27^th place)

imperial.ac.uk (Global: 7,025^th place; Chinese: 4,775^th place)

indianexpress.com (Global: 60^th place; Chinese: 1,119^th place)

indiatoday.in (Global: 94^th place; Chinese: 1,782^nd place)

info.gov.hk (Global: 2,665^th place; Chinese: 114^th place)

inform.kz (Global: 4,199^th place; Chinese: 2,502^nd place)

irna.ir (Global: 643^rd place; Chinese: low place)

jamanetwork.com (Global: 2,650^th place; Chinese: 1,976^th place)